id	sid	tid	token	lemma	pos
iajs-3307	1	1	86	86	NUM
iajs-3307	1	2	this	this	DET
iajs-3307	1	3	work	work	NOUN
iajs-3307	1	4	is	be	AUX
iajs-3307	1	5	licensed	license	VERB
iajs-3307	1	6	under	under	ADP
iajs-3307	1	7	a	a	DET
iajs-3307	1	8	creative	creative	ADJ
iajs-3307	1	9	commons	common	NOUN
iajs-3307	1	10	attribution	attribution	NOUN
iajs-3307	1	11	4.0	4.0	NUM
iajs-3307	1	12	international	international	ADJ
iajs-3307	1	13	license	license	NOUN
iajs-3307	1	14	ihjpas	ihjpa	NOUN
iajs-3307	1	15	.	.	PUNCT
iajs-3307	2	1	37	37	NUM
iajs-3307	2	2	(	(	PUNCT
iajs-3307	2	3	1	1	NUM
iajs-3307	2	4	)	)	PUNCT
iajs-3307	2	5	2024	2024	NUM
iajs-3307	2	6	ibn	ibn	PROPN
iajs-3307	2	7	al	al	PROPN
iajs-3307	2	8	-	-	PUNCT
iajs-3307	2	9	haitham	haitham	PROPN
iajs-3307	2	10	journal	journal	PROPN
iajs-3307	2	11	for	for	ADP
iajs-3307	2	12	pure	pure	ADJ
iajs-3307	2	13	and	and	CCONJ
iajs-3307	2	14	applied	applied	ADJ
iajs-3307	2	15	sciences	sciences	PROPN
iajs-3307	2	16	journal	journal	PROPN
iajs-3307	2	17	homepage	homepage	NOUN
iajs-3307	2	18	:	:	PUNCT
iajs-3307	2	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3307	2	20	pissn	pissn	ADJ
iajs-3307	2	21	:	:	PUNCT
iajs-3307	2	22	1609	1609	NUM
iajs-3307	2	23	-	-	SYM
iajs-3307	2	24	4042	4042	NUM
iajs-3307	2	25	,	,	PUNCT
iajs-3307	2	26	eissn	eissn	NOUN
iajs-3307	2	27	:	:	PUNCT
iajs-3307	2	28	2521	2521	NUM
iajs-3307	2	29	-	-	SYM
iajs-3307	2	30	3407	3407	NUM
iajs-3307	2	31	1sura	1sura	NUM
iajs-3307	2	32	fouad	fouad	PROPN
iajs-3307	2	33	alsaffar	alsaffar	PROPN
iajs-3307	2	34	*	*	PROPN
iajs-3307	3	1	2sara	2sara	NUM
iajs-3307	3	2	khaleel	khaleel	NOUN
iajs-3307	3	3	ibrahim	ibrahim	PROPN
iajs-3307	3	4	*	*	PUNCT
iajs-3307	3	5	corresponding	correspond	VERB
iajs-3307	3	6	author	author	NOUN
iajs-3307	3	7	:	:	PUNCT
iajs-3307	3	8	suraa.alsaffar@sc.uobaghdad.edu.iq	suraa.alsaffar@sc.uobaghdad.edu.iq	PROPN
iajs-3307	3	9	abstract	abstract	ADJ
iajs-3307	3	10	polycystic	polycystic	ADJ
iajs-3307	3	11	ovarian	ovarian	ADJ
iajs-3307	3	12	syndrome	syndrome	NOUN
iajs-3307	3	13	(	(	PUNCT
iajs-3307	3	14	pcos	pcos	PROPN
iajs-3307	3	15	)	)	PUNCT
iajs-3307	3	16	is	be	AUX
iajs-3307	3	17	a	a	DET
iajs-3307	3	18	well	well	ADV
iajs-3307	3	19	-	-	PUNCT
iajs-3307	3	20	known	know	VERB
iajs-3307	3	21	endocrinopathy	endocrinopathy	ADJ
iajs-3307	3	22	and	and	CCONJ
iajs-3307	3	23	one	one	NUM
iajs-3307	3	24	of	of	ADP
iajs-3307	3	25	the	the	DET
iajs-3307	3	26	most	most	ADV
iajs-3307	3	27	frequent	frequent	ADJ
iajs-3307	3	28	endocrine	endocrine	NOUN
iajs-3307	3	29	-	-	PUNCT
iajs-3307	3	30	reproductive	reproductive	ADJ
iajs-3307	3	31	-	-	PUNCT
iajs-3307	3	32	metabolic	metabolic	NOUN
iajs-3307	3	33	syndromes	syndrome	NOUN
iajs-3307	3	34	in	in	ADP
iajs-3307	3	35	women	woman	NOUN
iajs-3307	3	36	,	,	PUNCT
iajs-3307	3	37	which	which	PRON
iajs-3307	3	38	can	can	AUX
iajs-3307	3	39	result	result	VERB
iajs-3307	3	40	in	in	ADP
iajs-3307	3	41	reduced	reduced	ADJ
iajs-3307	3	42	fertility	fertility	NOUN
iajs-3307	3	43	.	.	PUNCT
iajs-3307	4	1	while	while	SCONJ
iajs-3307	4	2	the	the	DET
iajs-3307	4	3	actual	actual	ADJ
iajs-3307	4	4	cause	cause	NOUN
iajs-3307	4	5	is	be	AUX
iajs-3307	4	6	unknown	unknown	ADJ
iajs-3307	4	7	,	,	PUNCT
iajs-3307	4	8	pcos	pcos	PROPN
iajs-3307	4	9	is	be	AUX
iajs-3307	4	10	regarded	regard	VERB
iajs-3307	4	11	as	as	ADP
iajs-3307	4	12	a	a	DET
iajs-3307	4	13	complicated	complicated	ADJ
iajs-3307	4	14	genetic	genetic	ADJ
iajs-3307	4	15	characteristic	characteristic	NOUN
iajs-3307	4	16	with	with	ADP
iajs-3307	4	17	a	a	DET
iajs-3307	4	18	great	great	ADJ
iajs-3307	4	19	degree	degree	NOUN
iajs-3307	4	20	of	of	ADP
iajs-3307	4	21	variability	variability	NOUN
iajs-3307	4	22	.	.	PUNCT
iajs-3307	5	1	moreover	moreover	ADV
iajs-3307	5	2	,	,	PUNCT
iajs-3307	5	3	hormones	hormone	NOUN
iajs-3307	5	4	and	and	CCONJ
iajs-3307	5	5	immune	immune	ADJ
iajs-3307	5	6	cells	cell	NOUN
iajs-3307	5	7	,	,	PUNCT
iajs-3307	5	8	including	include	VERB
iajs-3307	5	9	both	both	CCONJ
iajs-3307	5	10	innate	innate	ADJ
iajs-3307	5	11	and	and	CCONJ
iajs-3307	5	12	acquired	acquire	VERB
iajs-3307	5	13	immune	immune	ADJ
iajs-3307	5	14	cells	cell	NOUN
iajs-3307	5	15	,	,	PUNCT
iajs-3307	5	16	are	be	AUX
iajs-3307	5	17	thought	think	VERB
iajs-3307	5	18	to	to	PART
iajs-3307	5	19	interact	interact	VERB
iajs-3307	5	20	in	in	ADP
iajs-3307	5	21	pcos	pcos	PROPN
iajs-3307	5	22	.	.	PUNCT
iajs-3307	6	1	chronic	chronic	ADJ
iajs-3307	6	2	low	low	ADJ
iajs-3307	6	3	-	-	PUNCT
iajs-3307	6	4	grade	grade	NOUN
iajs-3307	6	5	inflammation	inflammation	NOUN
iajs-3307	6	6	raises	raise	VERB
iajs-3307	6	7	the	the	DET
iajs-3307	6	8	risk	risk	NOUN
iajs-3307	6	9	of	of	ADP
iajs-3307	6	10	autoimmune	autoimmune	ADJ
iajs-3307	6	11	disease	disease	NOUN
iajs-3307	6	12	.	.	PUNCT
iajs-3307	7	1	the	the	DET
iajs-3307	7	2	study	study	NOUN
iajs-3307	7	3	's	's	PART
iajs-3307	7	4	purpose	purpose	NOUN
iajs-3307	7	5	is	be	AUX
iajs-3307	7	6	to	to	PART
iajs-3307	7	7	investigate	investigate	VERB
iajs-3307	7	8	the	the	DET
iajs-3307	7	9	chemokine	chemokine	ADJ
iajs-3307	7	10	monocyte	monocyte	NOUN
iajs-3307	7	11	chemoattractant	chemoattractant	PROPN
iajs-3307	7	12	protein-1	protein-1	PROPN
iajs-3307	7	13	(	(	PUNCT
iajs-3307	7	14	mcp-1	mcp-1	NOUN
iajs-3307	7	15	)	)	PUNCT
iajs-3307	7	16	and	and	CCONJ
iajs-3307	7	17	fertility	fertility	NOUN
iajs-3307	7	18	hormones	hormone	NOUN
iajs-3307	7	19	in	in	ADP
iajs-3307	7	20	samples	sample	NOUN
iajs-3307	7	21	of	of	ADP
iajs-3307	7	22	women	woman	NOUN
iajs-3307	7	23	patients	patient	NOUN
iajs-3307	7	24	with	with	ADP
iajs-3307	7	25	polycystic	polycystic	ADJ
iajs-3307	7	26	ovary	ovary	ADJ
iajs-3307	7	27	syndrome	syndrome	NOUN
iajs-3307	7	28	(	(	PUNCT
iajs-3307	7	29	pcos	pcos	PROPN
iajs-3307	7	30	)	)	PUNCT
iajs-3307	7	31	in	in	ADP
iajs-3307	7	32	the	the	DET
iajs-3307	7	33	city	city	NOUN
iajs-3307	7	34	of	of	ADP
iajs-3307	7	35	medicine	medicine	NOUN
iajs-3307	7	36	.	.	PUNCT
iajs-3307	8	1	sixty	sixty	NUM
iajs-3307	8	2	pcos	pcos	PROPN
iajs-3307	8	3	women	woman	NOUN
iajs-3307	8	4	comprise	comprise	VERB
iajs-3307	8	5	30	30	NUM
iajs-3307	8	6	healthy	healthy	ADJ
iajs-3307	8	7	control	control	NOUN
iajs-3307	8	8	women	woman	NOUN
iajs-3307	8	9	;	;	PUNCT
iajs-3307	8	10	their	their	PRON
iajs-3307	8	11	average	average	ADJ
iajs-3307	8	12	age	age	NOUN
iajs-3307	8	13	was	be	AUX
iajs-3307	8	14	20–40	20–40	NUM
iajs-3307	8	15	years	year	NOUN
iajs-3307	8	16	,	,	PUNCT
iajs-3307	8	17	and	and	CCONJ
iajs-3307	8	18	their	their	PRON
iajs-3307	8	19	weight	weight	NOUN
iajs-3307	8	20	ranged	range	VERB
iajs-3307	8	21	from	from	ADP
iajs-3307	8	22	60	60	NUM
iajs-3307	8	23	to	to	PART
iajs-3307	8	24	100	100	NUM
iajs-3307	8	25	kg	kg	NOUN
iajs-3307	8	26	.	.	PUNCT
iajs-3307	9	1	the	the	DET
iajs-3307	9	2	results	result	NOUN
iajs-3307	9	3	showed	show	VERB
iajs-3307	9	4	an	an	DET
iajs-3307	9	5	increase	increase	NOUN
iajs-3307	9	6	in	in	ADP
iajs-3307	9	7	the	the	DET
iajs-3307	9	8	level	level	NOUN
iajs-3307	9	9	of	of	ADP
iajs-3307	9	10	mcp1	mcp1	PROPN
iajs-3307	9	11	in	in	ADP
iajs-3307	9	12	pcos	pcos	PROPN
iajs-3307	9	13	patients	patient	NOUN
iajs-3307	9	14	,	,	PUNCT
iajs-3307	9	15	but	but	CCONJ
iajs-3307	9	16	this	this	DET
iajs-3307	9	17	increase	increase	NOUN
iajs-3307	9	18	was	be	AUX
iajs-3307	9	19	not	not	PART
iajs-3307	9	20	significant	significant	ADJ
iajs-3307	9	21	(	(	PUNCT
iajs-3307	9	22	p<0.05	p<0.05	NOUN
iajs-3307	9	23	)	)	PUNCT
iajs-3307	9	24	,	,	PUNCT
iajs-3307	9	25	which	which	PRON
iajs-3307	9	26	was	be	AUX
iajs-3307	9	27	not	not	PART
iajs-3307	9	28	influenced	influence	VERB
iajs-3307	9	29	by	by	ADP
iajs-3307	9	30	bmi	bmi	NOUN
iajs-3307	9	31	or	or	CCONJ
iajs-3307	9	32	fertility	fertility	NOUN
iajs-3307	9	33	hormones	hormone	NOUN
iajs-3307	9	34	.	.	PUNCT
iajs-3307	10	1	as	as	ADV
iajs-3307	10	2	well	well	ADV
iajs-3307	10	3	as	as	ADP
iajs-3307	10	4	elevated	elevated	ADJ
iajs-3307	10	5	fertility	fertility	NOUN
iajs-3307	10	6	hormones	hormone	NOUN
iajs-3307	10	7	,	,	PUNCT
iajs-3307	10	8	this	this	DET
iajs-3307	10	9	study	study	NOUN
iajs-3307	10	10	,	,	PUNCT
iajs-3307	10	11	when	when	SCONJ
iajs-3307	10	12	compared	compare	VERB
iajs-3307	10	13	to	to	ADP
iajs-3307	10	14	controls	control	NOUN
iajs-3307	10	15	as	as	ADV
iajs-3307	10	16	well	well	ADV
iajs-3307	10	17	as	as	ADP
iajs-3307	10	18	patients	patient	NOUN
iajs-3307	10	19	with	with	ADP
iajs-3307	10	20	pcos	pco	NOUN
iajs-3307	10	21	,	,	PUNCT
iajs-3307	10	22	showed	show	VERB
iajs-3307	10	23	a	a	DET
iajs-3307	10	24	significant	significant	ADJ
iajs-3307	10	25	increase	increase	NOUN
iajs-3307	10	26	in	in	ADP
iajs-3307	10	27	the	the	DET
iajs-3307	10	28	level	level	NOUN
iajs-3307	10	29	of	of	ADP
iajs-3307	10	30	testosterone	testosterone	NOUN
iajs-3307	10	31	(	(	PUNCT
iajs-3307	10	32	14.63	14.63	NUM
iajs-3307	10	33	±2.30	±2.30	PROPN
iajs-3307	10	34	nmol	nmol	PROPN
iajs-3307	10	35	/	/	SYM
iajs-3307	10	36	l	l	NOUN
iajs-3307	10	37	)	)	PUNCT
iajs-3307	10	38	while	while	SCONJ
iajs-3307	10	39	in	in	ADP
iajs-3307	10	40	control	control	NOUN
iajs-3307	10	41	women	woman	NOUN
iajs-3307	10	42	(	(	PUNCT
iajs-3307	10	43	0.627	0.627	NUM
iajs-3307	10	44	±0.04	±0.04	PROPN
iajs-3307	10	45	)	)	PUNCT
iajs-3307	10	46	,	,	PUNCT
iajs-3307	10	47	lh	lh	PROPN
iajs-3307	10	48	hormone	hormone	NOUN
iajs-3307	10	49	in	in	ADP
iajs-3307	10	50	patients	patient	NOUN
iajs-3307	10	51	and	and	CCONJ
iajs-3307	10	52	control	control	NOUN
iajs-3307	10	53	group	group	NOUN
iajs-3307	10	54	(	(	PUNCT
iajs-3307	10	55	6.54	6.54	NUM
iajs-3307	10	56	±0.51	±0.51	PROPN
iajs-3307	10	57	miu	miu	PROPN
iajs-3307	10	58	/	/	SYM
iajs-3307	10	59	ml	ml	PROPN
iajs-3307	10	60	)	)	PUNCT
iajs-3307	10	61	,	,	PUNCT
iajs-3307	10	62	and	and	CCONJ
iajs-3307	10	63	2.93	2.93	NUM
iajs-3307	10	64	±0.18	±0.18	NOUN
iajs-3307	10	65	,	,	PUNCT
iajs-3307	10	66	respectively	respectively	ADV
iajs-3307	10	67	.	.	PUNCT
iajs-3307	11	1	prolactin	prolactin	ADJ
iajs-3307	11	2	hormone	hormone	NOUN
iajs-3307	11	3	was	be	AUX
iajs-3307	11	4	increased	increase	VERB
iajs-3307	11	5	in	in	ADP
iajs-3307	11	6	pcos	pcos	NOUN
iajs-3307	11	7	patients	patient	NOUN
iajs-3307	11	8	(	(	PUNCT
iajs-3307	11	9	16.27	16.27	NUM
iajs-3307	11	10	±1.25	±1.25	PROPN
iajs-3307	11	11	ng	ng	PROPN
iajs-3307	11	12	/	/	SYM
iajs-3307	11	13	ml	ml	NOUN
iajs-3307	11	14	)	)	PUNCT
iajs-3307	11	15	when	when	SCONJ
iajs-3307	11	16	compared	compare	VERB
iajs-3307	11	17	to	to	ADP
iajs-3307	11	18	the	the	DET
iajs-3307	11	19	control	control	NOUN
iajs-3307	11	20	group	group	NOUN
iajs-3307	11	21	\	\	PROPN
iajs-3307	11	22	(	(	PUNCT
iajs-3307	11	23	12.85	12.85	NUM
iajs-3307	11	24	±0.62	±0.62	NOUN
iajs-3307	11	25	)	)	PUNCT
iajs-3307	11	26	.	.	PUNCT
iajs-3307	12	1	there	there	PRON
iajs-3307	12	2	was	be	VERB
iajs-3307	12	3	no	no	DET
iajs-3307	12	4	significant	significant	ADJ
iajs-3307	12	5	difference	difference	NOUN
iajs-3307	12	6	in	in	ADP
iajs-3307	12	7	fsh	fsh	ADJ
iajs-3307	12	8	hormone	hormone	NOUN
iajs-3307	12	9	in	in	ADP
iajs-3307	12	10	women	woman	NOUN
iajs-3307	12	11	with	with	ADP
iajs-3307	12	12	pcos	pcos	PROPN
iajs-3307	12	13	(	(	PUNCT
iajs-3307	12	14	5.27	5.27	NUM
iajs-3307	12	15	±0.28	±0.28	PROPN
iajs-3307	12	16	miu	miu	PROPN
iajs-3307	12	17	/	/	SYM
iajs-3307	12	18	ml	ml	NOUN
iajs-3307	12	19	)	)	PUNCT
iajs-3307	12	20	compared	compare	VERB
iajs-3307	12	21	with	with	ADP
iajs-3307	12	22	the	the	DET
iajs-3307	12	23	control	control	NOUN
iajs-3307	12	24	group	group	NOUN
iajs-3307	12	25	(	(	PUNCT
iajs-3307	12	26	5.59	5.59	NUM
iajs-3307	12	27	±0.18	±0.18	NOUN
iajs-3307	12	28	)	)	PUNCT
iajs-3307	12	29	.	.	PUNCT
iajs-3307	13	1	keywords	keyword	NOUN
iajs-3307	13	2	:	:	PUNCT
iajs-3307	13	3	pcos	pco	NOUN
iajs-3307	13	4	,	,	PUNCT
iajs-3307	13	5	mcp-1	mcp-1	NOUN
iajs-3307	13	6	,	,	PUNCT
iajs-3307	13	7	testosterone	testosterone	NOUN
iajs-3307	13	8	,	,	PUNCT
iajs-3307	13	9	prolactin	prolactin	NOUN
iajs-3307	13	10	,	,	PUNCT
iajs-3307	13	11	lh	lh	PROPN
iajs-3307	13	12	,	,	PUNCT
iajs-3307	13	13	fsh	fsh	NOUN
iajs-3307	13	14	.	.	PUNCT
iajs-3307	14	1	1	1	X
iajs-3307	14	2	.	.	X
iajs-3307	14	3	introduction	introduction	NOUN
iajs-3307	14	4	polycystic	polycystic	ADJ
iajs-3307	14	5	ovarian	ovarian	ADJ
iajs-3307	14	6	syndrome	syndrome	NOUN
iajs-3307	14	7	(	(	PUNCT
iajs-3307	14	8	pcos	pcos	PROPN
iajs-3307	14	9	)	)	PUNCT
iajs-3307	14	10	is	be	AUX
iajs-3307	14	11	a	a	DET
iajs-3307	14	12	hormonal	hormonal	ADJ
iajs-3307	14	13	condition	condition	NOUN
iajs-3307	14	14	that	that	PRON
iajs-3307	14	15	is	be	AUX
iajs-3307	14	16	linked	link	VERB
iajs-3307	14	17	with	with	ADP
iajs-3307	14	18	a	a	DET
iajs-3307	14	19	number	number	NOUN
iajs-3307	14	20	of	of	ADP
iajs-3307	14	21	metabolic	metabolic	NOUN
iajs-3307	14	22	disorders	disorder	NOUN
iajs-3307	14	23	,	,	PUNCT
iajs-3307	14	24	including	include	VERB
iajs-3307	14	25	impaired	impaired	ADJ
iajs-3307	14	26	insulin	insulin	NOUN
iajs-3307	14	27	resistance	resistance	NOUN
iajs-3307	14	28	and	and	CCONJ
iajs-3307	14	29	glucose	glucose	NOUN
iajs-3307	14	30	metabolism	metabolism	NOUN
iajs-3307	14	31	.	.	PUNCT
iajs-3307	15	1	pcos	pcos	PROPN
iajs-3307	15	2	is	be	AUX
iajs-3307	15	3	also	also	ADV
iajs-3307	15	4	linked	link	VERB
iajs-3307	15	5	to	to	ADP
iajs-3307	15	6	an	an	DET
iajs-3307	15	7	increased	increase	VERB
iajs-3307	15	8	chance	chance	NOUN
iajs-3307	15	9	of	of	ADP
iajs-3307	15	10	developing	develop	VERB
iajs-3307	15	11	type	type	NOUN
iajs-3307	15	12	2	2	NUM
iajs-3307	15	13	diabetes	diabetes	NOUN
iajs-3307	15	14	,	,	PUNCT
iajs-3307	15	15	dyslipidemia	dyslipidemia	NOUN
iajs-3307	15	16	,	,	PUNCT
iajs-3307	15	17	and	and	CCONJ
iajs-3307	15	18	cardiovascular	cardiovascular	ADJ
iajs-3307	15	19	disorders	disorder	NOUN
iajs-3307	15	20	such	such	ADJ
iajs-3307	15	21	as	as	ADP
iajs-3307	15	22	hypertension	hypertension	NOUN
iajs-3307	15	23	and	and	CCONJ
iajs-3307	15	24	atherosclerosis	atherosclerosis	NOUN
iajs-3307	15	25	[	[	X
iajs-3307	15	26	1	1	NUM
iajs-3307	15	27	]	]	PUNCT
iajs-3307	15	28	.	.	PUNCT
iajs-3307	16	1	pcos	pcos	PROPN
iajs-3307	16	2	clinical	clinical	ADJ
iajs-3307	16	3	signs	sign	NOUN
iajs-3307	16	4	include	include	VERB
iajs-3307	16	5	clinical	clinical	ADJ
iajs-3307	16	6	or	or	CCONJ
iajs-3307	16	7	biochemical	biochemical	ADJ
iajs-3307	16	8	hyperandrogenism	hyperandrogenism	NOUN
iajs-3307	16	9	,	,	PUNCT
iajs-3307	16	10	polycystic	polycystic	ADJ
iajs-3307	16	11	ovaries	ovary	NOUN
iajs-3307	16	12	on	on	ADP
iajs-3307	16	13	ultrasonography	ultrasonography	NOUN
iajs-3307	16	14	,	,	PUNCT
iajs-3307	16	15	ovulatory	ovulatory	ADJ
iajs-3307	16	16	dysfunction	dysfunction	NOUN
iajs-3307	16	17	,	,	PUNCT
iajs-3307	16	18	doi.org/10.30526/37.1.3307	doi.org/10.30526/37.1.3307	NOUN
iajs-3307	16	19	received	receive	VERB
iajs-3307	16	20	5	5	NUM
iajs-3307	16	21	march	march	NOUN
iajs-3307	16	22	2023	2023	NUM
iajs-3307	16	23	,	,	PUNCT
iajs-3307	16	24	received	receive	VERB
iajs-3307	16	25	18	18	NUM
iajs-3307	16	26	april	april	PROPN
iajs-3307	16	27	2023	2023	NUM
iajs-3307	16	28	,	,	PUNCT
iajs-3307	16	29	accepted	accept	VERB
iajs-3307	16	30	25	25	NUM
iajs-3307	16	31	april	april	PROPN
iajs-3307	16	32	2023	2023	NUM
iajs-3307	16	33	,	,	PUNCT
iajs-3307	16	34	published	publish	VERB
iajs-3307	16	35	in	in	ADP
iajs-3307	16	36	20	20	NUM
iajs-3307	16	37	january	january	NOUN
iajs-3307	16	38	2024	2024	NUM
iajs-3307	16	39	assessment	assessment	NOUN
iajs-3307	16	40	of	of	ADP
iajs-3307	16	41	monocyte	monocyte	PROPN
iajs-3307	16	42	chemoattractant	chemoattractant	PROPN
iajs-3307	16	43	protein-1	protein-1	PROPN
iajs-3307	16	44	and	and	CCONJ
iajs-3307	16	45	fertility	fertility	NOUN
iajs-3307	16	46	hormones	hormone	NOUN
iajs-3307	16	47	in	in	ADP
iajs-3307	16	48	iraqi	iraqi	ADJ
iajs-3307	16	49	women	woman	NOUN
iajs-3307	16	50	with	with	ADP
iajs-3307	16	51	polycystic	polycystic	ADJ
iajs-3307	16	52	ovarian	ovarian	ADJ
iajs-3307	16	53	syndrome	syndrome	NOUN
iajs-3307	16	54	1,2department	1,2department	NUM
iajs-3307	16	55	of	of	ADP
iajs-3307	16	56	biology	biology	NOUN
iajs-3307	16	57	,	,	PUNCT
iajs-3307	16	58	college	college	NOUN
iajs-3307	16	59	of	of	ADP
iajs-3307	16	60	science	science	NOUN
iajs-3307	16	61	,	,	PUNCT
iajs-3307	16	62	university	university	NOUN
iajs-3307	16	63	of	of	ADP
iajs-3307	16	64	baghdad	baghdad	PROPN
iajs-3307	16	65	,	,	PUNCT
iajs-3307	16	66	baghdad	baghdad	PROPN
iajs-3307	16	67	,	,	PUNCT
iajs-3307	16	68	iraq	iraq	PROPN
iajs-3307	16	69	.	.	PUNCT
iajs-3307	17	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3307	17	2	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3307	17	3	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	VERB
iajs-3307	17	4	mailto:suraa.alsaffar@sc.uobaghdad.edu.iq	mailto:suraa.alsaffar@sc.uobaghdad.edu.iq	NUM
iajs-3307	17	5	https://orcid.org/0000-0002-4657-9404	https://orcid.org/0000-0002-4657-9404	PROPN
iajs-3307	17	6	mailto:suraa.alsaffar@sc.uobaghdad.edu.iq	mailto:suraa.alsaffar@sc.uobaghdad.edu.iq	PROPN
iajs-3307	17	7	https://orcid.org/0000-0000-0000-0000	https://orcid.org/0000-0000-0000-0000	PROPN
iajs-3307	17	8	mailto:alhalbosesarahkhaleel@gmail.com	mailto:alhalbosesarahkhaleel@gmail.com	NOUN
iajs-3307	17	9	ihjpas	ihjpas	PROPN
iajs-3307	17	10	.	.	PUNCT
iajs-3307	18	1	37	37	NUM
iajs-3307	18	2	(	(	PUNCT
iajs-3307	18	3	1	1	NUM
iajs-3307	18	4	)	)	PUNCT
iajs-3307	18	5	2024	2024	NUM
iajs-3307	18	6	87	87	NUM
iajs-3307	18	7	and	and	CCONJ
iajs-3307	18	8	obesity	obesity	NOUN
iajs-3307	19	1	[	[	X
iajs-3307	19	2	2	2	NUM
iajs-3307	19	3	]	]	PUNCT
iajs-3307	19	4	.	.	PUNCT
iajs-3307	20	1	pcos	pcos	PROPN
iajs-3307	20	2	affects	affect	VERB
iajs-3307	20	3	6%–10	6%–10	NUM
iajs-3307	20	4	%	%	NOUN
iajs-3307	20	5	of	of	ADP
iajs-3307	20	6	reproductive	reproductive	ADJ
iajs-3307	20	7	-	-	PUNCT
iajs-3307	20	8	age	age	NOUN
iajs-3307	20	9	women	woman	NOUN
iajs-3307	20	10	and	and	CCONJ
iajs-3307	20	11	is	be	AUX
iajs-3307	20	12	the	the	DET
iajs-3307	20	13	most	most	ADV
iajs-3307	20	14	common	common	ADJ
iajs-3307	20	15	cause	cause	NOUN
iajs-3307	20	16	of	of	ADP
iajs-3307	20	17	infertility	infertility	NOUN
iajs-3307	20	18	[	[	X
iajs-3307	20	19	3	3	NUM
iajs-3307	20	20	]	]	PUNCT
iajs-3307	20	21	.	.	PUNCT
iajs-3307	21	1	there	there	PRON
iajs-3307	21	2	is	be	VERB
iajs-3307	21	3	evidence	evidence	NOUN
iajs-3307	21	4	that	that	SCONJ
iajs-3307	21	5	pcos	pcos	PROPN
iajs-3307	21	6	is	be	AUX
iajs-3307	21	7	also	also	ADV
iajs-3307	21	8	a	a	DET
iajs-3307	21	9	proinflammatory	proinflammatory	ADJ
iajs-3307	21	10	condition	condition	NOUN
iajs-3307	21	11	,	,	PUNCT
iajs-3307	21	12	with	with	ADP
iajs-3307	21	13	chronic	chronic	ADJ
iajs-3307	21	14	low	low	ADJ
iajs-3307	21	15	-	-	PUNCT
iajs-3307	21	16	grade	grade	NOUN
iajs-3307	21	17	inflammation	inflammation	NOUN
iajs-3307	21	18	and	and	CCONJ
iajs-3307	21	19	elevated	elevated	ADJ
iajs-3307	21	20	levels	level	NOUN
iajs-3307	21	21	of	of	ADP
iajs-3307	21	22	many	many	ADJ
iajs-3307	21	23	inflammatory	inflammatory	ADJ
iajs-3307	21	24	cytokines	cytokine	NOUN
iajs-3307	21	25	linked	link	VERB
iajs-3307	21	26	to	to	ADP
iajs-3307	21	27	insulin	insulin	NOUN
iajs-3307	21	28	resistance	resistance	NOUN
iajs-3307	21	29	(	(	PUNCT
iajs-3307	21	30	ir	ir	NOUN
iajs-3307	21	31	)	)	PUNCT
iajs-3307	21	32	.	.	PUNCT
iajs-3307	22	1	diabetes	diabetes	NOUN
iajs-3307	22	2	mellitus	mellitus	NOUN
iajs-3307	22	3	and	and	CCONJ
iajs-3307	22	4	obesity	obesity	NOUN
iajs-3307	22	5	have	have	AUX
iajs-3307	22	6	also	also	ADV
iajs-3307	22	7	been	be	AUX
iajs-3307	22	8	linked	link	VERB
iajs-3307	22	9	to	to	ADP
iajs-3307	22	10	the	the	DET
iajs-3307	22	11	condition	condition	NOUN
iajs-3307	22	12	[	[	X
iajs-3307	22	13	4	4	NUM
iajs-3307	22	14	]	]	PUNCT
iajs-3307	22	15	.	.	PUNCT
iajs-3307	23	1	the	the	DET
iajs-3307	23	2	monocyte	monocyte	PROPN
iajs-3307	23	3	chemoattractant	chemoattractant	PROPN
iajs-3307	23	4	protein-1	protein-1	PROPN
iajs-3307	23	5	(	(	PUNCT
iajs-3307	23	6	mcp-1	mcp-1	NOUN
iajs-3307	23	7	)	)	PUNCT
iajs-3307	23	8	is	be	AUX
iajs-3307	23	9	a	a	DET
iajs-3307	23	10	secretory	secretory	ADJ
iajs-3307	23	11	chemokine	chemokine	NOUN
iajs-3307	23	12	encoded	encode	VERB
iajs-3307	23	13	by	by	ADP
iajs-3307	23	14	the	the	DET
iajs-3307	23	15	ccl2	ccl2	PROPN
iajs-3307	23	16	gene	gene	NOUN
iajs-3307	23	17	on	on	ADP
iajs-3307	23	18	chromosome	chromosome	NOUN
iajs-3307	23	19	17	17	NUM
iajs-3307	23	20	.	.	PUNCT
iajs-3307	24	1	it	it	PRON
iajs-3307	24	2	has	have	VERB
iajs-3307	24	3	76	76	NUM
iajs-3307	24	4	amino	amino	ADJ
iajs-3307	24	5	acids	acid	NOUN
iajs-3307	24	6	and	and	CCONJ
iajs-3307	24	7	is	be	AUX
iajs-3307	24	8	a	a	DET
iajs-3307	24	9	member	member	NOUN
iajs-3307	24	10	of	of	ADP
iajs-3307	24	11	the	the	DET
iajs-3307	24	12	c	c	PROPN
iajs-3307	24	13	-	-	PUNCT
iajs-3307	24	14	c	c	X
iajs-3307	24	15	chemokine	chemokine	ADJ
iajs-3307	24	16	family	family	NOUN
iajs-3307	25	1	[	[	X
iajs-3307	25	2	1	1	NUM
iajs-3307	25	3	]	]	PUNCT
iajs-3307	25	4	.	.	PUNCT
iajs-3307	26	1	it	it	PRON
iajs-3307	26	2	has	have	AUX
iajs-3307	26	3	been	be	AUX
iajs-3307	26	4	found	find	VERB
iajs-3307	26	5	that	that	SCONJ
iajs-3307	26	6	macrophages	macrophage	NOUN
iajs-3307	26	7	and	and	CCONJ
iajs-3307	26	8	monocytes	monocyte	NOUN
iajs-3307	26	9	are	be	AUX
iajs-3307	26	10	the	the	DET
iajs-3307	26	11	primary	primary	ADJ
iajs-3307	26	12	producers	producer	NOUN
iajs-3307	26	13	.	.	PUNCT
iajs-3307	27	1	however	however	ADV
iajs-3307	27	2	,	,	PUNCT
iajs-3307	27	3	mcp-1	mcp-1	NOUN
iajs-3307	27	4	can	can	AUX
iajs-3307	27	5	be	be	AUX
iajs-3307	27	6	secreted	secrete	VERB
iajs-3307	27	7	by	by	ADP
iajs-3307	27	8	non	non	ADJ
iajs-3307	27	9	-	-	ADJ
iajs-3307	27	10	immune	immune	ADJ
iajs-3307	27	11	cells	cell	NOUN
iajs-3307	27	12	such	such	ADJ
iajs-3307	27	13	as	as	ADP
iajs-3307	27	14	fibroblasts	fibroblast	NOUN
iajs-3307	27	15	,	,	PUNCT
iajs-3307	27	16	endothelial	endothelial	ADJ
iajs-3307	27	17	,	,	PUNCT
iajs-3307	27	18	epithelial	epithelial	ADJ
iajs-3307	27	19	,	,	PUNCT
iajs-3307	27	20	and	and	CCONJ
iajs-3307	27	21	smooth	smooth	ADJ
iajs-3307	27	22	muscle	muscle	NOUN
iajs-3307	27	23	cells	cell	NOUN
iajs-3307	27	24	[	[	X
iajs-3307	27	25	1	1	NUM
iajs-3307	27	26	]	]	PUNCT
iajs-3307	27	27	.	.	PUNCT
iajs-3307	28	1	it	it	PRON
iajs-3307	28	2	has	have	VERB
iajs-3307	28	3	an	an	DET
iajs-3307	28	4	important	important	ADJ
iajs-3307	28	5	role	role	NOUN
iajs-3307	28	6	in	in	ADP
iajs-3307	28	7	t	t	PROPN
iajs-3307	28	8	-	-	PUNCT
iajs-3307	28	9	lymphocyte	lymphocyte	NOUN
iajs-3307	28	10	differentiation	differentiation	NOUN
iajs-3307	28	11	and	and	CCONJ
iajs-3307	28	12	monocyte	monocyte	NOUN
iajs-3307	28	13	chemotaxis	chemotaxis	NOUN
iajs-3307	28	14	,	,	PUNCT
iajs-3307	28	15	with	with	ADP
iajs-3307	28	16	a	a	DET
iajs-3307	28	17	critical	critical	ADJ
iajs-3307	28	18	role	role	NOUN
iajs-3307	28	19	in	in	ADP
iajs-3307	28	20	the	the	DET
iajs-3307	28	21	pathogenesis	pathogenesis	NOUN
iajs-3307	28	22	of	of	ADP
iajs-3307	28	23	numerous	numerous	ADJ
iajs-3307	28	24	diseases	disease	NOUN
iajs-3307	28	25	[	[	X
iajs-3307	28	26	5	5	NUM
iajs-3307	28	27	]	]	PUNCT
iajs-3307	28	28	.	.	PUNCT
iajs-3307	29	1	the	the	DET
iajs-3307	29	2	receptor	receptor	NOUN
iajs-3307	29	3	of	of	ADP
iajs-3307	29	4	mcp1	mcp1	PROPN
iajs-3307	29	5	,	,	PUNCT
iajs-3307	29	6	chemokine	chemokine	ADJ
iajs-3307	29	7	receptor	receptor	NOUN
iajs-3307	29	8	2	2	NUM
iajs-3307	29	9	(	(	PUNCT
iajs-3307	29	10	ccr2	ccr2	PROPN
iajs-3307	29	11	)	)	PUNCT
iajs-3307	29	12	,	,	PUNCT
iajs-3307	29	13	is	be	AUX
iajs-3307	29	14	expressed	express	VERB
iajs-3307	29	15	on	on	ADP
iajs-3307	29	16	a	a	DET
iajs-3307	29	17	variety	variety	NOUN
iajs-3307	29	18	of	of	ADP
iajs-3307	29	19	ovarian	ovarian	ADJ
iajs-3307	29	20	cell	cell	NOUN
iajs-3307	29	21	types	type	NOUN
iajs-3307	29	22	and	and	CCONJ
iajs-3307	29	23	serves	serve	VERB
iajs-3307	29	24	critical	critical	ADJ
iajs-3307	29	25	regulatory	regulatory	ADJ
iajs-3307	29	26	roles	role	NOUN
iajs-3307	29	27	in	in	ADP
iajs-3307	29	28	a	a	DET
iajs-3307	29	29	variety	variety	NOUN
iajs-3307	29	30	of	of	ADP
iajs-3307	29	31	ovarian	ovarian	ADJ
iajs-3307	29	32	functions	function	NOUN
iajs-3307	29	33	such	such	ADJ
iajs-3307	29	34	as	as	ADP
iajs-3307	29	35	folliculogenesis	folliculogenesis	NOUN
iajs-3307	29	36	,	,	PUNCT
iajs-3307	29	37	luteolysis	luteolysis	NOUN
iajs-3307	29	38	,	,	PUNCT
iajs-3307	29	39	and	and	CCONJ
iajs-3307	29	40	ovulation	ovulation	NOUN
iajs-3307	30	1	[	[	X
iajs-3307	30	2	6	6	NUM
iajs-3307	30	3	]	]	PUNCT
iajs-3307	30	4	.	.	PUNCT
iajs-3307	31	1	in	in	ADP
iajs-3307	31	2	human	human	ADJ
iajs-3307	31	3	reproduction	reproduction	NOUN
iajs-3307	31	4	,	,	PUNCT
iajs-3307	31	5	it	it	PRON
iajs-3307	31	6	has	have	VERB
iajs-3307	31	7	a	a	DET
iajs-3307	31	8	crucial	crucial	ADJ
iajs-3307	31	9	role	role	NOUN
iajs-3307	31	10	in	in	ADP
iajs-3307	31	11	immunological	immunological	ADJ
iajs-3307	31	12	detection	detection	NOUN
iajs-3307	31	13	,	,	PUNCT
iajs-3307	31	14	pregnancy	pregnancy	NOUN
iajs-3307	31	15	maintenance	maintenance	NOUN
iajs-3307	31	16	,	,	PUNCT
iajs-3307	31	17	parturition	parturition	NOUN
iajs-3307	31	18	,	,	PUNCT
iajs-3307	31	19	and	and	CCONJ
iajs-3307	31	20	acceptance	acceptance	NOUN
iajs-3307	31	21	of	of	ADP
iajs-3307	31	22	the	the	DET
iajs-3307	31	23	fetal	fetal	ADJ
iajs-3307	31	24	allograft	allograft	NOUN
iajs-3307	31	25	[	[	X
iajs-3307	31	26	7	7	NUM
iajs-3307	31	27	]	]	PUNCT
iajs-3307	31	28	.	.	PUNCT
iajs-3307	32	1	several	several	ADJ
iajs-3307	32	2	studies	study	NOUN
iajs-3307	32	3	have	have	AUX
iajs-3307	32	4	discovered	discover	VERB
iajs-3307	32	5	a	a	DET
iajs-3307	32	6	correlation	correlation	NOUN
iajs-3307	32	7	between	between	ADP
iajs-3307	32	8	pcos	pcos	PROPN
iajs-3307	32	9	as	as	ADP
iajs-3307	32	10	a	a	DET
iajs-3307	32	11	cause	cause	NOUN
iajs-3307	32	12	of	of	ADP
iajs-3307	32	13	infertility	infertility	NOUN
iajs-3307	32	14	and	and	CCONJ
iajs-3307	32	15	elevated	elevated	ADJ
iajs-3307	32	16	levels	level	NOUN
iajs-3307	32	17	of	of	ADP
iajs-3307	32	18	proinflammatory	proinflammatory	ADJ
iajs-3307	32	19	cytokines	cytokine	NOUN
iajs-3307	32	20	and	and	CCONJ
iajs-3307	32	21	chemokines	chemokine	NOUN
iajs-3307	32	22	such	such	ADJ
iajs-3307	32	23	as	as	ADP
iajs-3307	32	24	mcp-1	mcp-1	NOUN
iajs-3307	32	25	[	[	X
iajs-3307	32	26	8	8	NUM
iajs-3307	32	27	]	]	PUNCT
iajs-3307	32	28	.	.	PUNCT
iajs-3307	33	1	the	the	DET
iajs-3307	33	2	levels	level	NOUN
iajs-3307	33	3	of	of	ADP
iajs-3307	33	4	mcp-1	mcp-1	NOUN
iajs-3307	33	5	,	,	PUNCT
iajs-3307	33	6	on	on	ADP
iajs-3307	33	7	the	the	DET
iajs-3307	33	8	other	other	ADJ
iajs-3307	33	9	hand	hand	NOUN
iajs-3307	33	10	,	,	PUNCT
iajs-3307	33	11	are	be	AUX
iajs-3307	33	12	elevated	elevate	VERB
iajs-3307	33	13	in	in	ADP
iajs-3307	33	14	obesity	obesity	NOUN
iajs-3307	33	15	and	and	CCONJ
iajs-3307	33	16	abnormally	abnormally	ADV
iajs-3307	33	17	increased	increase	VERB
iajs-3307	33	18	,	,	PUNCT
iajs-3307	33	19	eventually	eventually	ADV
iajs-3307	33	20	resulting	result	VERB
iajs-3307	33	21	in	in	ADP
iajs-3307	33	22	the	the	DET
iajs-3307	33	23	recruitment	recruitment	NOUN
iajs-3307	33	24	of	of	ADP
iajs-3307	33	25	tissue	tissue	NOUN
iajs-3307	33	26	monocytes	monocyte	VERB
iajs-3307	33	27	and	and	CCONJ
iajs-3307	33	28	,	,	PUNCT
iajs-3307	33	29	as	as	ADP
iajs-3307	33	30	a	a	DET
iajs-3307	33	31	result	result	NOUN
iajs-3307	33	32	,	,	PUNCT
iajs-3307	33	33	contributing	contribute	VERB
iajs-3307	33	34	to	to	ADP
iajs-3307	33	35	the	the	DET
iajs-3307	33	36	adipose	adipose	ADJ
iajs-3307	33	37	tissue	tissue	NOUN
iajs-3307	33	38	's	's	PART
iajs-3307	33	39	chronic	chronic	ADJ
iajs-3307	33	40	low	low	ADJ
iajs-3307	33	41	-	-	PUNCT
iajs-3307	33	42	grade	grade	NOUN
iajs-3307	33	43	condition	condition	NOUN
iajs-3307	33	44	[	[	X
iajs-3307	33	45	9	9	NUM
iajs-3307	33	46	]	]	PUNCT
iajs-3307	33	47	.	.	PUNCT
iajs-3307	34	1	obesity	obesity	NOUN
iajs-3307	34	2	can	can	AUX
iajs-3307	34	3	have	have	VERB
iajs-3307	34	4	a	a	DET
iajs-3307	34	5	negative	negative	ADJ
iajs-3307	34	6	impact	impact	NOUN
iajs-3307	34	7	on	on	ADP
iajs-3307	34	8	fertility	fertility	NOUN
iajs-3307	34	9	.	.	PUNCT
iajs-3307	35	1	obesity	obesity	NOUN
iajs-3307	35	2	at	at	ADP
iajs-3307	35	3	a	a	DET
iajs-3307	35	4	young	young	ADJ
iajs-3307	35	5	age	age	NOUN
iajs-3307	35	6	causes	cause	VERB
iajs-3307	35	7	the	the	DET
iajs-3307	35	8	development	development	NOUN
iajs-3307	35	9	of	of	ADP
iajs-3307	35	10	menstrual	menstrual	ADJ
iajs-3307	35	11	abnormalities	abnormality	NOUN
iajs-3307	35	12	in	in	ADP
iajs-3307	35	13	women	woman	NOUN
iajs-3307	35	14	.	.	PUNCT
iajs-3307	36	1	and	and	CCONJ
iajs-3307	36	2	in	in	ADP
iajs-3307	36	3	women	woman	NOUN
iajs-3307	36	4	,	,	PUNCT
iajs-3307	36	5	a	a	DET
iajs-3307	36	6	bmi	bmi	NOUN
iajs-3307	36	7	greater	great	ADJ
iajs-3307	36	8	than	than	ADP
iajs-3307	36	9	30	30	NUM
iajs-3307	36	10	kg	kg	NOUN
iajs-3307	36	11	/	/	SYM
iajs-3307	36	12	m2	m2	PROPN
iajs-3307	36	13	may	may	AUX
iajs-3307	36	14	also	also	ADV
iajs-3307	36	15	raise	raise	VERB
iajs-3307	36	16	the	the	DET
iajs-3307	36	17	chance	chance	NOUN
iajs-3307	36	18	of	of	ADP
iajs-3307	36	19	miscarriage	miscarriage	NOUN
iajs-3307	36	20	and	and	CCONJ
iajs-3307	36	21	affect	affect	VERB
iajs-3307	36	22	the	the	DET
iajs-3307	36	23	results	result	NOUN
iajs-3307	36	24	of	of	ADP
iajs-3307	36	25	assisted	assist	VERB
iajs-3307	36	26	reproduction	reproduction	NOUN
iajs-3307	36	27	operations	operation	NOUN
iajs-3307	36	28	and	and	CCONJ
iajs-3307	36	29	pregnancy	pregnancy	NOUN
iajs-3307	37	1	[	[	X
iajs-3307	37	2	10	10	NUM
iajs-3307	37	3	]	]	PUNCT
iajs-3307	37	4	.	.	PUNCT
iajs-3307	38	1	testosterone	testosterone	NOUN
iajs-3307	38	2	is	be	AUX
iajs-3307	38	3	an	an	DET
iajs-3307	38	4	important	important	ADJ
iajs-3307	38	5	yet	yet	ADV
iajs-3307	38	6	enigmatic	enigmatic	ADJ
iajs-3307	38	7	female	female	ADJ
iajs-3307	38	8	hormone	hormone	NOUN
iajs-3307	38	9	.	.	PUNCT
iajs-3307	39	1	it	it	PRON
iajs-3307	39	2	serves	serve	VERB
iajs-3307	39	3	as	as	ADP
iajs-3307	39	4	an	an	DET
iajs-3307	39	5	androgen	androgen	NOUN
iajs-3307	39	6	directly	directly	ADV
iajs-3307	39	7	as	as	ADV
iajs-3307	39	8	well	well	ADV
iajs-3307	39	9	as	as	ADP
iajs-3307	39	10	being	be	AUX
iajs-3307	39	11	an	an	DET
iajs-3307	39	12	essential	essential	ADJ
iajs-3307	39	13	precursor	precursor	NOUN
iajs-3307	39	14	for	for	ADP
iajs-3307	39	15	oestradiol	oestradiol	NOUN
iajs-3307	39	16	production	production	NOUN
iajs-3307	39	17	[	[	X
iajs-3307	39	18	11	11	NUM
iajs-3307	39	19	]	]	PUNCT
iajs-3307	39	20	.	.	PUNCT
iajs-3307	40	1	in	in	ADP
iajs-3307	40	2	women	woman	NOUN
iajs-3307	40	3	,	,	PUNCT
iajs-3307	40	4	testosterone	testosterone	NOUN
iajs-3307	40	5	has	have	VERB
iajs-3307	40	6	physiological	physiological	ADJ
iajs-3307	40	7	effects	effect	NOUN
iajs-3307	40	8	on	on	ADP
iajs-3307	40	9	both	both	CCONJ
iajs-3307	40	10	reproductive	reproductive	ADJ
iajs-3307	40	11	and	and	CCONJ
iajs-3307	40	12	nonreproductive	nonreproductive	ADJ
iajs-3307	40	13	tissues	tissue	NOUN
iajs-3307	40	14	.	.	PUNCT
iajs-3307	41	1	testosterone	testosterone	NOUN
iajs-3307	41	2	levels	level	NOUN
iajs-3307	41	3	are	be	AUX
iajs-3307	41	4	significantly	significantly	ADV
iajs-3307	41	5	related	relate	VERB
iajs-3307	41	6	to	to	ADP
iajs-3307	41	7	sexual	sexual	ADJ
iajs-3307	41	8	function	function	NOUN
iajs-3307	41	9	in	in	ADP
iajs-3307	41	10	women	woman	NOUN
iajs-3307	41	11	[	[	X
iajs-3307	41	12	12	12	NUM
iajs-3307	41	13	]	]	PUNCT
iajs-3307	41	14	.	.	PUNCT
iajs-3307	42	1	the	the	DET
iajs-3307	42	2	androstenedione	androstenedione	NOUN
iajs-3307	42	3	and	and	CCONJ
iajs-3307	42	4	dehydroepiandrosterone	dehydroepiandrosterone	PROPN
iajs-3307	42	5	(	(	PUNCT
iajs-3307	42	6	dhea	dhea	PROPN
iajs-3307	42	7	)	)	PUNCT
iajs-3307	42	8	,	,	PUNCT
iajs-3307	42	9	which	which	PRON
iajs-3307	42	10	are	be	AUX
iajs-3307	42	11	pre	pre	ADJ
iajs-3307	42	12	-	-	NOUN
iajs-3307	42	13	androgens	androgens	ADJ
iajs-3307	42	14	,	,	PUNCT
iajs-3307	42	15	are	be	AUX
iajs-3307	42	16	synthesized	synthesize	VERB
iajs-3307	42	17	primarily	primarily	ADV
iajs-3307	42	18	in	in	ADP
iajs-3307	42	19	the	the	DET
iajs-3307	42	20	adrenal	adrenal	ADJ
iajs-3307	42	21	,	,	PUNCT
iajs-3307	42	22	gonad	gonad	ADJ
iajs-3307	42	23	,	,	PUNCT
iajs-3307	42	24	and	and	CCONJ
iajs-3307	42	25	peripheral	peripheral	ADJ
iajs-3307	42	26	tissues	tissue	NOUN
iajs-3307	42	27	,	,	PUNCT
iajs-3307	42	28	whereas	whereas	SCONJ
iajs-3307	42	29	testosterone	testosterone	NOUN
iajs-3307	42	30	synthesis	synthesis	NOUN
iajs-3307	42	31	occurs	occur	VERB
iajs-3307	42	32	mostly	mostly	ADV
iajs-3307	42	33	in	in	ADP
iajs-3307	42	34	the	the	DET
iajs-3307	42	35	ovaries	ovary	NOUN
iajs-3307	42	36	as	as	ADV
iajs-3307	42	37	well	well	ADV
iajs-3307	42	38	as	as	ADP
iajs-3307	42	39	adipose	adipose	ADP
iajs-3307	42	40	tissue	tissue	NOUN
iajs-3307	42	41	and	and	CCONJ
iajs-3307	42	42	other	other	ADJ
iajs-3307	42	43	peripheral	peripheral	ADJ
iajs-3307	42	44	tissues	tissue	NOUN
iajs-3307	42	45	.	.	PUNCT
iajs-3307	43	1	also	also	ADV
iajs-3307	43	2	,	,	PUNCT
iajs-3307	43	3	increased	increase	VERB
iajs-3307	43	4	serum	serum	NOUN
iajs-3307	43	5	testosterone	testosterone	NOUN
iajs-3307	43	6	levels	level	NOUN
iajs-3307	43	7	are	be	AUX
iajs-3307	43	8	linked	link	VERB
iajs-3307	43	9	to	to	ADP
iajs-3307	43	10	insulin	insulin	NOUN
iajs-3307	43	11	resistance	resistance	NOUN
iajs-3307	43	12	,	,	PUNCT
iajs-3307	43	13	obesity	obesity	NOUN
iajs-3307	43	14	,	,	PUNCT
iajs-3307	43	15	particularly	particularly	ADV
iajs-3307	43	16	abdominal	abdominal	ADJ
iajs-3307	43	17	obesity	obesity	NOUN
iajs-3307	43	18	,	,	PUNCT
iajs-3307	43	19	and	and	CCONJ
iajs-3307	43	20	increased	increase	VERB
iajs-3307	43	21	glucose	glucose	NOUN
iajs-3307	43	22	tolerance	tolerance	NOUN
iajs-3307	43	23	tests	test	NOUN
iajs-3307	43	24	.	.	PUNCT
iajs-3307	44	1	as	as	ADP
iajs-3307	44	2	a	a	DET
iajs-3307	44	3	result	result	NOUN
iajs-3307	44	4	of	of	ADP
iajs-3307	44	5	increased	increase	VERB
iajs-3307	44	6	androgen	androgen	NOUN
iajs-3307	44	7	and	and	CCONJ
iajs-3307	44	8	insulin	insulin	NOUN
iajs-3307	44	9	resistance	resistance	NOUN
iajs-3307	44	10	in	in	ADP
iajs-3307	44	11	pcos	pcos	PROPN
iajs-3307	44	12	patients	patient	NOUN
iajs-3307	44	13	,	,	PUNCT
iajs-3307	44	14	testosterone	testosterone	NOUN
iajs-3307	44	15	production	production	NOUN
iajs-3307	44	16	in	in	ADP
iajs-3307	44	17	the	the	DET
iajs-3307	44	18	ovaries	ovary	NOUN
iajs-3307	44	19	rises	rise	VERB
iajs-3307	44	20	.	.	PUNCT
iajs-3307	45	1	luteinizing	luteinize	VERB
iajs-3307	45	2	hormone	hormone	NOUN
iajs-3307	45	3	(	(	PUNCT
iajs-3307	45	4	lh	lh	PROPN
iajs-3307	45	5	)	)	PUNCT
iajs-3307	45	6	is	be	AUX
iajs-3307	45	7	a	a	DET
iajs-3307	45	8	gonadotropin	gonadotropin	NOUN
iajs-3307	45	9	that	that	PRON
iajs-3307	45	10	is	be	AUX
iajs-3307	45	11	secreted	secrete	VERB
iajs-3307	45	12	from	from	ADP
iajs-3307	45	13	the	the	DET
iajs-3307	45	14	anterior	anterior	ADJ
iajs-3307	45	15	pituitary	pituitary	ADJ
iajs-3307	45	16	gland	gland	NOUN
iajs-3307	45	17	as	as	ADP
iajs-3307	45	18	a	a	DET
iajs-3307	45	19	result	result	NOUN
iajs-3307	45	20	of	of	ADP
iajs-3307	45	21	high	high	ADJ
iajs-3307	45	22	-	-	PUNCT
iajs-3307	45	23	frequency	frequency	NOUN
iajs-3307	45	24	gonadotropin	gonadotropin	NOUN
iajs-3307	45	25	-	-	PUNCT
iajs-3307	45	26	releasing	release	VERB
iajs-3307	45	27	hormone	hormone	NOUN
iajs-3307	45	28	(	(	PUNCT
iajs-3307	45	29	gnrh	gnrh	NOUN
iajs-3307	45	30	)	)	PUNCT
iajs-3307	45	31	release	release	NOUN
iajs-3307	45	32	.	.	PUNCT
iajs-3307	46	1	lh	lh	PROPN
iajs-3307	46	2	promotes	promote	VERB
iajs-3307	46	3	ovulation	ovulation	NOUN
iajs-3307	46	4	,	,	PUNCT
iajs-3307	46	5	prepares	prepare	VERB
iajs-3307	46	6	for	for	ADP
iajs-3307	46	7	fertilized	fertilize	VERB
iajs-3307	46	8	oocyte	oocyte	ADJ
iajs-3307	46	9	uterine	uterine	ADJ
iajs-3307	46	10	implantation	implantation	NOUN
iajs-3307	46	11	,	,	PUNCT
iajs-3307	46	12	and	and	CCONJ
iajs-3307	46	13	stimulates	stimulate	VERB
iajs-3307	46	14	ovarian	ovarian	ADJ
iajs-3307	46	15	progesterone	progesterone	NOUN
iajs-3307	46	16	production	production	NOUN
iajs-3307	46	17	via	via	ADP
iajs-3307	46	18	theca	theca	NOUN
iajs-3307	46	19	and	and	CCONJ
iajs-3307	46	20	luteinized	luteinize	VERB
iajs-3307	46	21	granulosa	granulosa	NOUN
iajs-3307	46	22	cells	cell	NOUN
iajs-3307	46	23	[	[	X
iajs-3307	46	24	13	13	NUM
iajs-3307	46	25	]	]	PUNCT
iajs-3307	46	26	.	.	PUNCT
iajs-3307	47	1	in	in	ADP
iajs-3307	47	2	women	woman	NOUN
iajs-3307	47	3	with	with	ADP
iajs-3307	47	4	pcos	pcos	PROPN
iajs-3307	47	5	,	,	PUNCT
iajs-3307	47	6	a	a	DET
iajs-3307	47	7	change	change	NOUN
iajs-3307	47	8	in	in	ADP
iajs-3307	47	9	gnrh	gnrh	NOUN
iajs-3307	47	10	secretion	secretion	NOUN
iajs-3307	47	11	has	have	AUX
iajs-3307	47	12	been	be	AUX
iajs-3307	47	13	seen	see	VERB
iajs-3307	47	14	,	,	PUNCT
iajs-3307	47	15	leading	lead	VERB
iajs-3307	47	16	to	to	ADP
iajs-3307	47	17	an	an	DET
iajs-3307	47	18	increase	increase	NOUN
iajs-3307	47	19	in	in	ADP
iajs-3307	47	20	luteinizing	luteinize	VERB
iajs-3307	47	21	hormone	hormone	NOUN
iajs-3307	47	22	(	(	PUNCT
iajs-3307	47	23	lh	lh	PROPN
iajs-3307	47	24	)	)	PUNCT
iajs-3307	47	25	secretion	secretion	NOUN
iajs-3307	47	26	with	with	ADP
iajs-3307	47	27	normal	normal	ADJ
iajs-3307	47	28	follicle	follicle	NOUN
iajs-3307	47	29	-	-	PUNCT
iajs-3307	47	30	stimulating	stimulate	VERB
iajs-3307	47	31	hormone	hormone	NOUN
iajs-3307	47	32	(	(	PUNCT
iajs-3307	47	33	fsh	fsh	NOUN
iajs-3307	47	34	)	)	PUNCT
iajs-3307	47	35	secretion	secretion	NOUN
iajs-3307	47	36	[	[	X
iajs-3307	47	37	14	14	NUM
iajs-3307	47	38	]	]	PUNCT
iajs-3307	47	39	.	.	PUNCT
iajs-3307	48	1	as	as	ADP
iajs-3307	48	2	a	a	DET
iajs-3307	48	3	result	result	NOUN
iajs-3307	48	4	of	of	ADP
iajs-3307	48	5	high	high	ADJ
iajs-3307	48	6	lh	lh	PROPN
iajs-3307	48	7	levels	level	NOUN
iajs-3307	48	8	,	,	PUNCT
iajs-3307	48	9	ovulation	ovulation	NOUN
iajs-3307	48	10	does	do	AUX
iajs-3307	48	11	not	not	PART
iajs-3307	48	12	occur	occur	VERB
iajs-3307	48	13	in	in	ADP
iajs-3307	48	14	polycystic	polycystic	ADJ
iajs-3307	48	15	ovarian	ovarian	ADJ
iajs-3307	48	16	disease	disease	NOUN
iajs-3307	48	17	patients	patient	NOUN
iajs-3307	48	18	[	[	X
iajs-3307	48	19	15	15	NUM
iajs-3307	48	20	]	]	PUNCT
iajs-3307	48	21	.	.	PUNCT
iajs-3307	49	1	the	the	DET
iajs-3307	49	2	ovary	ovary	NOUN
iajs-3307	49	3	is	be	AUX
iajs-3307	49	4	the	the	DET
iajs-3307	49	5	primary	primary	ADJ
iajs-3307	49	6	androgen	androgen	NOUN
iajs-3307	49	7	source	source	NOUN
iajs-3307	49	8	in	in	ADP
iajs-3307	49	9	pcos	pcos	PROPN
iajs-3307	49	10	,	,	PUNCT
iajs-3307	49	11	and	and	CCONJ
iajs-3307	49	12	adrenal	adrenal	ADJ
iajs-3307	49	13	hyperandrogenism	hyperandrogenism	NOUN
iajs-3307	49	14	may	may	AUX
iajs-3307	49	15	be	be	AUX
iajs-3307	49	16	caused	cause	VERB
iajs-3307	49	17	by	by	ADP
iajs-3307	49	18	a	a	DET
iajs-3307	49	19	combination	combination	NOUN
iajs-3307	49	20	of	of	ADP
iajs-3307	49	21	factors	factor	NOUN
iajs-3307	49	22	such	such	ADJ
iajs-3307	49	23	as	as	ADP
iajs-3307	49	24	altered	alter	VERB
iajs-3307	49	25	cortisol	cortisol	ADJ
iajs-3307	49	26	metabolism	metabolism	NOUN
iajs-3307	49	27	,	,	PUNCT
iajs-3307	49	28	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-3307	49	29	,	,	PUNCT
iajs-3307	49	30	and	and	CCONJ
iajs-3307	49	31	increased	increase	VERB
iajs-3307	49	32	ovarian	ovarian	ADJ
iajs-3307	49	33	steroid	steroid	NOUN
iajs-3307	49	34	production	production	NOUN
iajs-3307	49	35	.	.	PUNCT
iajs-3307	50	1	[	[	X
iajs-3307	50	2	16	16	NUM
iajs-3307	50	3	]	]	PUNCT
iajs-3307	50	4	.	.	PUNCT
iajs-3307	51	1	the	the	DET
iajs-3307	51	2	prolactin	prolactin	ADJ
iajs-3307	51	3	hormone	hormone	NOUN
iajs-3307	51	4	(	(	PUNCT
iajs-3307	51	5	prh	prh	NOUN
iajs-3307	51	6	)	)	PUNCT
iajs-3307	51	7	is	be	AUX
iajs-3307	51	8	primarily	primarily	ADV
iajs-3307	51	9	synthesized	synthesize	VERB
iajs-3307	51	10	and	and	CCONJ
iajs-3307	51	11	produced	produce	VERB
iajs-3307	51	12	by	by	ADP
iajs-3307	51	13	lactotroph	lactotroph	PROPN
iajs-3307	51	14	cells	cell	NOUN
iajs-3307	51	15	of	of	ADP
iajs-3307	51	16	the	the	DET
iajs-3307	51	17	anterior	anterior	ADJ
iajs-3307	51	18	pituitary	pituitary	ADJ
iajs-3307	51	19	gland	gland	NOUN
iajs-3307	51	20	.	.	PUNCT
iajs-3307	52	1	it	it	PRON
iajs-3307	52	2	induces	induce	VERB
iajs-3307	52	3	the	the	DET
iajs-3307	52	4	proliferation	proliferation	NOUN
iajs-3307	52	5	and	and	CCONJ
iajs-3307	52	6	differentiation	differentiation	NOUN
iajs-3307	52	7	of	of	ADP
iajs-3307	52	8	mammary	mammary	ADJ
iajs-3307	52	9	cells	cell	NOUN
iajs-3307	52	10	,	,	PUNCT
iajs-3307	52	11	which	which	PRON
iajs-3307	52	12	is	be	AUX
iajs-3307	52	13	necessary	necessary	ADJ
iajs-3307	52	14	for	for	ADP
iajs-3307	52	15	lactation	lactation	NOUN
iajs-3307	52	16	.	.	PUNCT
iajs-3307	53	1	the	the	DET
iajs-3307	53	2	prolactin	prolactin	ADJ
iajs-3307	53	3	receptor	receptor	NOUN
iajs-3307	53	4	(	(	PUNCT
iajs-3307	53	5	prl	prl	NOUN
iajs-3307	53	6	r	r	NOUN
iajs-3307	53	7	)	)	PUNCT
iajs-3307	53	8	is	be	AUX
iajs-3307	53	9	widely	widely	ADV
iajs-3307	53	10	expressed	express	VERB
iajs-3307	53	11	;	;	PUNCT
iajs-3307	53	12	however	however	ADV
iajs-3307	53	13	,	,	PUNCT
iajs-3307	53	14	there	there	PRON
iajs-3307	53	15	is	be	VERB
iajs-3307	53	16	ihjpas	ihjpa	NOUN
iajs-3307	53	17	.	.	PUNCT
iajs-3307	54	1	37	37	NUM
iajs-3307	54	2	(	(	PUNCT
iajs-3307	54	3	1	1	NUM
iajs-3307	54	4	)	)	PUNCT
iajs-3307	54	5	2024	2024	NUM
iajs-3307	54	6	88	88	NUM
iajs-3307	54	7	tissue	tissue	NOUN
iajs-3307	54	8	-	-	PUNCT
iajs-3307	54	9	specific	specific	ADJ
iajs-3307	54	10	variation	variation	NOUN
iajs-3307	54	11	in	in	ADP
iajs-3307	54	12	expression	expression	NOUN
iajs-3307	54	13	patterns	pattern	NOUN
iajs-3307	54	14	.	.	PUNCT
iajs-3307	55	1	there	there	PRON
iajs-3307	55	2	are	be	VERB
iajs-3307	55	3	several	several	ADJ
iajs-3307	55	4	functions	function	NOUN
iajs-3307	55	5	of	of	ADP
iajs-3307	55	6	prolactin	prolactin	NOUN
iajs-3307	55	7	,	,	PUNCT
iajs-3307	55	8	both	both	CCONJ
iajs-3307	55	9	physiological	physiological	ADJ
iajs-3307	55	10	(	(	PUNCT
iajs-3307	55	11	lactation	lactation	NOUN
iajs-3307	55	12	,	,	PUNCT
iajs-3307	55	13	reproduction	reproduction	NOUN
iajs-3307	55	14	,	,	PUNCT
iajs-3307	55	15	metabolism	metabolism	NOUN
iajs-3307	55	16	,	,	PUNCT
iajs-3307	55	17	growth	growth	NOUN
iajs-3307	55	18	,	,	PUNCT
iajs-3307	55	19	behavior	behavior	NOUN
iajs-3307	55	20	,	,	PUNCT
iajs-3307	55	21	and	and	CCONJ
iajs-3307	55	22	electrolyte	electrolyte	ADJ
iajs-3307	55	23	transport	transport	NOUN
iajs-3307	55	24	)	)	PUNCT
iajs-3307	55	25	and	and	CCONJ
iajs-3307	55	26	pathological	pathological	ADJ
iajs-3307	55	27	(	(	PUNCT
iajs-3307	55	28	carcinogenesis	carcinogenesis	NOUN
iajs-3307	55	29	and	and	CCONJ
iajs-3307	55	30	immunity	immunity	NOUN
iajs-3307	55	31	)	)	PUNCT
iajs-3307	56	1	[	[	X
iajs-3307	56	2	17	17	NUM
iajs-3307	56	3	]	]	PUNCT
iajs-3307	56	4	.	.	PUNCT
iajs-3307	57	1	prl	prl	PROPN
iajs-3307	57	2	serum	serum	PROPN
iajs-3307	57	3	levels	level	NOUN
iajs-3307	57	4	have	have	AUX
iajs-3307	57	5	been	be	AUX
iajs-3307	57	6	observed	observe	VERB
iajs-3307	57	7	to	to	PART
iajs-3307	57	8	be	be	AUX
iajs-3307	57	9	variable	variable	ADJ
iajs-3307	57	10	and	and	CCONJ
iajs-3307	57	11	inconsistent	inconsistent	ADJ
iajs-3307	57	12	in	in	ADP
iajs-3307	57	13	pcos	pcos	PROPN
iajs-3307	57	14	.	.	PUNCT
iajs-3307	58	1	as	as	ADP
iajs-3307	58	2	a	a	DET
iajs-3307	58	3	result	result	NOUN
iajs-3307	58	4	,	,	PUNCT
iajs-3307	58	5	some	some	DET
iajs-3307	58	6	studies	study	NOUN
iajs-3307	58	7	have	have	AUX
iajs-3307	58	8	found	find	VERB
iajs-3307	58	9	that	that	SCONJ
iajs-3307	58	10	anovulatory	anovulatory	NOUN
iajs-3307	58	11	women	woman	NOUN
iajs-3307	58	12	with	with	ADP
iajs-3307	58	13	pcos	pcos	PROPN
iajs-3307	58	14	have	have	VERB
iajs-3307	58	15	greater	great	ADJ
iajs-3307	58	16	serum	serum	NOUN
iajs-3307	58	17	levels	level	NOUN
iajs-3307	58	18	of	of	ADP
iajs-3307	58	19	prl	prl	PROPN
iajs-3307	58	20	than	than	ADP
iajs-3307	58	21	controls	control	NOUN
iajs-3307	58	22	[	[	X
iajs-3307	58	23	18	18	NUM
iajs-3307	58	24	]	]	PUNCT
iajs-3307	58	25	,	,	PUNCT
iajs-3307	58	26	while	while	SCONJ
iajs-3307	58	27	others	other	NOUN
iajs-3307	58	28	have	have	AUX
iajs-3307	58	29	discovered	discover	VERB
iajs-3307	58	30	evidence	evidence	NOUN
iajs-3307	58	31	of	of	ADP
iajs-3307	58	32	dysregulation	dysregulation	NOUN
iajs-3307	58	33	[	[	X
iajs-3307	58	34	19	19	NUM
iajs-3307	58	35	]	]	PUNCT
iajs-3307	58	36	,	,	PUNCT
iajs-3307	58	37	or	or	CCONJ
iajs-3307	58	38	prl	prl	PROPN
iajs-3307	58	39	levels	level	NOUN
iajs-3307	58	40	comparable	comparable	ADJ
iajs-3307	58	41	to	to	ADP
iajs-3307	58	42	controls	control	NOUN
iajs-3307	58	43	[	[	X
iajs-3307	58	44	20	20	NUM
iajs-3307	58	45	]	]	PUNCT
iajs-3307	58	46	.	.	PUNCT
iajs-3307	59	1	follicle	follicle	AUX
iajs-3307	59	2	stimulating	stimulate	VERB
iajs-3307	59	3	hormone	hormone	NOUN
iajs-3307	59	4	(	(	PUNCT
iajs-3307	59	5	fsh	fsh	NOUN
iajs-3307	59	6	)	)	PUNCT
iajs-3307	59	7	is	be	AUX
iajs-3307	59	8	a	a	DET
iajs-3307	59	9	hormone	hormone	NOUN
iajs-3307	59	10	secreted	secrete	VERB
iajs-3307	59	11	by	by	ADP
iajs-3307	59	12	the	the	DET
iajs-3307	59	13	anterior	anterior	ADJ
iajs-3307	59	14	pituitary	pituitary	ADJ
iajs-3307	59	15	gland	gland	NOUN
iajs-3307	59	16	in	in	ADP
iajs-3307	59	17	response	response	NOUN
iajs-3307	59	18	to	to	PART
iajs-3307	59	19	hypothalamic	hypothalamic	VERB
iajs-3307	59	20	gonadotropin	gonadotropin	NOUN
iajs-3307	59	21	-	-	PUNCT
iajs-3307	59	22	releasing	release	VERB
iajs-3307	59	23	hormone	hormone	NOUN
iajs-3307	59	24	(	(	PUNCT
iajs-3307	59	25	gnrh	gnrh	NOUN
iajs-3307	59	26	)	)	PUNCT
iajs-3307	59	27	.	.	PUNCT
iajs-3307	60	1	[	[	X
iajs-3307	60	2	21	21	NUM
iajs-3307	60	3	]	]	PUNCT
iajs-3307	60	4	,	,	PUNCT
iajs-3307	60	5	is	be	AUX
iajs-3307	60	6	involved	involve	VERB
iajs-3307	60	7	in	in	ADP
iajs-3307	60	8	sexual	sexual	ADJ
iajs-3307	60	9	development	development	NOUN
iajs-3307	60	10	and	and	CCONJ
iajs-3307	60	11	reproduction	reproduction	NOUN
iajs-3307	60	12	,	,	PUNCT
iajs-3307	60	13	specifically	specifically	ADV
iajs-3307	60	14	in	in	ADP
iajs-3307	60	15	women	woman	NOUN
iajs-3307	60	16	,	,	PUNCT
iajs-3307	60	17	and	and	CCONJ
iajs-3307	60	18	is	be	AUX
iajs-3307	60	19	involved	involve	VERB
iajs-3307	60	20	in	in	ADP
iajs-3307	60	21	follicular	follicular	ADJ
iajs-3307	60	22	development	development	NOUN
iajs-3307	60	23	and	and	CCONJ
iajs-3307	60	24	estrogen	estrogen	NOUN
iajs-3307	60	25	production	production	NOUN
iajs-3307	61	1	[	[	X
iajs-3307	61	2	22	22	NUM
iajs-3307	61	3	]	]	PUNCT
iajs-3307	61	4	.	.	PUNCT
iajs-3307	62	1	a	a	DET
iajs-3307	62	2	disruption	disruption	NOUN
iajs-3307	62	3	in	in	ADP
iajs-3307	62	4	the	the	DET
iajs-3307	62	5	gonadotropin	gonadotropin	NOUN
iajs-3307	62	6	-	-	PUNCT
iajs-3307	62	7	releasing	release	VERB
iajs-3307	62	8	hormone	hormone	NOUN
iajs-3307	62	9	(	(	PUNCT
iajs-3307	62	10	gnrh	gnrh	NOUN
iajs-3307	62	11	)	)	PUNCT
iajs-3307	62	12	secretion	secretion	NOUN
iajs-3307	62	13	pattern	pattern	NOUN
iajs-3307	62	14	causes	cause	VERB
iajs-3307	62	15	a	a	DET
iajs-3307	62	16	relative	relative	ADJ
iajs-3307	62	17	increase	increase	NOUN
iajs-3307	62	18	in	in	ADP
iajs-3307	62	19	lh	lh	PROPN
iajs-3307	62	20	to	to	ADP
iajs-3307	62	21	fsh	fsh	PROPN
iajs-3307	62	22	release	release	PROPN
iajs-3307	62	23	.	.	PUNCT
iajs-3307	63	1	in	in	ADP
iajs-3307	63	2	non	non	ADJ
iajs-3307	63	3	-	-	ADJ
iajs-3307	63	4	pcos	pcos	ADJ
iajs-3307	63	5	women	woman	NOUN
iajs-3307	63	6	,	,	PUNCT
iajs-3307	63	7	the	the	DET
iajs-3307	63	8	ratio	ratio	NOUN
iajs-3307	63	9	of	of	ADP
iajs-3307	63	10	lh	lh	PROPN
iajs-3307	63	11	to	to	ADP
iajs-3307	63	12	fsh	fsh	PROPN
iajs-3307	63	13	is	be	AUX
iajs-3307	63	14	typically	typically	ADV
iajs-3307	63	15	between	between	ADP
iajs-3307	63	16	1	1	NUM
iajs-3307	63	17	and	and	CCONJ
iajs-3307	63	18	2	2	NUM
iajs-3307	63	19	.	.	PUNCT
iajs-3307	64	1	this	this	DET
iajs-3307	64	2	ratio	ratio	NOUN
iajs-3307	64	3	is	be	AUX
iajs-3307	64	4	reversed	reverse	VERB
iajs-3307	64	5	in	in	ADP
iajs-3307	64	6	women	woman	NOUN
iajs-3307	64	7	with	with	ADP
iajs-3307	64	8	polycystic	polycystic	ADJ
iajs-3307	64	9	ovarian	ovarian	ADJ
iajs-3307	64	10	disorder	disorder	NOUN
iajs-3307	64	11	,	,	PUNCT
iajs-3307	64	12	and	and	CCONJ
iajs-3307	64	13	it	it	PRON
iajs-3307	64	14	can	can	AUX
iajs-3307	64	15	reach	reach	VERB
iajs-3307	64	16	as	as	ADV
iajs-3307	64	17	high	high	ADJ
iajs-3307	64	18	as	as	ADP
iajs-3307	64	19	2	2	NUM
iajs-3307	64	20	or	or	CCONJ
iajs-3307	64	21	3	3	NUM
iajs-3307	64	22	[	[	X
iajs-3307	64	23	23	23	NUM
iajs-3307	64	24	]	]	PUNCT
iajs-3307	64	25	.	.	PUNCT
iajs-3307	65	1	continuous	continuous	ADJ
iajs-3307	65	2	use	use	NOUN
iajs-3307	65	3	of	of	ADP
iajs-3307	65	4	gnrh	gnrh	NOUN
iajs-3307	65	5	lowers	lower	VERB
iajs-3307	65	6	the	the	DET
iajs-3307	65	7	anterior	anterior	ADJ
iajs-3307	65	8	pituitary	pituitary	NOUN
iajs-3307	65	9	's	's	PART
iajs-3307	65	10	secretion	secretion	NOUN
iajs-3307	65	11	of	of	ADP
iajs-3307	65	12	fsh	fsh	NOUN
iajs-3307	65	13	and	and	CCONJ
iajs-3307	65	14	lh	lh	PROPN
iajs-3307	65	15	,	,	PUNCT
iajs-3307	65	16	which	which	PRON
iajs-3307	65	17	suppresses	suppress	VERB
iajs-3307	65	18	ovulation	ovulation	NOUN
iajs-3307	65	19	and	and	CCONJ
iajs-3307	65	20	estrogen	estrogen	NOUN
iajs-3307	65	21	formation	formation	NOUN
iajs-3307	65	22	in	in	ADP
iajs-3307	65	23	women	woman	NOUN
iajs-3307	65	24	.	.	PUNCT
iajs-3307	66	1	fsh	fsh	ADJ
iajs-3307	66	2	production	production	NOUN
iajs-3307	66	3	is	be	AUX
iajs-3307	66	4	reduced	reduce	VERB
iajs-3307	66	5	by	by	ADP
iajs-3307	66	6	negative	negative	ADJ
iajs-3307	66	7	feedback	feedback	NOUN
iajs-3307	66	8	from	from	ADP
iajs-3307	66	9	estrogen	estrogen	NOUN
iajs-3307	66	10	levels	level	NOUN
iajs-3307	66	11	[	[	X
iajs-3307	66	12	24	24	NUM
iajs-3307	66	13	]	]	PUNCT
iajs-3307	66	14	.	.	PUNCT
iajs-3307	67	1	2	2	X
iajs-3307	67	2	.	.	X
iajs-3307	67	3	materials	material	NOUN
iajs-3307	67	4	and	and	CCONJ
iajs-3307	67	5	methods	method	NOUN
iajs-3307	67	6	the	the	DET
iajs-3307	67	7	study	study	NOUN
iajs-3307	67	8	was	be	AUX
iajs-3307	67	9	an	an	DET
iajs-3307	67	10	investigation	investigation	NOUN
iajs-3307	67	11	of	of	ADP
iajs-3307	67	12	a	a	DET
iajs-3307	67	13	sample	sample	NOUN
iajs-3307	67	14	of	of	ADP
iajs-3307	67	15	pcos	pcos	PROPN
iajs-3307	67	16	patients	patient	NOUN
iajs-3307	67	17	in	in	ADP
iajs-3307	67	18	infertility	infertility	NOUN
iajs-3307	67	19	consultations	consultation	NOUN
iajs-3307	67	20	in	in	ADP
iajs-3307	67	21	baghdad	baghdad	PROPN
iajs-3307	67	22	,	,	PUNCT
iajs-3307	67	23	medical	medical	ADJ
iajs-3307	67	24	city	city	NOUN
iajs-3307	67	25	.	.	PUNCT
iajs-3307	68	1	sixty	sixty	NUM
iajs-3307	68	2	pcos	pcos	PROPN
iajs-3307	68	3	women	woman	NOUN
iajs-3307	68	4	comprise	comprise	VERB
iajs-3307	68	5	30	30	NUM
iajs-3307	68	6	non	non	ADJ
iajs-3307	68	7	-	-	ADJ
iajs-3307	68	8	pcos	pcos	ADJ
iajs-3307	68	9	women	woman	NOUN
iajs-3307	68	10	.	.	PUNCT
iajs-3307	69	1	the	the	DET
iajs-3307	69	2	average	average	ADJ
iajs-3307	69	3	age	age	NOUN
iajs-3307	69	4	of	of	ADP
iajs-3307	69	5	patients	patient	NOUN
iajs-3307	69	6	and	and	CCONJ
iajs-3307	69	7	control	control	NOUN
iajs-3307	69	8	groups	group	NOUN
iajs-3307	69	9	was	be	AUX
iajs-3307	69	10	20–40	20–40	NUM
iajs-3307	69	11	years	year	NOUN
iajs-3307	69	12	.	.	PUNCT
iajs-3307	70	1	the	the	DET
iajs-3307	70	2	study	study	NOUN
iajs-3307	70	3	was	be	AUX
iajs-3307	70	4	approved	approve	VERB
iajs-3307	70	5	by	by	ADP
iajs-3307	70	6	the	the	DET
iajs-3307	70	7	university	university	PROPN
iajs-3307	70	8	of	of	ADP
iajs-3307	70	9	baghdad	baghdad	PROPN
iajs-3307	70	10	,	,	PUNCT
iajs-3307	70	11	college	college	NOUN
iajs-3307	70	12	of	of	ADP
iajs-3307	70	13	sciences	science	NOUN
iajs-3307	70	14	,	,	PUNCT
iajs-3307	70	15	ethics	ethic	NOUN
iajs-3307	70	16	approval	approval	NOUN
iajs-3307	70	17	no	no	INTJ
iajs-3307	70	18	.	.	PUNCT
iajs-3307	71	1	(	(	PUNCT
iajs-3307	71	2	ref	ref	NOUN
iajs-3307	71	3	.	.	PUNCT
iajs-3307	71	4	:	:	PUNCT
iajs-3307	72	1	csec/1022/0120	csec/1022/0120	X
iajs-3307	72	2	)	)	PUNCT
iajs-3307	72	3	on	on	ADP
iajs-3307	72	4	october	october	PROPN
iajs-3307	72	5	5	5	NUM
iajs-3307	72	6	,	,	PUNCT
iajs-3307	72	7	2022	2022	NUM
iajs-3307	72	8	.	.	PUNCT
iajs-3307	73	1	written	write	VERB
iajs-3307	73	2	consent	consent	NOUN
iajs-3307	73	3	was	be	AUX
iajs-3307	73	4	obtained	obtain	VERB
iajs-3307	73	5	before	before	ADP
iajs-3307	73	6	participating	participate	VERB
iajs-3307	73	7	in	in	ADP
iajs-3307	73	8	this	this	DET
iajs-3307	73	9	study	study	NOUN
iajs-3307	73	10	from	from	ADP
iajs-3307	73	11	all	all	DET
iajs-3307	73	12	subjects	subject	NOUN
iajs-3307	73	13	,	,	PUNCT
iajs-3307	73	14	and	and	CCONJ
iajs-3307	73	15	all	all	DET
iajs-3307	73	16	parameters	parameter	NOUN
iajs-3307	73	17	were	be	AUX
iajs-3307	73	18	assessed	assess	VERB
iajs-3307	73	19	from	from	ADP
iajs-3307	73	20	samples	sample	NOUN
iajs-3307	73	21	of	of	ADP
iajs-3307	73	22	blood	blood	NOUN
iajs-3307	73	23	(	(	PUNCT
iajs-3307	73	24	serum	serum	NOUN
iajs-3307	73	25	)	)	PUNCT
iajs-3307	73	26	from	from	ADP
iajs-3307	73	27	patients	patient	NOUN
iajs-3307	73	28	and	and	CCONJ
iajs-3307	73	29	control	control	NOUN
iajs-3307	73	30	groups	group	NOUN
iajs-3307	73	31	.	.	PUNCT
iajs-3307	74	1	the	the	DET
iajs-3307	74	2	blood	blood	NOUN
iajs-3307	74	3	sample	sample	NOUN
iajs-3307	74	4	was	be	AUX
iajs-3307	74	5	pulled	pull	VERB
iajs-3307	74	6	from	from	ADP
iajs-3307	74	7	pcos	pcos	PROPN
iajs-3307	74	8	and	and	CCONJ
iajs-3307	74	9	non	non	ADJ
iajs-3307	74	10	-	-	ADJ
iajs-3307	74	11	pcos	pcos	ADJ
iajs-3307	74	12	individuals	individual	NOUN
iajs-3307	74	13	at	at	ADP
iajs-3307	74	14	the	the	DET
iajs-3307	74	15	early	early	ADJ
iajs-3307	74	16	follicular	follicular	ADJ
iajs-3307	74	17	phase	phase	NOUN
iajs-3307	74	18	.	.	PUNCT
iajs-3307	75	1	the	the	DET
iajs-3307	75	2	diagnosis	diagnosis	NOUN
iajs-3307	75	3	of	of	ADP
iajs-3307	75	4	pcos	pcos	PROPN
iajs-3307	75	5	was	be	AUX
iajs-3307	75	6	based	base	VERB
iajs-3307	75	7	on	on	ADP
iajs-3307	75	8	the	the	DET
iajs-3307	75	9	2003	2003	NUM
iajs-3307	75	10	rotterdam	rotterdam	NOUN
iajs-3307	75	11	criteria	criterion	NOUN
iajs-3307	75	12	and	and	CCONJ
iajs-3307	75	13	the	the	DET
iajs-3307	75	14	2006	2006	NUM
iajs-3307	75	15	androgen	androgen	NOUN
iajs-3307	75	16	excess	excess	NOUN
iajs-3307	75	17	and	and	CCONJ
iajs-3307	75	18	pcos	pcos	ADJ
iajs-3307	75	19	society	society	NOUN
iajs-3307	75	20	[	[	X
iajs-3307	75	21	25	25	NUM
iajs-3307	75	22	]	]	PUNCT
iajs-3307	75	23	by	by	ADP
iajs-3307	75	24	doctors	doctor	NOUN
iajs-3307	75	25	in	in	ADP
iajs-3307	75	26	infertility	infertility	NOUN
iajs-3307	75	27	consultation	consultation	NOUN
iajs-3307	75	28	in	in	ADP
iajs-3307	75	29	baghdad	baghdad	PROPN
iajs-3307	75	30	medical	medical	ADJ
iajs-3307	75	31	city	city	NOUN
iajs-3307	75	32	during	during	ADP
iajs-3307	75	33	the	the	DET
iajs-3307	75	34	period	period	NOUN
iajs-3307	75	35	from	from	ADP
iajs-3307	75	36	october	october	PROPN
iajs-3307	75	37	2022	2022	NUM
iajs-3307	75	38	to	to	ADP
iajs-3307	75	39	january	january	PROPN
iajs-3307	75	40	2023	2023	NUM
iajs-3307	75	41	.	.	PUNCT
iajs-3307	76	1	laboratory	laboratory	NOUN
iajs-3307	76	2	tests	test	NOUN
iajs-3307	76	3	included	include	VERB
iajs-3307	76	4	fertility	fertility	NOUN
iajs-3307	76	5	hormones	hormone	NOUN
iajs-3307	76	6	(	(	PUNCT
iajs-3307	76	7	testosterone	testosterone	NOUN
iajs-3307	76	8	,	,	PUNCT
iajs-3307	76	9	lh	lh	NOUN
iajs-3307	76	10	,	,	PUNCT
iajs-3307	76	11	prolactin	prolactin	NOUN
iajs-3307	76	12	,	,	PUNCT
iajs-3307	76	13	and	and	CCONJ
iajs-3307	76	14	fsh	fsh	ADJ
iajs-3307	76	15	)	)	PUNCT
iajs-3307	76	16	and	and	CCONJ
iajs-3307	76	17	chemokines	chemokine	NOUN
iajs-3307	76	18	(	(	PUNCT
iajs-3307	76	19	mcp	mcp	PROPN
iajs-3307	76	20	1	1	NUM
iajs-3307	76	21	)	)	PUNCT
iajs-3307	76	22	.	.	PUNCT
iajs-3307	77	1	five	five	NUM
iajs-3307	77	2	ml	ml	NOUN
iajs-3307	77	3	of	of	ADP
iajs-3307	77	4	venous	venous	ADJ
iajs-3307	77	5	blood	blood	NOUN
iajs-3307	77	6	was	be	AUX
iajs-3307	77	7	collected	collect	VERB
iajs-3307	77	8	from	from	ADP
iajs-3307	77	9	study	study	NOUN
iajs-3307	77	10	subjects	subject	NOUN
iajs-3307	77	11	,	,	PUNCT
iajs-3307	77	12	and	and	CCONJ
iajs-3307	77	13	serum	serum	NOUN
iajs-3307	77	14	was	be	AUX
iajs-3307	77	15	kept	keep	VERB
iajs-3307	77	16	at	at	ADP
iajs-3307	77	17	-20	-20	PROPN
iajs-3307	77	18	°	°	ADP
iajs-3307	77	19	c	c	NOUN
iajs-3307	77	20	until	until	SCONJ
iajs-3307	77	21	used	use	VERB
iajs-3307	77	22	.	.	PUNCT
iajs-3307	78	1	the	the	DET
iajs-3307	78	2	body	body	NOUN
iajs-3307	78	3	mass	mass	PROPN
iajs-3307	78	4	index	index	NOUN
iajs-3307	78	5	(	(	PUNCT
iajs-3307	78	6	bmi	bmi	PROPN
iajs-3307	78	7	)	)	PUNCT
iajs-3307	78	8	of	of	ADP
iajs-3307	78	9	the	the	DET
iajs-3307	78	10	studied	study	VERB
iajs-3307	78	11	subjects	subject	NOUN
iajs-3307	78	12	was	be	AUX
iajs-3307	78	13	calculated	calculate	VERB
iajs-3307	78	14	using	use	VERB
iajs-3307	78	15	the	the	DET
iajs-3307	78	16	following	follow	VERB
iajs-3307	78	17	equation	equation	NOUN
iajs-3307	78	18	:	:	PUNCT
iajs-3307	78	19	weight	weight	NOUN
iajs-3307	78	20	(	(	PUNCT
iajs-3307	78	21	kg	kg	NOUN
iajs-3307	78	22	)	)	PUNCT
iajs-3307	78	23	divided	divide	VERB
iajs-3307	78	24	by	by	ADP
iajs-3307	78	25	height	height	NOUN
iajs-3307	78	26	(	(	PUNCT
iajs-3307	78	27	m2	m2	PROPN
iajs-3307	78	28	)	)	PUNCT
iajs-3307	78	29	squared	square	VERB
iajs-3307	78	30	.	.	PUNCT
iajs-3307	79	1	2.1	2.1	NUM
iajs-3307	79	2	.	.	PUNCT
iajs-3307	79	3	measurement	measurement	NOUN
iajs-3307	79	4	of	of	ADP
iajs-3307	79	5	parameters	parameter	NOUN
iajs-3307	79	6	the	the	DET
iajs-3307	79	7	chemokine	chemokine	ADJ
iajs-3307	79	8	(	(	PUNCT
iajs-3307	79	9	mcp	mcp	PROPN
iajs-3307	79	10	1	1	NUM
iajs-3307	79	11	)	)	PUNCT
iajs-3307	79	12	value	value	NOUN
iajs-3307	79	13	was	be	AUX
iajs-3307	79	14	measured	measure	VERB
iajs-3307	79	15	by	by	ADP
iajs-3307	79	16	elisa	elisa	NOUN
iajs-3307	79	17	technique	technique	NOUN
iajs-3307	79	18	according	accord	VERB
iajs-3307	79	19	to	to	ADP
iajs-3307	79	20	the	the	DET
iajs-3307	79	21	kit	kit	NOUN
iajs-3307	79	22	procedure	procedure	NOUN
iajs-3307	79	23	(	(	PUNCT
iajs-3307	79	24	cat	cat	NOUN
iajs-3307	79	25	no	no	INTJ
iajs-3307	79	26	.	.	PROPN
iajs-3307	79	27	elk5252	elk5252	NOUN
iajs-3307	79	28	,	,	PUNCT
iajs-3307	79	29	to	to	PART
iajs-3307	79	30	company	company	VERB
iajs-3307	79	31	elk	elk	NOUN
iajs-3307	79	32	biotechnology	biotechnology	NOUN
iajs-3307	79	33	)	)	PUNCT
iajs-3307	79	34	of	of	ADP
iajs-3307	79	35	chinese	chinese	ADJ
iajs-3307	79	36	origin	origin	NOUN
iajs-3307	79	37	.	.	PUNCT
iajs-3307	80	1	hormones	hormone	NOUN
iajs-3307	80	2	(	(	PUNCT
iajs-3307	80	3	testosterone	testosterone	NOUN
iajs-3307	80	4	,	,	PUNCT
iajs-3307	80	5	lh	lh	NOUN
iajs-3307	80	6	,	,	PUNCT
iajs-3307	80	7	prolactin	prolactin	NOUN
iajs-3307	80	8	,	,	PUNCT
iajs-3307	80	9	and	and	CCONJ
iajs-3307	80	10	fsh	fsh	NOUN
iajs-3307	80	11	)	)	PUNCT
iajs-3307	80	12	were	be	AUX
iajs-3307	80	13	measured	measure	VERB
iajs-3307	80	14	by	by	ADP
iajs-3307	80	15	an	an	DET
iajs-3307	80	16	american	american	PROPN
iajs-3307	80	17	abbott	abbott	PROPN
iajs-3307	80	18	architect	architect	PROPN
iajs-3307	80	19	plus	plus	CCONJ
iajs-3307	80	20	i1000sr	i1000sr	PROPN
iajs-3307	80	21	device	device	NOUN
iajs-3307	80	22	based	base	VERB
iajs-3307	80	23	on	on	ADP
iajs-3307	80	24	eclia	eclia	NOUN
iajs-3307	80	25	technology	technology	NOUN
iajs-3307	80	26	using	use	VERB
iajs-3307	80	27	a	a	DET
iajs-3307	80	28	special	special	ADJ
iajs-3307	80	29	kit	kit	NOUN
iajs-3307	80	30	for	for	ADP
iajs-3307	80	31	each	each	DET
iajs-3307	80	32	parameter	parameter	NOUN
iajs-3307	80	33	.	.	PUNCT
iajs-3307	81	1	also	also	ADV
iajs-3307	81	2	,	,	PUNCT
iajs-3307	81	3	bmi	bmi	PROPN
iajs-3307	81	4	was	be	AUX
iajs-3307	81	5	measured	measure	VERB
iajs-3307	81	6	according	accord	VERB
iajs-3307	81	7	to	to	ADP
iajs-3307	81	8	the	the	DET
iajs-3307	81	9	equation	equation	NOUN
iajs-3307	81	10	of	of	ADP
iajs-3307	81	11	weight	weight	NOUN
iajs-3307	81	12	divided	divide	VERB
iajs-3307	81	13	by	by	ADP
iajs-3307	81	14	height	height	NOUN
iajs-3307	81	15	squared	square	VERB
iajs-3307	81	16	.	.	PUNCT
iajs-3307	82	1	2.3	2.3	NUM
iajs-3307	82	2	.	.	PUNCT
iajs-3307	83	1	statistical	statistical	ADJ
iajs-3307	83	2	analysis	analysis	NOUN
iajs-3307	83	3	the	the	DET
iajs-3307	83	4	statistical	statistical	ADJ
iajs-3307	83	5	analysis	analysis	NOUN
iajs-3307	83	6	system	system	NOUN
iajs-3307	83	7	-	-	PUNCT
iajs-3307	83	8	sas	sas	PROPN
iajs-3307	83	9	(	(	PUNCT
iajs-3307	83	10	2018	2018	NUM
iajs-3307	83	11	)	)	PUNCT
iajs-3307	83	12	program	program	NOUN
iajs-3307	83	13	was	be	AUX
iajs-3307	83	14	used	use	VERB
iajs-3307	83	15	to	to	PART
iajs-3307	83	16	detect	detect	VERB
iajs-3307	83	17	the	the	DET
iajs-3307	83	18	effect	effect	NOUN
iajs-3307	83	19	of	of	ADP
iajs-3307	83	20	different	different	ADJ
iajs-3307	83	21	factors	factor	NOUN
iajs-3307	83	22	on	on	ADP
iajs-3307	83	23	study	study	NOUN
iajs-3307	83	24	parameters	parameter	NOUN
iajs-3307	83	25	.	.	PUNCT
iajs-3307	84	1	3	3	X
iajs-3307	84	2	.	.	X
iajs-3307	84	3	results	result	NOUN
iajs-3307	84	4	according	accord	VERB
iajs-3307	84	5	to	to	ADP
iajs-3307	84	6	the	the	DET
iajs-3307	84	7	current	current	ADJ
iajs-3307	84	8	study	study	NOUN
iajs-3307	84	9	,	,	PUNCT
iajs-3307	84	10	there	there	PRON
iajs-3307	84	11	is	be	VERB
iajs-3307	84	12	no	no	DET
iajs-3307	84	13	significant	significant	ADJ
iajs-3307	84	14	difference	difference	NOUN
iajs-3307	84	15	between	between	ADP
iajs-3307	84	16	bmi	bmi	NOUN
iajs-3307	84	17	and	and	CCONJ
iajs-3307	84	18	mcp1	mcp1	PROPN
iajs-3307	84	19	(	(	PUNCT
iajs-3307	84	20	correlation	correlation	NOUN
iajs-3307	84	21	coefficient	coefficient	NOUN
iajs-3307	84	22	-	-	PUNCT
iajs-3307	84	23	r	r	NOUN
iajs-3307	84	24	0.06	0.06	NUM
iajs-3307	84	25	)	)	PUNCT
iajs-3307	84	26	,	,	PUNCT
iajs-3307	84	27	no	no	DET
iajs-3307	84	28	correlation	correlation	NOUN
iajs-3307	84	29	was	be	AUX
iajs-3307	84	30	found	find	VERB
iajs-3307	84	31	between	between	ADP
iajs-3307	84	32	waist	waist	NOUN
iajs-3307	84	33	-	-	PUNCT
iajs-3307	84	34	hip	hip	NOUN
iajs-3307	84	35	ratio	ratio	NOUN
iajs-3307	84	36	(	(	PUNCT
iajs-3307	84	37	whr	whr	PROPN
iajs-3307	84	38	)	)	PUNCT
iajs-3307	84	39	,	,	PUNCT
iajs-3307	84	40	and	and	CCONJ
iajs-3307	84	41	ihjpas	ihjpa	VERB
iajs-3307	84	42	.	.	PUNCT
iajs-3307	85	1	37	37	NUM
iajs-3307	85	2	(	(	PUNCT
iajs-3307	85	3	1	1	NUM
iajs-3307	85	4	)	)	PUNCT
iajs-3307	85	5	2024	2024	NUM
iajs-3307	85	6	89	89	NUM
iajs-3307	85	7	there	there	PRON
iajs-3307	85	8	is	be	VERB
iajs-3307	85	9	also	also	ADV
iajs-3307	85	10	no	no	DET
iajs-3307	85	11	significant	significant	ADJ
iajs-3307	85	12	difference	difference	NOUN
iajs-3307	85	13	between	between	ADP
iajs-3307	85	14	fertility	fertility	NOUN
iajs-3307	85	15	hormones	hormone	NOUN
iajs-3307	85	16	(	(	PUNCT
iajs-3307	85	17	testosterone	testosterone	NOUN
iajs-3307	85	18	,	,	PUNCT
iajs-3307	85	19	lh	lh	NOUN
iajs-3307	85	20	,	,	PUNCT
iajs-3307	85	21	prolactin	prolactin	NOUN
iajs-3307	85	22	and	and	CCONJ
iajs-3307	85	23	fsh	fsh	ADJ
iajs-3307	85	24	)	)	PUNCT
iajs-3307	85	25	and	and	CCONJ
iajs-3307	85	26	mcp1	mcp1	PROPN
iajs-3307	85	27	,	,	PUNCT
iajs-3307	85	28	whose	whose	DET
iajs-3307	85	29	correlation	correlation	NOUN
iajs-3307	85	30	coefficients	coefficient	NOUN
iajs-3307	85	31	were	be	AUX
iajs-3307	85	32	(	(	PUNCT
iajs-3307	85	33	0.02	0.02	NUM
iajs-3307	85	34	,	,	PUNCT
iajs-3307	85	35	0.04	0.04	NUM
iajs-3307	85	36	,	,	PUNCT
iajs-3307	85	37	0.07	0.07	NUM
iajs-3307	85	38	,	,	PUNCT
iajs-3307	85	39	and	and	CCONJ
iajs-3307	85	40	0.01	0.01	NUM
iajs-3307	85	41	,	,	PUNCT
iajs-3307	85	42	respectively	respectively	ADV
iajs-3307	85	43	)	)	PUNCT
iajs-3307	85	44	(	(	PUNCT
iajs-3307	85	45	table	table	NOUN
iajs-3307	85	46	1	1	NUM
iajs-3307	85	47	)	)	PUNCT
iajs-3307	85	48	.	.	PUNCT
iajs-3307	86	1	the	the	DET
iajs-3307	86	2	monocyte	monocyte	PROPN
iajs-3307	86	3	chemoattractant	chemoattractant	PROPN
iajs-3307	86	4	protein-1	protein-1	PROPN
iajs-3307	86	5	(	(	PUNCT
iajs-3307	86	6	mcp-1	mcp-1	NOUN
iajs-3307	86	7	)	)	PUNCT
iajs-3307	86	8	increased	increase	VERB
iajs-3307	86	9	in	in	ADP
iajs-3307	86	10	pcos	pcos	NOUN
iajs-3307	86	11	patients	patient	NOUN
iajs-3307	86	12	(	(	PUNCT
iajs-3307	86	13	154.53	154.53	NUM
iajs-3307	86	14	±	±	NUM
iajs-3307	86	15	14.92	14.92	NUM
iajs-3307	86	16	)	)	PUNCT
iajs-3307	86	17	but	but	CCONJ
iajs-3307	86	18	was	be	AUX
iajs-3307	86	19	not	not	PART
iajs-3307	86	20	significant	significant	ADJ
iajs-3307	86	21	when	when	SCONJ
iajs-3307	86	22	compared	compare	VERB
iajs-3307	86	23	to	to	ADP
iajs-3307	86	24	the	the	DET
iajs-3307	86	25	control	control	NOUN
iajs-3307	86	26	(	(	PUNCT
iajs-3307	86	27	123.5	123.5	NUM
iajs-3307	86	28	±	±	NUM
iajs-3307	86	29	11.91	11.91	NUM
iajs-3307	86	30	)	)	PUNCT
iajs-3307	86	31	.	.	PUNCT
iajs-3307	87	1	in	in	ADP
iajs-3307	87	2	our	our	PRON
iajs-3307	87	3	current	current	ADJ
iajs-3307	87	4	study	study	NOUN
iajs-3307	87	5	,	,	PUNCT
iajs-3307	87	6	testosterone	testosterone	NOUN
iajs-3307	87	7	results	result	NOUN
iajs-3307	87	8	indicated	indicate	VERB
iajs-3307	87	9	a	a	DET
iajs-3307	87	10	significant	significant	ADJ
iajs-3307	87	11	(	(	PUNCT
iajs-3307	87	12	p<0.05	p<0.05	NOUN
iajs-3307	87	13	)	)	PUNCT
iajs-3307	87	14	increase	increase	NOUN
iajs-3307	87	15	in	in	ADP
iajs-3307	87	16	the	the	DET
iajs-3307	87	17	pco	pco	NOUN
iajs-3307	87	18	group	group	NOUN
iajs-3307	87	19	(	(	PUNCT
iajs-3307	87	20	14.63	14.63	NUM
iajs-3307	87	21	±2.30	±2.30	PROPN
iajs-3307	87	22	nmol	nmol	PROPN
iajs-3307	87	23	/	/	SYM
iajs-3307	87	24	l	l	NOUN
iajs-3307	87	25	)	)	PUNCT
iajs-3307	87	26	compared	compare	VERB
iajs-3307	87	27	to	to	ADP
iajs-3307	87	28	the	the	DET
iajs-3307	87	29	control	control	NOUN
iajs-3307	87	30	(	(	PUNCT
iajs-3307	87	31	0.627	0.627	NUM
iajs-3307	87	32	±0.04	±0.04	PROPN
iajs-3307	87	33	nmol	nmol	PROPN
iajs-3307	87	34	/	/	SYM
iajs-3307	87	35	l	l	NOUN
iajs-3307	87	36	)	)	PUNCT
iajs-3307	87	37	.	.	PUNCT
iajs-3307	88	1	lh	lh	PROPN
iajs-3307	88	2	levels	level	NOUN
iajs-3307	88	3	showed	show	VERB
iajs-3307	88	4	a	a	DET
iajs-3307	88	5	significant	significant	ADJ
iajs-3307	88	6	(	(	PUNCT
iajs-3307	88	7	p<0.05	p<0.05	NOUN
iajs-3307	88	8	)	)	PUNCT
iajs-3307	88	9	increase	increase	NOUN
iajs-3307	88	10	in	in	ADP
iajs-3307	88	11	the	the	DET
iajs-3307	88	12	pcos	pcos	PROPN
iajs-3307	88	13	group	group	NOUN
iajs-3307	88	14	compared	compare	VERB
iajs-3307	88	15	to	to	ADP
iajs-3307	88	16	the	the	DET
iajs-3307	88	17	control	control	NOUN
iajs-3307	88	18	(	(	PUNCT
iajs-3307	88	19	6.54	6.54	NUM
iajs-3307	88	20	±0.51	±0.51	PROPN
iajs-3307	88	21	miu	miu	PROPN
iajs-3307	88	22	/	/	SYM
iajs-3307	88	23	ml	ml	PROPN
iajs-3307	88	24	)	)	PUNCT
iajs-3307	88	25	and	and	CCONJ
iajs-3307	88	26	(	(	PUNCT
iajs-3307	88	27	2.93	2.93	NUM
iajs-3307	88	28	±0.18	±0.18	PROPN
iajs-3307	88	29	miu	miu	PROPN
iajs-3307	88	30	/	/	SYM
iajs-3307	88	31	ml	ml	PROPN
iajs-3307	88	32	)	)	PUNCT
iajs-3307	88	33	,	,	PUNCT
iajs-3307	88	34	respectively	respectively	ADV
iajs-3307	88	35	.	.	PUNCT
iajs-3307	89	1	prolactin	prolactin	ADJ
iajs-3307	89	2	hormone	hormone	NOUN
iajs-3307	89	3	was	be	AUX
iajs-3307	89	4	increased	increase	VERB
iajs-3307	89	5	in	in	ADP
iajs-3307	89	6	pcos	pcos	NOUN
iajs-3307	89	7	patients	patient	NOUN
iajs-3307	89	8	(	(	PUNCT
iajs-3307	89	9	16.27	16.27	NUM
iajs-3307	89	10	±1.25	±1.25	PROPN
iajs-3307	89	11	ng	ng	PROPN
iajs-3307	89	12	/	/	SYM
iajs-3307	89	13	ml	ml	NOUN
iajs-3307	89	14	)	)	PUNCT
iajs-3307	89	15	when	when	SCONJ
iajs-3307	89	16	compared	compare	VERB
iajs-3307	89	17	to	to	ADP
iajs-3307	89	18	the	the	DET
iajs-3307	89	19	control	control	NOUN
iajs-3307	89	20	group	group	NOUN
iajs-3307	89	21	(	(	PUNCT
iajs-3307	89	22	12.85	12.85	NUM
iajs-3307	89	23	±0.62	±0.62	NOUN
iajs-3307	89	24	)	)	PUNCT
iajs-3307	89	25	.	.	PUNCT
iajs-3307	90	1	the	the	DET
iajs-3307	90	2	level	level	NOUN
iajs-3307	90	3	of	of	ADP
iajs-3307	90	4	fsh	fsh	NOUN
iajs-3307	90	5	showed	show	VERB
iajs-3307	90	6	no	no	DET
iajs-3307	90	7	significant	significant	ADJ
iajs-3307	90	8	difference	difference	NOUN
iajs-3307	90	9	between	between	ADP
iajs-3307	90	10	pcos	pcos	PROPN
iajs-3307	90	11	and	and	CCONJ
iajs-3307	90	12	the	the	DET
iajs-3307	90	13	control	control	NOUN
iajs-3307	90	14	(	(	PUNCT
iajs-3307	90	15	5.27	5.27	NUM
iajs-3307	90	16	±0.28	±0.28	PROPN
iajs-3307	90	17	miu	miu	PROPN
iajs-3307	90	18	/	/	SYM
iajs-3307	90	19	ml	ml	PROPN
iajs-3307	90	20	)	)	PUNCT
iajs-3307	90	21	and	and	CCONJ
iajs-3307	90	22	(	(	PUNCT
iajs-3307	90	23	5.59	5.59	NUM
iajs-3307	90	24	±0.18	±0.18	PROPN
iajs-3307	90	25	miu	miu	PROPN
iajs-3307	90	26	/	/	SYM
iajs-3307	90	27	ml	ml	PROPN
iajs-3307	90	28	)	)	PUNCT
iajs-3307	90	29	,	,	PUNCT
iajs-3307	90	30	respectively	respectively	ADV
iajs-3307	90	31	(	(	PUNCT
iajs-3307	90	32	table	table	NOUN
iajs-3307	90	33	2	2	NUM
iajs-3307	90	34	)	)	PUNCT
iajs-3307	90	35	.	.	PUNCT
iajs-3307	91	1	table	table	NOUN
iajs-3307	91	2	1	1	NUM
iajs-3307	91	3	.	.	PUNCT
iajs-3307	92	1	correlation	correlation	NOUN
iajs-3307	92	2	coefficient	coefficient	NOUN
iajs-3307	92	3	between	between	ADP
iajs-3307	92	4	mcp-1	mcp-1	PRON
iajs-3307	92	5	and	and	CCONJ
iajs-3307	92	6	others	other	NOUN
iajs-3307	92	7	parameters	parameter	NOUN
iajs-3307	92	8	.	.	PUNCT
iajs-3307	93	1	parameters	parameter	NOUN
iajs-3307	93	2	correlation	correlation	NOUN
iajs-3307	93	3	coefficient	coefficient	NOUN
iajs-3307	93	4	-	-	PUNCT
iajs-3307	93	5	r	r	NOUN
iajs-3307	93	6	mcp	mcp	PROPN
iajs-3307	93	7	1	1	NUM
iajs-3307	93	8	age	age	NOUN
iajs-3307	93	9	-0.009	-0.009	NUM
iajs-3307	93	10	ns	ns	NUM
iajs-3307	93	11	bmi	bmi	PROPN
iajs-3307	93	12	0.06	0.06	NUM
iajs-3307	93	13	ns	ns	NUM
iajs-3307	93	14	waist	waist	NOUN
iajs-3307	93	15	hips	hip	NOUN
iajs-3307	93	16	ratio	ratio	NOUN
iajs-3307	93	17	0.09	0.09	NUM
iajs-3307	93	18	ns	ns	NUM
iajs-3307	93	19	duration	duration	NOUN
iajs-3307	93	20	of	of	ADP
iajs-3307	93	21	pco	pco	NOUN
iajs-3307	93	22	-0.03	-0.03	X
iajs-3307	93	23	ns	ns	NUM
iajs-3307	93	24	duration	duration	NOUN
iajs-3307	93	25	of	of	ADP
iajs-3307	93	26	treatment	treatment	NOUN
iajs-3307	93	27	0.10	0.10	NUM
iajs-3307	93	28	ns	ns	ADJ
iajs-3307	93	29	number	number	NOUN
iajs-3307	93	30	of	of	ADP
iajs-3307	93	31	children	child	NOUN
iajs-3307	93	32	0.15	0.15	NUM
iajs-3307	93	33	ns	ns	NOUN
iajs-3307	93	34	fsh	fsh	PROPN
iajs-3307	93	35	0.04	0.04	NUM
iajs-3307	93	36	ns	ns	NOUN
iajs-3307	93	37	lh	lh	PROPN
iajs-3307	93	38	0.02	0.02	NUM
iajs-3307	93	39	ns	ns	NUM
iajs-3307	93	40	prolactin	prolactin	NOUN
iajs-3307	93	41	0.07	0.07	NUM
iajs-3307	93	42	ns	ns	NUM
iajs-3307	93	43	testosterone	testosterone	NOUN
iajs-3307	93	44	0.01	0.01	NUM
iajs-3307	93	45	ns	ns	NUM
iajs-3307	93	46	*	*	PUNCT
iajs-3307	93	47	(	(	PUNCT
iajs-3307	93	48	p≤0.05	p≤0.05	NOUN
iajs-3307	93	49	)	)	PUNCT
iajs-3307	93	50	,	,	PUNCT
iajs-3307	93	51	*	*	PUNCT
iajs-3307	93	52	*	*	PUNCT
iajs-3307	93	53	(	(	PUNCT
iajs-3307	93	54	p≤0.01	p≤0.01	NOUN
iajs-3307	93	55	)	)	PUNCT
iajs-3307	93	56	,	,	PUNCT
iajs-3307	93	57	ns	ns	CCONJ
iajs-3307	93	58	:	:	PUNCT
iajs-3307	93	59	non	non	ADJ
iajs-3307	93	60	-	-	ADJ
iajs-3307	93	61	significant	significant	ADJ
iajs-3307	93	62	.	.	PUNCT
iajs-3307	94	1	table	table	NOUN
iajs-3307	94	2	2	2	NUM
iajs-3307	94	3	.	.	X
iajs-3307	94	4	comparison	comparison	NOUN
iajs-3307	94	5	between	between	ADP
iajs-3307	94	6	pcos	pcos	PROPN
iajs-3307	94	7	and	and	CCONJ
iajs-3307	94	8	non	non	NOUN
iajs-3307	94	9	pcos	pcos	NOUN
iajs-3307	94	10	groups	group	NOUN
iajs-3307	94	11	in	in	ADP
iajs-3307	94	12	mcp	mcp	PROPN
iajs-3307	94	13	1	1	NUM
iajs-3307	94	14	and	and	CCONJ
iajs-3307	94	15	hormones	hormone	NOUN
iajs-3307	94	16	levels	level	NOUN
iajs-3307	94	17	group	group	NOUN
iajs-3307	94	18	mean	mean	VERB
iajs-3307	94	19	±	±	PROPN
iajs-3307	94	20	se	se	PROPN
iajs-3307	94	21	fsh	fsh	PROPN
iajs-3307	94	22	(	(	PUNCT
iajs-3307	94	23	miu/	miu/	PROPN
iajs-3307	94	24	ml	ml	NOUN
iajs-3307	94	25	)	)	PUNCT
iajs-3307	94	26	lh	lh	PROPN
iajs-3307	94	27	(	(	PUNCT
iajs-3307	94	28	miu/	miu/	PROPN
iajs-3307	94	29	ml	ml	NOUN
iajs-3307	94	30	)	)	PUNCT
iajs-3307	94	31	prolactin	prolactin	NOUN
iajs-3307	94	32	(	(	PUNCT
iajs-3307	94	33	ng	ng	NOUN
iajs-3307	94	34	/	/	SYM
iajs-3307	94	35	ml	ml	NOUN
iajs-3307	94	36	)	)	PUNCT
iajs-3307	94	37	testosterone	testosterone	NOUN
iajs-3307	94	38	(	(	PUNCT
iajs-3307	94	39	nmol/	nmol/	NUM
iajs-3307	94	40	l	l	NOUN
iajs-3307	94	41	)	)	PUNCT
iajs-3307	94	42	mcp	mcp	PROPN
iajs-3307	94	43	1	1	NUM
iajs-3307	94	44	(	(	PUNCT
iajs-3307	94	45	pg	pg	NOUN
iajs-3307	94	46	/	/	SYM
iajs-3307	94	47	ml	ml	NOUN
iajs-3307	94	48	)	)	PUNCT
iajs-3307	94	49	patients	patient	NOUN
iajs-3307	94	50	5.27	5.27	NUM
iajs-3307	94	51	±0.28	±0.28	PROPN
iajs-3307	94	52	6.54	6.54	NUM
iajs-3307	94	53	±0.51	±0.51	PROPN
iajs-3307	94	54	16.27	16.27	NUM
iajs-3307	94	55	±1.25	±1.25	PROPN
iajs-3307	94	56	14.63	14.63	NUM
iajs-3307	94	57	±2.30	±2.30	PROPN
iajs-3307	94	58	154.53	154.53	NUM
iajs-3307	94	59	±14.92	±14.92	PRON
iajs-3307	94	60	control	control	VERB
iajs-3307	94	61	5.59	5.59	NUM
iajs-3307	94	62	±0.18	±0.18	NOUN
iajs-3307	94	63	2.93	2.93	NUM
iajs-3307	94	64	±0.18	±0.18	NOUN
iajs-3307	94	65	12.85	12.85	NUM
iajs-3307	94	66	±0.62	±0.62	PROPN
iajs-3307	94	67	0.627	0.627	NUM
iajs-3307	94	68	±0.04	±0.04	PROPN
iajs-3307	94	69	123.5	123.5	NUM
iajs-3307	94	70	±11.91	±11.91	NOUN
iajs-3307	94	71	t	t	PROPN
iajs-3307	94	72	-	-	PUNCT
iajs-3307	94	73	test	test	NOUN
iajs-3307	94	74	0.819	0.819	NUM
iajs-3307	94	75	ns	ns	NUM
iajs-3307	94	76	1.441	1.441	NUM
iajs-3307	94	77	*	*	PUNCT
iajs-3307	94	78	*	*	PUNCT
iajs-3307	94	79	3.562	3.562	NUM
iajs-3307	94	80	ns	ns	NUM
iajs-3307	94	81	6.334	6.334	NUM
iajs-3307	94	82	*	*	PUNCT
iajs-3307	94	83	*	*	PUNCT
iajs-3307	94	84	44.445	44.445	NUM
iajs-3307	94	85	ns	ns	NUM
iajs-3307	94	86	p	p	NOUN
iajs-3307	94	87	-	-	PUNCT
iajs-3307	94	88	value	value	NOUN
iajs-3307	94	89	0.434	0.434	NUM
iajs-3307	94	90	0.0011	0.0011	NUM
iajs-3307	94	91	0.0602	0.0602	NUM
iajs-3307	94	92	0.0011	0.0011	NUM
iajs-3307	94	93	0.0642	0.0642	NUM
iajs-3307	94	94	*	*	PUNCT
iajs-3307	94	95	*	*	PUNCT
iajs-3307	94	96	(	(	PUNCT
iajs-3307	94	97	p≤0.01	p≤0.01	NOUN
iajs-3307	94	98	)	)	PUNCT
iajs-3307	94	99	,	,	PUNCT
iajs-3307	94	100	ns	ns	CCONJ
iajs-3307	94	101	:	:	PUNCT
iajs-3307	94	102	non	non	ADJ
iajs-3307	94	103	-	-	ADJ
iajs-3307	94	104	significant	significant	ADJ
iajs-3307	94	105	.	.	PUNCT
iajs-3307	95	1	4	4	X
iajs-3307	95	2	.	.	X
iajs-3307	95	3	discussion	discussion	NOUN
iajs-3307	95	4	polycystic	polycystic	ADJ
iajs-3307	95	5	ovarian	ovarian	ADJ
iajs-3307	95	6	syndrome	syndrome	NOUN
iajs-3307	95	7	is	be	AUX
iajs-3307	95	8	a	a	DET
iajs-3307	95	9	frequent	frequent	ADJ
iajs-3307	95	10	reproductive	reproductive	ADJ
iajs-3307	95	11	condition	condition	NOUN
iajs-3307	95	12	that	that	PRON
iajs-3307	95	13	can	can	AUX
iajs-3307	95	14	lead	lead	VERB
iajs-3307	95	15	to	to	ADP
iajs-3307	95	16	infertility	infertility	NOUN
iajs-3307	95	17	and	and	CCONJ
iajs-3307	95	18	has	have	VERB
iajs-3307	95	19	serious	serious	ADJ
iajs-3307	95	20	social	social	ADJ
iajs-3307	95	21	,	,	PUNCT
iajs-3307	95	22	medical	medical	ADJ
iajs-3307	95	23	,	,	PUNCT
iajs-3307	95	24	and	and	CCONJ
iajs-3307	95	25	economic	economic	ADJ
iajs-3307	95	26	consequences	consequence	NOUN
iajs-3307	95	27	for	for	ADP
iajs-3307	95	28	individuals	individual	NOUN
iajs-3307	95	29	.	.	PUNCT
iajs-3307	96	1	its	its	PRON
iajs-3307	96	2	reasons	reason	NOUN
iajs-3307	96	3	are	be	AUX
iajs-3307	96	4	still	still	ADV
iajs-3307	96	5	unclear	unclear	ADJ
iajs-3307	96	6	.	.	PUNCT
iajs-3307	97	1	several	several	ADJ
iajs-3307	97	2	studies	study	NOUN
iajs-3307	97	3	have	have	AUX
iajs-3307	97	4	been	be	AUX
iajs-3307	97	5	published	publish	VERB
iajs-3307	97	6	in	in	ADP
iajs-3307	97	7	order	order	NOUN
iajs-3307	97	8	to	to	PART
iajs-3307	97	9	investigate	investigate	VERB
iajs-3307	97	10	the	the	DET
iajs-3307	97	11	levels	level	NOUN
iajs-3307	97	12	of	of	ADP
iajs-3307	97	13	mcp-1	mcp-1	NOUN
iajs-3307	97	14	in	in	ADP
iajs-3307	97	15	pcos	pcos	ADJ
iajs-3307	97	16	women	woman	NOUN
iajs-3307	97	17	.	.	PUNCT
iajs-3307	98	1	according	accord	VERB
iajs-3307	98	2	to	to	ADP
iajs-3307	98	3	some	some	DET
iajs-3307	98	4	studies	study	NOUN
iajs-3307	98	5	,	,	PUNCT
iajs-3307	98	6	circulating	circulate	VERB
iajs-3307	98	7	mcp-1	mcp-1	DET
iajs-3307	98	8	levels	level	NOUN
iajs-3307	98	9	in	in	ADP
iajs-3307	98	10	pcos	pcos	PROPN
iajs-3307	98	11	patients	patient	NOUN
iajs-3307	98	12	are	be	AUX
iajs-3307	98	13	much	much	ADV
iajs-3307	98	14	higher	high	ADJ
iajs-3307	98	15	than	than	ADP
iajs-3307	98	16	in	in	ADP
iajs-3307	98	17	non	non	ADJ
iajs-3307	98	18	-	-	ADJ
iajs-3307	98	19	pcos	pcos	ADJ
iajs-3307	98	20	individuals	individual	NOUN
iajs-3307	98	21	[	[	X
iajs-3307	98	22	26	26	NUM
iajs-3307	98	23	]	]	PUNCT
iajs-3307	98	24	.	.	PUNCT
iajs-3307	99	1	however	however	ADV
iajs-3307	99	2	,	,	PUNCT
iajs-3307	99	3	other	other	ADJ
iajs-3307	99	4	investigations	investigation	NOUN
iajs-3307	99	5	have	have	AUX
iajs-3307	99	6	found	find	VERB
iajs-3307	99	7	no	no	DET
iajs-3307	99	8	significant	significant	ADJ
iajs-3307	99	9	differences	difference	NOUN
iajs-3307	99	10	in	in	ADP
iajs-3307	99	11	levels	level	NOUN
iajs-3307	99	12	of	of	ADP
iajs-3307	99	13	mcp-1	mcp-1	PUNCT
iajs-3307	99	14	between	between	ADP
iajs-3307	99	15	non	non	ADJ
iajs-3307	99	16	-	-	ADJ
iajs-3307	99	17	pcos	pcos	ADJ
iajs-3307	99	18	and	and	CCONJ
iajs-3307	99	19	pcos	pcos	NOUN
iajs-3307	99	20	women	woman	NOUN
iajs-3307	99	21	[	[	X
iajs-3307	99	22	27	27	NUM
iajs-3307	99	23	,	,	PUNCT
iajs-3307	99	24	28	28	NUM
iajs-3307	99	25	]	]	PUNCT
iajs-3307	99	26	.	.	PUNCT
iajs-3307	100	1	ihjpas	ihjpas	PROPN
iajs-3307	100	2	.	.	PUNCT
iajs-3307	101	1	37	37	NUM
iajs-3307	101	2	(	(	PUNCT
iajs-3307	101	3	1	1	NUM
iajs-3307	101	4	)	)	PUNCT
iajs-3307	101	5	2024	2024	NUM
iajs-3307	101	6	90	90	NUM
iajs-3307	101	7	in	in	ADP
iajs-3307	101	8	our	our	PRON
iajs-3307	101	9	current	current	ADJ
iajs-3307	101	10	study	study	NOUN
iajs-3307	101	11	,	,	PUNCT
iajs-3307	101	12	mcp-1	mcp-1	X
iajs-3307	101	13	in	in	ADP
iajs-3307	101	14	women	woman	NOUN
iajs-3307	101	15	with	with	ADP
iajs-3307	101	16	pcos	pcos	PROPN
iajs-3307	101	17	(	(	PUNCT
iajs-3307	101	18	154.53	154.53	NUM
iajs-3307	101	19	±	±	NUM
iajs-3307	101	20	14.92	14.92	NUM
iajs-3307	101	21	)	)	PUNCT
iajs-3307	101	22	was	be	AUX
iajs-3307	101	23	higher	high	ADJ
iajs-3307	101	24	than	than	ADP
iajs-3307	101	25	in	in	ADP
iajs-3307	101	26	women	woman	NOUN
iajs-3307	101	27	without	without	ADP
iajs-3307	101	28	pcos	pcos	PROPN
iajs-3307	101	29	(	(	PUNCT
iajs-3307	101	30	123.5	123.5	NUM
iajs-3307	101	31	±	±	NUM
iajs-3307	101	32	11.91	11.91	NUM
iajs-3307	101	33	)	)	PUNCT
iajs-3307	101	34	,	,	PUNCT
iajs-3307	101	35	but	but	CCONJ
iajs-3307	101	36	did	do	AUX
iajs-3307	101	37	not	not	PART
iajs-3307	101	38	reach	reach	VERB
iajs-3307	101	39	the	the	DET
iajs-3307	101	40	degree	degree	NOUN
iajs-3307	101	41	of	of	ADP
iajs-3307	101	42	probability	probability	NOUN
iajs-3307	101	43	(	(	PUNCT
iajs-3307	101	44	0.05	0.05	NUM
iajs-3307	101	45	)	)	PUNCT
iajs-3307	101	46	.	.	PUNCT
iajs-3307	102	1	mcp1	mcp1	PROPN
iajs-3307	102	2	,	,	PUNCT
iajs-3307	102	3	regarded	regard	VERB
iajs-3307	102	4	as	as	ADP
iajs-3307	102	5	a	a	DET
iajs-3307	102	6	chemotactic	chemotactic	ADJ
iajs-3307	102	7	cytokine	cytokine	NOUN
iajs-3307	102	8	,	,	PUNCT
iajs-3307	102	9	regulates	regulate	VERB
iajs-3307	102	10	the	the	DET
iajs-3307	102	11	placement	placement	NOUN
iajs-3307	102	12	of	of	ADP
iajs-3307	102	13	leukocytes	leukocyte	NOUN
iajs-3307	102	14	and	and	CCONJ
iajs-3307	102	15	monocytes	monocyte	VERB
iajs-3307	102	16	in	in	ADP
iajs-3307	102	17	tissues	tissue	NOUN
iajs-3307	102	18	during	during	ADP
iajs-3307	102	19	inflammation	inflammation	NOUN
iajs-3307	102	20	and	and	CCONJ
iajs-3307	102	21	infection	infection	NOUN
iajs-3307	102	22	response	response	NOUN
iajs-3307	102	23	[	[	X
iajs-3307	102	24	29	29	NUM
iajs-3307	102	25	]	]	PUNCT
iajs-3307	102	26	.	.	PUNCT
iajs-3307	103	1	the	the	DET
iajs-3307	103	2	interaction	interaction	NOUN
iajs-3307	103	3	of	of	ADP
iajs-3307	103	4	mcp-1	mcp-1	NOUN
iajs-3307	103	5	with	with	ADP
iajs-3307	103	6	its	its	PRON
iajs-3307	103	7	receptor	receptor	NOUN
iajs-3307	103	8	ccr2	ccr2	NOUN
iajs-3307	103	9	is	be	AUX
iajs-3307	103	10	critical	critical	ADJ
iajs-3307	103	11	in	in	ADP
iajs-3307	103	12	inflammation	inflammation	NOUN
iajs-3307	103	13	and	and	CCONJ
iajs-3307	103	14	inflammation	inflammation	NOUN
iajs-3307	103	15	-	-	PUNCT
iajs-3307	103	16	related	relate	VERB
iajs-3307	103	17	diseases	disease	NOUN
iajs-3307	103	18	,	,	PUNCT
iajs-3307	103	19	and	and	CCONJ
iajs-3307	103	20	mcp-1	mcp-1	NOUN
iajs-3307	103	21	-	-	ADJ
iajs-3307	103	22	ccr2	ccr2	ADJ
iajs-3307	103	23	binding	binding	NOUN
iajs-3307	103	24	contributes	contribute	VERB
iajs-3307	103	25	to	to	ADP
iajs-3307	103	26	the	the	DET
iajs-3307	103	27	innate	innate	ADJ
iajs-3307	103	28	immune	immune	ADJ
iajs-3307	103	29	response	response	NOUN
iajs-3307	103	30	by	by	ADP
iajs-3307	103	31	attracting	attract	VERB
iajs-3307	103	32	monocytes	monocyte	NOUN
iajs-3307	103	33	to	to	ADP
iajs-3307	103	34	the	the	DET
iajs-3307	103	35	sites	site	NOUN
iajs-3307	103	36	of	of	ADP
iajs-3307	103	37	inflammation	inflammation	NOUN
iajs-3307	103	38	.	.	PUNCT
iajs-3307	104	1	[	[	X
iajs-3307	104	2	5	5	NUM
iajs-3307	104	3	]	]	PUNCT
iajs-3307	104	4	.	.	PUNCT
iajs-3307	105	1	mcp-1	mcp-1	PRON
iajs-3307	105	2	may	may	AUX
iajs-3307	105	3	be	be	AUX
iajs-3307	105	4	involved	involve	VERB
iajs-3307	105	5	in	in	ADP
iajs-3307	105	6	ovulation	ovulation	NOUN
iajs-3307	105	7	,	,	PUNCT
iajs-3307	105	8	follicular	follicular	ADJ
iajs-3307	105	9	growth	growth	NOUN
iajs-3307	105	10	,	,	PUNCT
iajs-3307	105	11	and	and	CCONJ
iajs-3307	105	12	the	the	DET
iajs-3307	105	13	formation	formation	NOUN
iajs-3307	105	14	and	and	CCONJ
iajs-3307	105	15	regression	regression	NOUN
iajs-3307	105	16	of	of	ADP
iajs-3307	105	17	the	the	DET
iajs-3307	105	18	corpus	corpus	NOUN
iajs-3307	105	19	luteum	luteum	NOUN
iajs-3307	105	20	.	.	PUNCT
iajs-3307	106	1	the	the	DET
iajs-3307	106	2	authors	author	NOUN
iajs-3307	106	3	hypothesized	hypothesize	VERB
iajs-3307	106	4	that	that	SCONJ
iajs-3307	106	5	increased	increase	VERB
iajs-3307	106	6	levels	level	NOUN
iajs-3307	106	7	of	of	ADP
iajs-3307	106	8	mcp-1	mcp-1	NOUN
iajs-3307	106	9	may	may	AUX
iajs-3307	106	10	have	have	VERB
iajs-3307	106	11	an	an	DET
iajs-3307	106	12	effect	effect	NOUN
iajs-3307	106	13	on	on	ADP
iajs-3307	106	14	follicular	follicular	ADJ
iajs-3307	106	15	cell	cell	NOUN
iajs-3307	106	16	function	function	NOUN
iajs-3307	106	17	and	and	CCONJ
iajs-3307	106	18	oocyte	oocyte	ADJ
iajs-3307	106	19	quality	quality	NOUN
iajs-3307	106	20	by	by	ADP
iajs-3307	106	21	causing	cause	VERB
iajs-3307	106	22	an	an	DET
iajs-3307	106	23	intracellular	intracellular	ADJ
iajs-3307	106	24	proinflammatory	proinflammatory	ADJ
iajs-3307	106	25	state	state	NOUN
iajs-3307	106	26	via	via	ADP
iajs-3307	106	27	mcp-1	mcp-1	NOUN
iajs-3307	106	28	receptor	receptor	NOUN
iajs-3307	106	29	activation	activation	NOUN
iajs-3307	106	30	or	or	CCONJ
iajs-3307	106	31	an	an	DET
iajs-3307	106	32	influx	influx	NOUN
iajs-3307	106	33	of	of	ADP
iajs-3307	106	34	monocytes	monocyte	NOUN
iajs-3307	106	35	into	into	ADP
iajs-3307	106	36	the	the	DET
iajs-3307	106	37	ovary	ovary	NOUN
iajs-3307	106	38	[	[	X
iajs-3307	106	39	8	8	NUM
iajs-3307	106	40	]	]	PUNCT
iajs-3307	106	41	.	.	PUNCT
iajs-3307	107	1	it	it	PRON
iajs-3307	107	2	has	have	AUX
iajs-3307	107	3	been	be	AUX
iajs-3307	107	4	linked	link	VERB
iajs-3307	107	5	to	to	ADP
iajs-3307	107	6	the	the	DET
iajs-3307	107	7	development	development	NOUN
iajs-3307	107	8	of	of	ADP
iajs-3307	107	9	a	a	DET
iajs-3307	107	10	variety	variety	NOUN
iajs-3307	107	11	of	of	ADP
iajs-3307	107	12	disease	disease	NOUN
iajs-3307	107	13	disorders	disorder	NOUN
iajs-3307	107	14	,	,	PUNCT
iajs-3307	107	15	both	both	PRON
iajs-3307	107	16	directly	directly	ADV
iajs-3307	107	17	and	and	CCONJ
iajs-3307	107	18	indirectly	indirectly	ADV
iajs-3307	107	19	,	,	PUNCT
iajs-3307	107	20	including	include	VERB
iajs-3307	107	21	the	the	DET
iajs-3307	107	22	corona	corona	NOUN
iajs-3307	107	23	virus	virus	NOUN
iajs-3307	107	24	,	,	PUNCT
iajs-3307	107	25	cancer	cancer	NOUN
iajs-3307	107	26	,	,	PUNCT
iajs-3307	107	27	neuroinflammatory	neuroinflammatory	ADJ
iajs-3307	107	28	disorders	disorder	NOUN
iajs-3307	107	29	,	,	PUNCT
iajs-3307	107	30	cardiovascular	cardiovascular	ADJ
iajs-3307	107	31	diseases	disease	NOUN
iajs-3307	107	32	,	,	PUNCT
iajs-3307	107	33	rheumatoid	rheumatoid	NOUN
iajs-3307	107	34	arthritis	arthritis	NOUN
iajs-3307	107	35	,	,	PUNCT
iajs-3307	107	36	insulin	insulin	NOUN
iajs-3307	107	37	resistance	resistance	NOUN
iajs-3307	107	38	,	,	PUNCT
iajs-3307	107	39	and	and	CCONJ
iajs-3307	107	40	respiratory	respiratory	ADJ
iajs-3307	107	41	tract	tract	NOUN
iajs-3307	107	42	infection	infection	NOUN
iajs-3307	107	43	[	[	X
iajs-3307	107	44	30	30	NUM
iajs-3307	107	45	]	]	PUNCT
iajs-3307	107	46	.	.	PUNCT
iajs-3307	108	1	in	in	ADP
iajs-3307	108	2	the	the	DET
iajs-3307	108	3	present	present	ADJ
iajs-3307	108	4	study	study	NOUN
iajs-3307	108	5	,	,	PUNCT
iajs-3307	108	6	we	we	PRON
iajs-3307	108	7	conducted	conduct	VERB
iajs-3307	108	8	analysis	analysis	NOUN
iajs-3307	108	9	based	base	VERB
iajs-3307	108	10	on	on	ADP
iajs-3307	108	11	patients	patient	NOUN
iajs-3307	108	12	'	'	PART
iajs-3307	108	13	bmi	bmi	NOUN
iajs-3307	108	14	(	(	PUNCT
iajs-3307	108	15	<	<	X
iajs-3307	108	16	25	25	NUM
iajs-3307	108	17	and	and	CCONJ
iajs-3307	108	18	≥25	≥25	NUM
iajs-3307	108	19	)	)	PUNCT
iajs-3307	108	20	.	.	PUNCT
iajs-3307	109	1	the	the	DET
iajs-3307	109	2	results	result	NOUN
iajs-3307	109	3	of	of	ADP
iajs-3307	109	4	the	the	DET
iajs-3307	109	5	study	study	NOUN
iajs-3307	109	6	showed	show	VERB
iajs-3307	109	7	no	no	DET
iajs-3307	109	8	significant	significant	ADJ
iajs-3307	109	9	relationship	relationship	NOUN
iajs-3307	109	10	between	between	ADP
iajs-3307	109	11	mcp1	mcp1	PROPN
iajs-3307	109	12	and	and	CCONJ
iajs-3307	109	13	either	either	CCONJ
iajs-3307	109	14	the	the	DET
iajs-3307	109	15	non	non	ADJ
iajs-3307	109	16	-	-	ADJ
iajs-3307	109	17	obese	obese	ADJ
iajs-3307	109	18	or	or	CCONJ
iajs-3307	109	19	obese	obese	ADJ
iajs-3307	109	20	groups	group	NOUN
iajs-3307	109	21	.	.	PUNCT
iajs-3307	110	1	the	the	DET
iajs-3307	110	2	small	small	ADJ
iajs-3307	110	3	size	size	NOUN
iajs-3307	110	4	of	of	ADP
iajs-3307	110	5	the	the	DET
iajs-3307	110	6	included	include	VERB
iajs-3307	110	7	studies	study	NOUN
iajs-3307	110	8	is	be	AUX
iajs-3307	110	9	a	a	DET
iajs-3307	110	10	limitation	limitation	NOUN
iajs-3307	110	11	of	of	ADP
iajs-3307	110	12	this	this	DET
iajs-3307	110	13	study	study	NOUN
iajs-3307	110	14	,	,	PUNCT
iajs-3307	110	15	which	which	PRON
iajs-3307	110	16	will	will	AUX
iajs-3307	110	17	influence	influence	VERB
iajs-3307	110	18	the	the	DET
iajs-3307	110	19	analysis	analysis	NOUN
iajs-3307	110	20	results	result	NOUN
iajs-3307	110	21	.	.	PUNCT
iajs-3307	111	1	also	also	ADV
iajs-3307	111	2	,	,	PUNCT
iajs-3307	111	3	there	there	PRON
iajs-3307	111	4	were	be	VERB
iajs-3307	111	5	no	no	DET
iajs-3307	111	6	significant	significant	ADJ
iajs-3307	111	7	associations	association	NOUN
iajs-3307	111	8	between	between	ADP
iajs-3307	111	9	mcp1	mcp1	PROPN
iajs-3307	111	10	and	and	CCONJ
iajs-3307	111	11	fertility	fertility	NOUN
iajs-3307	111	12	hormones	hormone	NOUN
iajs-3307	111	13	;	;	PUNCT
iajs-3307	111	14	the	the	DET
iajs-3307	111	15	lack	lack	NOUN
iajs-3307	111	16	of	of	ADP
iajs-3307	111	17	significant	significant	ADJ
iajs-3307	111	18	associations	association	NOUN
iajs-3307	111	19	between	between	ADP
iajs-3307	111	20	these	these	DET
iajs-3307	111	21	hormones	hormone	NOUN
iajs-3307	111	22	and	and	CCONJ
iajs-3307	111	23	mcp1	mcp1	PROPN
iajs-3307	111	24	may	may	AUX
iajs-3307	111	25	indicate	indicate	VERB
iajs-3307	111	26	that	that	SCONJ
iajs-3307	111	27	changes	change	NOUN
iajs-3307	111	28	in	in	ADP
iajs-3307	111	29	these	these	DET
iajs-3307	111	30	hormones	hormone	NOUN
iajs-3307	111	31	alone	alone	ADV
iajs-3307	111	32	are	be	AUX
iajs-3307	111	33	insufficient	insufficient	ADJ
iajs-3307	111	34	to	to	PART
iajs-3307	111	35	generate	generate	VERB
iajs-3307	111	36	any	any	DET
iajs-3307	111	37	corresponding	corresponding	ADJ
iajs-3307	111	38	changes	change	NOUN
iajs-3307	111	39	in	in	ADP
iajs-3307	111	40	chemoattractant	chemoattractant	ADJ
iajs-3307	111	41	cytokine	cytokine	NOUN
iajs-3307	111	42	activity	activity	NOUN
iajs-3307	111	43	.	.	PUNCT
iajs-3307	112	1	luteinizing	luteinize	VERB
iajs-3307	112	2	hormone	hormone	NOUN
iajs-3307	112	3	(	(	PUNCT
iajs-3307	112	4	lh	lh	PROPN
iajs-3307	112	5	)	)	PUNCT
iajs-3307	112	6	was	be	AUX
iajs-3307	112	7	higher	high	ADJ
iajs-3307	112	8	in	in	ADP
iajs-3307	112	9	patients	patient	NOUN
iajs-3307	112	10	’	'	PUNCT
iajs-3307	112	11	group	group	NOUN
iajs-3307	112	12	(	(	PUNCT
iajs-3307	112	13	6.54	6.54	NUM
iajs-3307	112	14	±0.51	±0.51	PROPN
iajs-3307	112	15	miu	miu	PROPN
iajs-3307	112	16	/	/	SYM
iajs-3307	112	17	ml	ml	NOUN
iajs-3307	112	18	)	)	PUNCT
iajs-3307	112	19	than	than	ADP
iajs-3307	112	20	control	control	NOUN
iajs-3307	112	21	group	group	NOUN
iajs-3307	112	22	(	(	PUNCT
iajs-3307	112	23	2.93	2.93	NUM
iajs-3307	112	24	±0.18	±0.18	PROPN
iajs-3307	112	25	miu	miu	PROPN
iajs-3307	112	26	/	/	SYM
iajs-3307	112	27	ml	ml	PROPN
iajs-3307	112	28	)	)	PUNCT
iajs-3307	112	29	.	.	PUNCT
iajs-3307	113	1	the	the	DET
iajs-3307	113	2	results	result	NOUN
iajs-3307	113	3	of	of	ADP
iajs-3307	113	4	the	the	DET
iajs-3307	113	5	current	current	ADJ
iajs-3307	113	6	study	study	NOUN
iajs-3307	113	7	were	be	AUX
iajs-3307	113	8	similar	similar	ADJ
iajs-3307	113	9	to	to	ADP
iajs-3307	113	10	many	many	ADJ
iajs-3307	113	11	previous	previous	ADJ
iajs-3307	113	12	studies	study	NOUN
iajs-3307	113	13	which	which	PRON
iajs-3307	113	14	reported	report	VERB
iajs-3307	113	15	that	that	SCONJ
iajs-3307	113	16	increased	increase	VERB
iajs-3307	113	17	levels	level	NOUN
iajs-3307	113	18	of	of	ADP
iajs-3307	113	19	lh	lh	PROPN
iajs-3307	113	20	hormone	hormone	NOUN
iajs-3307	113	21	are	be	AUX
iajs-3307	113	22	mostly	mostly	ADV
iajs-3307	113	23	due	due	ADJ
iajs-3307	113	24	to	to	ADP
iajs-3307	113	25	gnrh	gnrh	NOUN
iajs-3307	113	26	dysfunction	dysfunction	NOUN
iajs-3307	113	27	.	.	PUNCT
iajs-3307	114	1	disruptions	disruption	NOUN
iajs-3307	114	2	in	in	ADP
iajs-3307	114	3	the	the	DET
iajs-3307	114	4	hypothalamic	hypothalamic	ADJ
iajs-3307	114	5	-	-	PUNCT
iajs-3307	114	6	pituitary	pituitary	ADJ
iajs-3307	114	7	-	-	PUNCT
iajs-3307	114	8	ovarian	ovarian	ADJ
iajs-3307	114	9	or	or	CCONJ
iajs-3307	114	10	adrenal	adrenal	ADJ
iajs-3307	114	11	axis	axis	NOUN
iajs-3307	114	12	have	have	AUX
iajs-3307	114	13	been	be	AUX
iajs-3307	114	14	implicated	implicate	VERB
iajs-3307	114	15	in	in	ADP
iajs-3307	114	16	the	the	DET
iajs-3307	114	17	etiology	etiology	NOUN
iajs-3307	114	18	of	of	ADP
iajs-3307	114	19	polycystic	polycystic	ADJ
iajs-3307	114	20	ovarian	ovarian	ADJ
iajs-3307	114	21	syndrome	syndrome	NOUN
iajs-3307	114	22	.	.	PUNCT
iajs-3307	115	1	anomalies	anomaly	NOUN
iajs-3307	115	2	in	in	ADP
iajs-3307	115	3	the	the	DET
iajs-3307	115	4	gonadotrophin	gonadotrophin	NOUN
iajs-3307	115	5	-	-	PUNCT
iajs-3307	115	6	releasing	release	VERB
iajs-3307	115	7	hormone	hormone	NOUN
iajs-3307	115	8	(	(	PUNCT
iajs-3307	115	9	gnrh	gnrh	NOUN
iajs-3307	115	10	)	)	PUNCT
iajs-3307	115	11	secretion	secretion	NOUN
iajs-3307	115	12	mechanism	mechanism	NOUN
iajs-3307	115	13	cause	cause	VERB
iajs-3307	115	14	a	a	DET
iajs-3307	115	15	relative	relative	ADJ
iajs-3307	115	16	increase	increase	NOUN
iajs-3307	115	17	in	in	ADP
iajs-3307	115	18	lh	lh	PROPN
iajs-3307	115	19	to	to	ADP
iajs-3307	115	20	fsh	fsh	NOUN
iajs-3307	115	21	release	release	NOUN
iajs-3307	115	22	[	[	X
iajs-3307	115	23	23	23	NUM
iajs-3307	115	24	]	]	PUNCT
iajs-3307	115	25	.	.	PUNCT
iajs-3307	116	1	lh	lh	PROPN
iajs-3307	116	2	is	be	AUX
iajs-3307	116	3	responsible	responsible	ADJ
iajs-3307	116	4	for	for	ADP
iajs-3307	116	5	ovulation	ovulation	NOUN
iajs-3307	116	6	(	(	PUNCT
iajs-3307	116	7	releasing	release	VERB
iajs-3307	116	8	eggs	egg	NOUN
iajs-3307	116	9	from	from	ADP
iajs-3307	116	10	the	the	DET
iajs-3307	116	11	ovary	ovary	NOUN
iajs-3307	116	12	)	)	PUNCT
iajs-3307	116	13	.	.	PUNCT
iajs-3307	117	1	the	the	DET
iajs-3307	117	2	aberrant	aberrant	ADJ
iajs-3307	117	3	release	release	NOUN
iajs-3307	117	4	of	of	ADP
iajs-3307	117	5	ovarian	ovarian	ADJ
iajs-3307	117	6	androstenedione	androstenedione	NOUN
iajs-3307	117	7	appears	appear	VERB
iajs-3307	117	8	to	to	PART
iajs-3307	117	9	be	be	AUX
iajs-3307	117	10	an	an	DET
iajs-3307	117	11	inherent	inherent	ADJ
iajs-3307	117	12	feature	feature	NOUN
iajs-3307	117	13	of	of	ADP
iajs-3307	117	14	pcos	pcos	PROPN
iajs-3307	117	15	theca	theca	PROPN
iajs-3307	117	16	/	/	SYM
iajs-3307	117	17	granulose	granulose	NOUN
iajs-3307	117	18	cells	cell	NOUN
iajs-3307	117	19	.	.	PUNCT
iajs-3307	118	1	chronic	chronic	ADJ
iajs-3307	118	2	lh	lh	PROPN
iajs-3307	118	3	stimulation	stimulation	NOUN
iajs-3307	118	4	in	in	ADP
iajs-3307	118	5	pcos	pcos	PROPN
iajs-3307	118	6	causes	cause	VERB
iajs-3307	118	7	the	the	DET
iajs-3307	118	8	theca	theca	NOUN
iajs-3307	118	9	compartment	compartment	NOUN
iajs-3307	118	10	to	to	PART
iajs-3307	118	11	secrete	secrete	VERB
iajs-3307	118	12	androgens	androgen	NOUN
iajs-3307	118	13	continuously	continuously	ADV
iajs-3307	118	14	[	[	X
iajs-3307	118	15	31	31	NUM
iajs-3307	118	16	]	]	PUNCT
iajs-3307	118	17	.	.	PUNCT
iajs-3307	119	1	prolactin	prolactin	ADJ
iajs-3307	119	2	hormone	hormone	NOUN
iajs-3307	119	3	showed	show	VERB
iajs-3307	119	4	no	no	DET
iajs-3307	119	5	significant	significant	ADJ
iajs-3307	119	6	increase	increase	NOUN
iajs-3307	119	7	in	in	ADP
iajs-3307	119	8	the	the	DET
iajs-3307	119	9	pcos	pcos	PROPN
iajs-3307	119	10	group	group	NOUN
iajs-3307	119	11	compared	compare	VERB
iajs-3307	119	12	to	to	ADP
iajs-3307	119	13	non	non	ADJ
iajs-3307	119	14	-	-	ADJ
iajs-3307	119	15	pcos	pcos	ADJ
iajs-3307	119	16	individuals	individual	NOUN
iajs-3307	119	17	.	.	PUNCT
iajs-3307	120	1	high	high	ADJ
iajs-3307	120	2	blood	blood	NOUN
iajs-3307	120	3	prl	prl	PROPN
iajs-3307	120	4	levels	level	NOUN
iajs-3307	120	5	above	above	ADP
iajs-3307	120	6	the	the	DET
iajs-3307	120	7	normal	normal	ADJ
iajs-3307	120	8	range	range	NOUN
iajs-3307	120	9	can	can	AUX
iajs-3307	120	10	directly	directly	ADV
iajs-3307	120	11	block	block	VERB
iajs-3307	120	12	the	the	DET
iajs-3307	120	13	production	production	NOUN
iajs-3307	120	14	and	and	CCONJ
iajs-3307	120	15	release	release	NOUN
iajs-3307	120	16	of	of	ADP
iajs-3307	120	17	gonadotropin	gonadotropin	NOUN
iajs-3307	120	18	-	-	PUNCT
iajs-3307	120	19	releasing	release	VERB
iajs-3307	120	20	hormone	hormone	NOUN
iajs-3307	120	21	(	(	PUNCT
iajs-3307	120	22	gnrh	gnrh	NOUN
iajs-3307	120	23	)	)	PUNCT
iajs-3307	120	24	from	from	ADP
iajs-3307	120	25	the	the	DET
iajs-3307	120	26	hypothalamus	hypothalamus	NOUN
iajs-3307	120	27	,	,	PUNCT
iajs-3307	120	28	as	as	ADV
iajs-3307	120	29	well	well	ADV
iajs-3307	120	30	as	as	ADP
iajs-3307	120	31	limit	limit	VERB
iajs-3307	120	32	gnrh	gnrh	NOUN
iajs-3307	120	33	secretion	secretion	NOUN
iajs-3307	120	34	to	to	ADP
iajs-3307	120	35	the	the	DET
iajs-3307	120	36	portal	portal	ADJ
iajs-3307	120	37	vein	vein	NOUN
iajs-3307	121	1	[	[	X
iajs-3307	121	2	32	32	NUM
iajs-3307	121	3	]	]	PUNCT
iajs-3307	121	4	.	.	PUNCT
iajs-3307	122	1	[	[	X
iajs-3307	122	2	33	33	NUM
iajs-3307	122	3	]	]	PUNCT
iajs-3307	122	4	were	be	AUX
iajs-3307	122	5	proposed	propose	VERB
iajs-3307	122	6	that	that	SCONJ
iajs-3307	122	7	the	the	DET
iajs-3307	122	8	stimulatory	stimulatory	ADJ
iajs-3307	122	9	effects	effect	NOUN
iajs-3307	122	10	of	of	ADP
iajs-3307	122	11	recombinant	recombinant	ADJ
iajs-3307	122	12	human	human	ADJ
iajs-3307	122	13	follicle	follicle	NOUN
iajs-3307	122	14	-	-	PUNCT
iajs-3307	122	15	stimulating	stimulate	VERB
iajs-3307	122	16	hormone	hormone	NOUN
iajs-3307	122	17	(	(	PUNCT
iajs-3307	122	18	r	r	NOUN
iajs-3307	122	19	-	-	PUNCT
iajs-3307	122	20	hfsh	hfsh	NOUN
iajs-3307	122	21	)	)	PUNCT
iajs-3307	122	22	increased	increase	VERB
iajs-3307	122	23	the	the	DET
iajs-3307	122	24	capacity	capacity	NOUN
iajs-3307	122	25	for	for	ADP
iajs-3307	122	26	estradiol	estradiol	PROPN
iajs-3307	122	27	(	(	PUNCT
iajs-3307	122	28	e2	e2	PROPN
iajs-3307	122	29	)	)	PUNCT
iajs-3307	122	30	generation	generation	NOUN
iajs-3307	122	31	in	in	ADP
iajs-3307	122	32	women	woman	NOUN
iajs-3307	122	33	with	with	ADP
iajs-3307	122	34	pcos	pco	NOUN
iajs-3307	122	35	,	,	PUNCT
iajs-3307	122	36	which	which	PRON
iajs-3307	122	37	may	may	AUX
iajs-3307	122	38	lead	lead	VERB
iajs-3307	122	39	to	to	ADP
iajs-3307	122	40	an	an	DET
iajs-3307	122	41	increase	increase	NOUN
iajs-3307	122	42	in	in	ADP
iajs-3307	122	43	prl	prl	PROPN
iajs-3307	122	44	.	.	PUNCT
iajs-3307	123	1	since	since	SCONJ
iajs-3307	123	2	dopamine	dopamine	NOUN
iajs-3307	123	3	inhibits	inhibit	VERB
iajs-3307	123	4	the	the	DET
iajs-3307	123	5	secretion	secretion	NOUN
iajs-3307	123	6	of	of	ADP
iajs-3307	123	7	pituitary	pituitary	ADJ
iajs-3307	123	8	prolactin	prolactin	NOUN
iajs-3307	123	9	,	,	PUNCT
iajs-3307	123	10	excessive	excessive	ADJ
iajs-3307	123	11	luteinizing	luteinizing	NOUN
iajs-3307	123	12	hormone	hormone	NOUN
iajs-3307	123	13	(	(	PUNCT
iajs-3307	123	14	lh	lh	PROPN
iajs-3307	123	15	)	)	PUNCT
iajs-3307	123	16	and	and	CCONJ
iajs-3307	123	17	prolactin	prolactin	NOUN
iajs-3307	123	18	(	(	PUNCT
iajs-3307	123	19	prl	prl	NOUN
iajs-3307	123	20	)	)	PUNCT
iajs-3307	123	21	production	production	NOUN
iajs-3307	123	22	in	in	ADP
iajs-3307	123	23	pcos	pcos	PROPN
iajs-3307	123	24	women	woman	NOUN
iajs-3307	123	25	may	may	AUX
iajs-3307	123	26	be	be	AUX
iajs-3307	123	27	connected	connect	VERB
iajs-3307	123	28	to	to	ADP
iajs-3307	123	29	low	low	ADJ
iajs-3307	123	30	dopamine	dopamine	NOUN
iajs-3307	123	31	(	(	PUNCT
iajs-3307	123	32	da	da	NOUN
iajs-3307	123	33	)	)	PUNCT
iajs-3307	123	34	hypothalamic	hypothalamic	ADJ
iajs-3307	123	35	tone	tone	NOUN
iajs-3307	123	36	.	.	PUNCT
iajs-3307	124	1	the	the	DET
iajs-3307	124	2	reduced	reduce	VERB
iajs-3307	124	3	dopamine	dopamine	NOUN
iajs-3307	124	4	levels	level	NOUN
iajs-3307	124	5	result	result	VERB
iajs-3307	124	6	in	in	ADP
iajs-3307	124	7	hyperprolactinemia	hyperprolactinemia	PROPN
iajs-3307	125	1	[	[	X
iajs-3307	125	2	34	34	NUM
iajs-3307	125	3	]	]	PUNCT
iajs-3307	125	4	.	.	PUNCT
iajs-3307	126	1	testosterone	testosterone	NOUN
iajs-3307	126	2	levels	level	NOUN
iajs-3307	126	3	in	in	ADP
iajs-3307	126	4	the	the	DET
iajs-3307	126	5	current	current	ADJ
iajs-3307	126	6	research	research	NOUN
iajs-3307	126	7	were	be	AUX
iajs-3307	126	8	elevated	elevate	VERB
iajs-3307	126	9	significantly	significantly	ADV
iajs-3307	126	10	(	(	PUNCT
iajs-3307	126	11	p<0.05	p<0.05	NOUN
iajs-3307	126	12	)	)	PUNCT
iajs-3307	126	13	in	in	ADP
iajs-3307	126	14	the	the	DET
iajs-3307	126	15	pcos	pcos	PROPN
iajs-3307	126	16	group	group	NOUN
iajs-3307	126	17	compared	compare	VERB
iajs-3307	126	18	to	to	ADP
iajs-3307	126	19	the	the	DET
iajs-3307	126	20	control	control	NOUN
iajs-3307	126	21	group	group	NOUN
iajs-3307	126	22	,	,	PUNCT
iajs-3307	126	23	and	and	CCONJ
iajs-3307	126	24	this	this	DET
iajs-3307	126	25	rise	rise	NOUN
iajs-3307	126	26	may	may	AUX
iajs-3307	126	27	be	be	AUX
iajs-3307	126	28	due	due	ADJ
iajs-3307	126	29	to	to	ADP
iajs-3307	126	30	obesity	obesity	NOUN
iajs-3307	126	31	,	,	PUNCT
iajs-3307	126	32	particularly	particularly	ADV
iajs-3307	126	33	abdominal	abdominal	ADJ
iajs-3307	126	34	obesity	obesity	NOUN
iajs-3307	126	35	,	,	PUNCT
iajs-3307	126	36	and	and	CCONJ
iajs-3307	126	37	insulin	insulin	NOUN
iajs-3307	126	38	resistance	resistance	NOUN
iajs-3307	126	39	,	,	PUNCT
iajs-3307	126	40	which	which	PRON
iajs-3307	126	41	are	be	AUX
iajs-3307	126	42	linked	link	VERB
iajs-3307	126	43	to	to	ADP
iajs-3307	126	44	elevated	elevated	ADJ
iajs-3307	126	45	blood	blood	NOUN
iajs-3307	126	46	testosterone	testosterone	NOUN
iajs-3307	126	47	levels	level	NOUN
iajs-3307	126	48	.	.	PUNCT
iajs-3307	127	1	as	as	SCONJ
iajs-3307	127	2	a	a	DET
iajs-3307	127	3	result	result	NOUN
iajs-3307	127	4	ihjpas	ihjpa	VERB
iajs-3307	127	5	.	.	PUNCT
iajs-3307	128	1	37	37	NUM
iajs-3307	128	2	(	(	PUNCT
iajs-3307	128	3	1	1	NUM
iajs-3307	128	4	)	)	PUNCT
iajs-3307	128	5	2024	2024	NUM
iajs-3307	128	6	91	91	NUM
iajs-3307	128	7	of	of	ADP
iajs-3307	128	8	increased	increase	VERB
iajs-3307	128	9	androgen	androgen	NOUN
iajs-3307	128	10	and	and	CCONJ
iajs-3307	128	11	insulin	insulin	NOUN
iajs-3307	128	12	resistance	resistance	NOUN
iajs-3307	128	13	in	in	ADP
iajs-3307	128	14	pcos	pcos	PROPN
iajs-3307	128	15	patients	patient	NOUN
iajs-3307	128	16	,	,	PUNCT
iajs-3307	128	17	testosterone	testosterone	NOUN
iajs-3307	128	18	production	production	NOUN
iajs-3307	128	19	in	in	ADP
iajs-3307	128	20	the	the	DET
iajs-3307	128	21	ovaries	ovary	NOUN
iajs-3307	128	22	rises	rise	VERB
iajs-3307	128	23	[	[	X
iajs-3307	128	24	35	35	NUM
iajs-3307	128	25	]	]	PUNCT
iajs-3307	128	26	.	.	PUNCT
iajs-3307	129	1	also	also	ADV
iajs-3307	129	2	,	,	PUNCT
iajs-3307	129	3	this	this	DET
iajs-3307	129	4	increase	increase	NOUN
iajs-3307	129	5	mostly	mostly	ADV
iajs-3307	129	6	results	result	VERB
iajs-3307	129	7	from	from	ADP
iajs-3307	129	8	the	the	DET
iajs-3307	129	9	inherent	inherent	ADJ
iajs-3307	129	10	alteration	alteration	NOUN
iajs-3307	129	11	of	of	ADP
iajs-3307	129	12	ovarian	ovarian	ADJ
iajs-3307	129	13	theca	theca	NOUN
iajs-3307	129	14	cells	cell	NOUN
iajs-3307	129	15	,	,	PUNCT
iajs-3307	129	16	characterized	characterize	VERB
iajs-3307	129	17	by	by	ADP
iajs-3307	129	18	a	a	DET
iajs-3307	129	19	disruption	disruption	NOUN
iajs-3307	129	20	in	in	ADP
iajs-3307	129	21	the	the	DET
iajs-3307	129	22	expression	expression	NOUN
iajs-3307	129	23	and/or	and/or	CCONJ
iajs-3307	129	24	activity	activity	NOUN
iajs-3307	129	25	of	of	ADP
iajs-3307	129	26	essential	essential	ADJ
iajs-3307	129	27	steroidogenic	steroidogenic	ADJ
iajs-3307	129	28	enzymes	enzyme	NOUN
iajs-3307	129	29	[	[	X
iajs-3307	129	30	36	36	NUM
iajs-3307	129	31	]	]	PUNCT
iajs-3307	129	32	.	.	PUNCT
iajs-3307	130	1	5	5	X
iajs-3307	130	2	.	.	X
iajs-3307	130	3	conclusions	conclusion	NOUN
iajs-3307	130	4	in	in	ADP
iajs-3307	130	5	the	the	DET
iajs-3307	130	6	current	current	ADJ
iajs-3307	130	7	study	study	NOUN
iajs-3307	130	8	,	,	PUNCT
iajs-3307	130	9	we	we	PRON
iajs-3307	130	10	concluded	conclude	VERB
iajs-3307	130	11	that	that	SCONJ
iajs-3307	130	12	mcp1	mcp1	PROPN
iajs-3307	130	13	increases	increase	VERB
iajs-3307	130	14	in	in	ADP
iajs-3307	130	15	patients	patient	NOUN
iajs-3307	130	16	with	with	ADP
iajs-3307	130	17	pcos	pco	NOUN
iajs-3307	130	18	,	,	PUNCT
iajs-3307	130	19	but	but	CCONJ
iajs-3307	130	20	this	this	DET
iajs-3307	130	21	increase	increase	NOUN
iajs-3307	130	22	is	be	AUX
iajs-3307	130	23	not	not	PART
iajs-3307	130	24	significant	significant	ADJ
iajs-3307	130	25	.	.	PUNCT
iajs-3307	131	1	it	it	PRON
iajs-3307	131	2	was	be	AUX
iajs-3307	131	3	not	not	PART
iajs-3307	131	4	influenced	influence	VERB
iajs-3307	131	5	by	by	ADP
iajs-3307	131	6	bmi	bmi	PROPN
iajs-3307	131	7	,	,	PUNCT
iajs-3307	131	8	waist	waist	NOUN
iajs-3307	131	9	-	-	PUNCT
iajs-3307	131	10	hip	hip	NOUN
iajs-3307	131	11	ratio	ratio	NOUN
iajs-3307	131	12	,	,	PUNCT
iajs-3307	131	13	or	or	CCONJ
iajs-3307	131	14	fertility	fertility	NOUN
iajs-3307	131	15	hormones	hormone	NOUN
iajs-3307	131	16	,	,	PUNCT
iajs-3307	131	17	as	as	ADV
iajs-3307	131	18	well	well	ADV
iajs-3307	131	19	as	as	ADP
iajs-3307	131	20	elevated	elevated	ADJ
iajs-3307	131	21	fertility	fertility	NOUN
iajs-3307	131	22	hormones	hormone	NOUN
iajs-3307	131	23	,	,	PUNCT
iajs-3307	131	24	as	as	SCONJ
iajs-3307	131	25	shown	show	VERB
iajs-3307	131	26	in	in	ADP
iajs-3307	131	27	this	this	DET
iajs-3307	131	28	study	study	NOUN
iajs-3307	131	29	.	.	PUNCT
iajs-3307	132	1	acknowledgment	acknowledgment	NOUN
iajs-3307	132	2	we	we	PRON
iajs-3307	132	3	extend	extend	VERB
iajs-3307	132	4	our	our	PRON
iajs-3307	132	5	sincere	sincere	ADJ
iajs-3307	132	6	thanks	thank	NOUN
iajs-3307	132	7	to	to	ADP
iajs-3307	132	8	editor	editor	NOUN
iajs-3307	132	9	-	-	PUNCT
iajs-3307	132	10	in	in	ADP
iajs-3307	132	11	-	-	PUNCT
iajs-3307	132	12	chief	chief	NOUN
iajs-3307	132	13	and	and	CCONJ
iajs-3307	132	14	members	member	NOUN
iajs-3307	132	15	of	of	ADP
iajs-3307	132	16	the	the	DET
iajs-3307	132	17	editorial	editorial	ADJ
iajs-3307	132	18	committee	committee	NOUN
iajs-3307	132	19	in	in	ADP
iajs-3307	132	20	ibn	ibn	PROPN
iajs-3307	132	21	al	al	PROPN
iajs-3307	132	22	-	-	PUNCT
iajs-3307	132	23	haitham	haitham	PROPN
iajs-3307	132	24	journal	journal	PROPN
iajs-3307	132	25	for	for	ADP
iajs-3307	132	26	pure	pure	ADJ
iajs-3307	132	27	and	and	CCONJ
iajs-3307	132	28	applied	applied	ADJ
iajs-3307	132	29	sciences	science	NOUN
iajs-3307	132	30	.	.	PUNCT
iajs-3307	133	1	conflict	conflict	NOUN
iajs-3307	133	2	of	of	ADP
iajs-3307	133	3	interest	interest	NOUN
iajs-3307	133	4	there	there	PRON
iajs-3307	133	5	are	be	VERB
iajs-3307	133	6	no	no	DET
iajs-3307	133	7	conflicts	conflict	NOUN
iajs-3307	133	8	of	of	ADP
iajs-3307	133	9	interest	interest	NOUN
iajs-3307	133	10	.	.	PUNCT
iajs-3307	134	1	funding	funding	NOUN
iajs-3307	134	2	there	there	PRON
iajs-3307	134	3	is	be	VERB
iajs-3307	134	4	no	no	DET
iajs-3307	134	5	funding	funding	NOUN
iajs-3307	134	6	for	for	ADP
iajs-3307	134	7	the	the	DET
iajs-3307	134	8	article	article	NOUN
iajs-3307	134	9	.	.	PUNCT
iajs-3307	135	1	ethical	ethical	ADJ
iajs-3307	135	2	clearance	clearance	NOUN
iajs-3307	135	3	the	the	DET
iajs-3307	135	4	study	study	NOUN
iajs-3307	135	5	was	be	AUX
iajs-3307	135	6	approved	approve	VERB
iajs-3307	135	7	by	by	ADP
iajs-3307	135	8	the	the	DET
iajs-3307	135	9	university	university	PROPN
iajs-3307	135	10	of	of	ADP
iajs-3307	135	11	baghdad	baghdad	PROPN
iajs-3307	135	12	,	,	PUNCT
iajs-3307	135	13	college	college	NOUN
iajs-3307	135	14	of	of	ADP
iajs-3307	135	15	sciences	science	NOUN
iajs-3307	135	16	,	,	PUNCT
iajs-3307	135	17	ethics	ethic	NOUN
iajs-3307	135	18	approval	approval	NOUN
iajs-3307	135	19	no	no	INTJ
iajs-3307	135	20	.	.	PUNCT
iajs-3307	136	1	(	(	PUNCT
iajs-3307	136	2	ref	ref	NOUN
iajs-3307	136	3	.	.	PUNCT
iajs-3307	136	4	:	:	PUNCT
iajs-3307	137	1	csec/1022/0120	csec/1022/0120	X
iajs-3307	137	2	)	)	PUNCT
iajs-3307	137	3	on	on	ADP
iajs-3307	137	4	october	october	PROPN
iajs-3307	137	5	5	5	NUM
iajs-3307	137	6	,	,	PUNCT
iajs-3307	137	7	2022	2022	NUM
iajs-3307	137	8	.	.	PUNCT
iajs-3307	138	1	references	reference	NOUN
iajs-3307	138	2	1	1	NUM
iajs-3307	138	3	.	.	PUNCT
iajs-3307	138	4	wu	wu	PROPN
iajs-3307	138	5	,	,	PUNCT
iajs-3307	138	6	z.	z.	PROPN
iajs-3307	138	7	;	;	PUNCT
iajs-3307	138	8	fang	fang	X
iajs-3307	138	9	,	,	PUNCT
iajs-3307	138	10	l.	l.	PROPN
iajs-3307	138	11	;	;	PUNCT
iajs-3307	138	12	li	li	PROPN
iajs-3307	138	13	,	,	PUNCT
iajs-3307	138	14	y.	y.	PROPN
iajs-3307	138	15	;	;	PUNCT
iajs-3307	138	16	yan	yan	PROPN
iajs-3307	138	17	,	,	PUNCT
iajs-3307	138	18	y.	y.	PROPN
iajs-3307	138	19	;	;	PUNCT
iajs-3307	138	20	thakur	thakur	PROPN
iajs-3307	138	21	,	,	PUNCT
iajs-3307	138	22	a.	a.	NOUN
iajs-3307	138	23	;	;	PUNCT
iajs-3307	138	24	cheng	cheng	PROPN
iajs-3307	138	25	,	,	PUNCT
iajs-3307	138	26	j.c	j.c	PROPN
iajs-3307	138	27	.	.	PROPN
iajs-3307	138	28	;	;	PUNCT
iajs-3307	138	29	sun	sun	PROPN
iajs-3307	138	30	,	,	PUNCT
iajs-3307	138	31	y.p	y.p	PROPN
iajs-3307	138	32	.	.	PROPN
iajs-3307	138	33	association	association	PROPN
iajs-3307	138	34	of	of	ADP
iajs-3307	138	35	circulating	circulate	VERB
iajs-3307	138	36	monocyte	monocyte	NOUN
iajs-3307	138	37	chemoattractant	chemoattractant	NOUN
iajs-3307	138	38	protein‐1	protein‐1	VERB
iajs-3307	138	39	levels	level	NOUN
iajs-3307	138	40	with	with	ADP
iajs-3307	138	41	polycystic	polycystic	ADJ
iajs-3307	138	42	ovary	ovary	ADJ
iajs-3307	138	43	syndrome	syndrome	NOUN
iajs-3307	138	44	:	:	PUNCT
iajs-3307	138	45	a	a	DET
iajs-3307	138	46	meta‐analysis	meta‐analysis	NOUN
iajs-3307	138	47	.	.	PUNCT
iajs-3307	138	48	am	be	AUX
iajs-3307	138	49	.	.	PUNCT
iajs-3307	139	1	j.	j.	PROPN
iajs-3307	139	2	reproduc	reproduc	PROPN
iajs-3307	139	3	.	.	PUNCT
iajs-3307	140	1	immunol	immunol	PROPN
iajs-3307	140	2	.	.	PUNCT
iajs-3307	140	3	,	,	PUNCT
iajs-3307	140	4	2021	2021	NUM
iajs-3307	140	5	;	;	PUNCT
iajs-3307	140	6	86	86	NUM
iajs-3307	140	7	,	,	PUNCT
iajs-3307	140	8	e13407	e13407	PROPN
iajs-3307	140	9	.	.	NOUN
iajs-3307	141	1	2	2	NUM
iajs-3307	141	2	.	.	X
iajs-3307	141	3	mccartney	mccartney	PROPN
iajs-3307	141	4	,	,	PUNCT
iajs-3307	141	5	c.r	c.r	PROPN
iajs-3307	141	6	.	.	PROPN
iajs-3307	141	7	;	;	PUNCT
iajs-3307	141	8	marshall	marshall	PROPN
iajs-3307	141	9	,	,	PUNCT
iajs-3307	141	10	j.c	j.c	PROPN
iajs-3307	141	11	.	.	PROPN
iajs-3307	141	12	polycystic	polycystic	ADJ
iajs-3307	141	13	ovary	ovary	ADJ
iajs-3307	141	14	syndrome	syndrome	NOUN
iajs-3307	141	15	.	.	PUNCT
iajs-3307	142	1	new	new	PROPN
iajs-3307	142	2	england	england	PROPN
iajs-3307	142	3	j.	j.	PROPN
iajs-3307	142	4	med	med	PROPN
iajs-3307	142	5	.	.	PROPN
iajs-3307	142	6	,	,	PUNCT
iajs-3307	142	7	2016	2016	NUM
iajs-3307	142	8	;	;	PUNCT
iajs-3307	142	9	375	375	NUM
iajs-3307	142	10	,	,	PUNCT
iajs-3307	142	11	54	54	NUM
iajs-3307	142	12	-	-	SYM
iajs-3307	142	13	64	64	NUM
iajs-3307	142	14	.	.	PUNCT
iajs-3307	143	1	3	3	X
iajs-3307	143	2	.	.	X
iajs-3307	143	3	lentscher	lentscher	PROPN
iajs-3307	143	4	,	,	PUNCT
iajs-3307	143	5	j.a	j.a	PROPN
iajs-3307	143	6	.	.	PROPN
iajs-3307	143	7	;	;	PUNCT
iajs-3307	143	8	slocum	slocum	PROPN
iajs-3307	143	9	,	,	PUNCT
iajs-3307	143	10	b.	b.	PROPN
iajs-3307	143	11	;	;	PUNCT
iajs-3307	143	12	torrealday	torrealday	PROPN
iajs-3307	143	13	,	,	PUNCT
iajs-3307	143	14	s.	s.	PROPN
iajs-3307	143	15	polycystic	polycystic	ADJ
iajs-3307	143	16	ovarian	ovarian	ADJ
iajs-3307	143	17	syndrome	syndrome	NOUN
iajs-3307	143	18	and	and	CCONJ
iajs-3307	143	19	fertility	fertility	NOUN
iajs-3307	143	20	.	.	PUNCT
iajs-3307	144	1	clin	clin	PROPN
iajs-3307	144	2	.	.	PUNCT
iajs-3307	145	1	obstet	obstet	PROPN
iajs-3307	145	2	.	.	PUNCT
iajs-3307	146	1	gynecol	gynecol	PROPN
iajs-3307	146	2	.	.	PROPN
iajs-3307	146	3	,	,	PUNCT
iajs-3307	146	4	2021	2021	NUM
iajs-3307	146	5	;	;	PUNCT
iajs-3307	146	6	64	64	NUM
iajs-3307	146	7	,	,	PUNCT
iajs-3307	146	8	65	65	NUM
iajs-3307	146	9	-	-	SYM
iajs-3307	146	10	75	75	NUM
iajs-3307	146	11	.	.	PUNCT
iajs-3307	147	1	4	4	X
iajs-3307	147	2	.	.	X
iajs-3307	148	1	ibrahim	ibrahim	PROPN
iajs-3307	148	2	,	,	PUNCT
iajs-3307	148	3	m.i.i	m.i.i	PROPN
iajs-3307	148	4	.	.	PUNCT
iajs-3307	148	5	;	;	PUNCT
iajs-3307	148	6	al	al	PROPN
iajs-3307	148	7	-	-	PUNCT
iajs-3307	148	8	saffar	saffar	PROPN
iajs-3307	148	9	,	,	PUNCT
iajs-3307	148	10	j.m	j.m	PROPN
iajs-3307	148	11	.	.	PROPN
iajs-3307	148	12	serum	serum	NOUN
iajs-3307	148	13	level	level	NOUN
iajs-3307	148	14	evaluation	evaluation	NOUN
iajs-3307	148	15	of	of	ADP
iajs-3307	148	16	interleukin-18	interleukin-18	PROPN
iajs-3307	148	17	in	in	ADP
iajs-3307	148	18	obese	obese	ADJ
iajs-3307	148	19	women	woman	NOUN
iajs-3307	148	20	with	with	ADP
iajs-3307	148	21	polycystic	polycystic	ADJ
iajs-3307	148	22	ovary	ovary	ADJ
iajs-3307	148	23	syndrome	syndrome	NOUN
iajs-3307	148	24	.	.	PUNCT
iajs-3307	149	1	iraqi	iraqi	ADJ
iajs-3307	149	2	j.	j.	PROPN
iajs-3307	149	3	sci	sci	PROPN
iajs-3307	149	4	.	.	PROPN
iajs-3307	149	5	2018	2018	NUM
iajs-3307	149	6	;	;	PUNCT
iajs-3307	149	7	1989	1989	NUM
iajs-3307	149	8	-	-	SYM
iajs-3307	149	9	1994	1994	NUM
iajs-3307	149	10	.	.	PUNCT
iajs-3307	150	1	5	5	X
iajs-3307	150	2	.	.	X
iajs-3307	150	3	bianconi	bianconi	NOUN
iajs-3307	150	4	,	,	PUNCT
iajs-3307	150	5	v.	v.	PROPN
iajs-3307	150	6	;	;	PUNCT
iajs-3307	150	7	sahebkar	sahebkar	PROPN
iajs-3307	150	8	,	,	PUNCT
iajs-3307	150	9	a.	a.	PROPN
iajs-3307	150	10	;	;	PUNCT
iajs-3307	150	11	atkin	atkin	PROPN
iajs-3307	150	12	,	,	PUNCT
iajs-3307	150	13	s.l	s.l	PROPN
iajs-3307	150	14	.	.	PROPN
iajs-3307	150	15	;	;	PUNCT
iajs-3307	150	16	pirro	pirro	PROPN
iajs-3307	150	17	,	,	PUNCT
iajs-3307	150	18	m.	m.	NOUN
iajs-3307	150	19	the	the	DET
iajs-3307	150	20	regulation	regulation	NOUN
iajs-3307	150	21	and	and	CCONJ
iajs-3307	150	22	importance	importance	NOUN
iajs-3307	150	23	of	of	ADP
iajs-3307	150	24	monocyte	monocyte	PROPN
iajs-3307	150	25	chemoattractant	chemoattractant	PROPN
iajs-3307	150	26	protein-1	protein-1	PROPN
iajs-3307	150	27	.	.	PUNCT
iajs-3307	150	28	curr	curr	PROPN
iajs-3307	150	29	.	.	PUNCT
iajs-3307	151	1	opinion	opinion	NOUN
iajs-3307	151	2	hematol	hematol	NOUN
iajs-3307	151	3	.	.	PUNCT
iajs-3307	151	4	,	,	PUNCT
iajs-3307	151	5	2018	2018	NUM
iajs-3307	151	6	;	;	PUNCT
iajs-3307	151	7	25	25	NUM
iajs-3307	151	8	,	,	PUNCT
iajs-3307	151	9	44	44	NUM
iajs-3307	151	10	-	-	SYM
iajs-3307	151	11	51	51	NUM
iajs-3307	151	12	.	.	NOUN
iajs-3307	152	1	6	6	NUM
iajs-3307	152	2	.	.	X
iajs-3307	152	3	dahm	dahm	NOUN
iajs-3307	152	4	-	-	PUNCT
iajs-3307	152	5	kähler	kähler	NOUN
iajs-3307	152	6	,	,	PUNCT
iajs-3307	152	7	p.	p.	NOUN
iajs-3307	152	8	;	;	PUNCT
iajs-3307	152	9	ghahremani	ghahremani	NOUN
iajs-3307	152	10	,	,	PUNCT
iajs-3307	152	11	m.	m.	NOUN
iajs-3307	152	12	;	;	PUNCT
iajs-3307	152	13	lind	lind	PROPN
iajs-3307	152	14	,	,	PUNCT
iajs-3307	152	15	a.-k	a.-k	PROPN
iajs-3307	152	16	.	.	PUNCT
iajs-3307	152	17	;	;	PUNCT
iajs-3307	153	1	sundfeldt	sundfeldt	PROPN
iajs-3307	153	2	,	,	PUNCT
iajs-3307	153	3	k.	k.	PROPN
iajs-3307	153	4	;	;	PUNCT
iajs-3307	153	5	brännström	brännström	NOUN
iajs-3307	153	6	,	,	PUNCT
iajs-3307	153	7	m.	m.	NOUN
iajs-3307	153	8	monocyte	monocyte	PROPN
iajs-3307	153	9	chemotactic	chemotactic	PROPN
iajs-3307	153	10	protein-1	protein-1	PROPN
iajs-3307	153	11	(	(	PUNCT
iajs-3307	153	12	mcp-1	mcp-1	NOUN
iajs-3307	153	13	)	)	PUNCT
iajs-3307	153	14	,	,	PUNCT
iajs-3307	153	15	its	its	PRON
iajs-3307	153	16	receptor	receptor	NOUN
iajs-3307	153	17	,	,	PUNCT
iajs-3307	153	18	and	and	CCONJ
iajs-3307	153	19	macrophages	macrophage	NOUN
iajs-3307	153	20	in	in	ADP
iajs-3307	153	21	the	the	DET
iajs-3307	153	22	perifollicular	perifollicular	ADJ
iajs-3307	153	23	stroma	stroma	NOUN
iajs-3307	153	24	during	during	ADP
iajs-3307	153	25	the	the	DET
iajs-3307	153	26	human	human	ADJ
iajs-3307	153	27	ovulatory	ovulatory	ADJ
iajs-3307	153	28	process	process	NOUN
iajs-3307	153	29	.	.	PUNCT
iajs-3307	154	1	fertil	fertil	PROPN
iajs-3307	154	2	.	.	PUNCT
iajs-3307	155	1	steril	steril	PROPN
iajs-3307	155	2	.	.	PROPN
iajs-3307	155	3	,	,	PUNCT
iajs-3307	155	4	2009	2009	NUM
iajs-3307	155	5	;	;	PUNCT
iajs-3307	155	6	91	91	NUM
iajs-3307	155	7	,	,	PUNCT
iajs-3307	155	8	231	231	NUM
iajs-3307	155	9	-	-	SYM
iajs-3307	155	10	239	239	NUM
iajs-3307	155	11	.	.	PUNCT
iajs-3307	156	1	7	7	X
iajs-3307	156	2	.	.	X
iajs-3307	156	3	yadav	yadav	PROPN
iajs-3307	156	4	,	,	PUNCT
iajs-3307	156	5	a.	a.	PROPN
iajs-3307	156	6	;	;	PUNCT
iajs-3307	156	7	saini	saini	PROPN
iajs-3307	156	8	,	,	PUNCT
iajs-3307	156	9	v.	v.	PROPN
iajs-3307	156	10	;	;	PUNCT
iajs-3307	156	11	arora	arora	PROPN
iajs-3307	156	12	,	,	PUNCT
iajs-3307	156	13	s.	s.	PROPN
iajs-3307	156	14	mcp-1	mcp-1	NOUN
iajs-3307	156	15	:	:	PUNCT
iajs-3307	156	16	chemoattractant	chemoattractant	VERB
iajs-3307	156	17	with	with	ADP
iajs-3307	156	18	a	a	DET
iajs-3307	156	19	role	role	NOUN
iajs-3307	156	20	beyond	beyond	ADP
iajs-3307	156	21	immunity	immunity	NOUN
iajs-3307	156	22	:	:	PUNCT
iajs-3307	156	23	a	a	DET
iajs-3307	156	24	review	review	NOUN
iajs-3307	156	25	.	.	PUNCT
iajs-3307	157	1	clin	clin	PROPN
iajs-3307	157	2	.	.	PUNCT
iajs-3307	158	1	chimica	chimica	PROPN
iajs-3307	158	2	acta	acta	PROPN
iajs-3307	158	3	,	,	PUNCT
iajs-3307	158	4	2010	2010	NUM
iajs-3307	158	5	;	;	PUNCT
iajs-3307	158	6	411	411	NUM
iajs-3307	158	7	,	,	PUNCT
iajs-3307	158	8	1570	1570	NUM
iajs-3307	158	9	-	-	SYM
iajs-3307	158	10	1579	1579	NUM
iajs-3307	158	11	.	.	PUNCT
iajs-3307	159	1	8	8	NUM
iajs-3307	159	2	.	.	X
iajs-3307	160	1	farman	farman	PROPN
iajs-3307	160	2	,	,	PUNCT
iajs-3307	160	3	h.a	h.a	PROPN
iajs-3307	160	4	.	.	PROPN
iajs-3307	160	5	;	;	PUNCT
iajs-3307	160	6	hussien	hussien	PROPN
iajs-3307	160	7	,	,	PUNCT
iajs-3307	160	8	h.k	h.k	PROPN
iajs-3307	160	9	.	.	PROPN
iajs-3307	160	10	evaluation	evaluation	NOUN
iajs-3307	160	11	of	of	ADP
iajs-3307	160	12	monocyte	monocyte	ADJ
iajs-3307	160	13	chemotactic	chemotactic	ADJ
iajs-3307	160	14	protein-1	protein-1	NUM
iajs-3307	160	15	level	level	NOUN
iajs-3307	160	16	in	in	ADP
iajs-3307	160	17	serum	serum	NOUN
iajs-3307	160	18	of	of	ADP
iajs-3307	160	19	fertile	fertile	ADJ
iajs-3307	160	20	and	and	CCONJ
iajs-3307	160	21	infertile	infertile	ADJ
iajs-3307	160	22	women	woman	NOUN
iajs-3307	160	23	.	.	PUNCT
iajs-3307	161	1	int	int	NOUN
iajs-3307	161	2	.	.	PUNCT
iajs-3307	162	1	j.	j.	PROPN
iajs-3307	162	2	health	health	PROPN
iajs-3307	162	3	sci	sci	PROPN
iajs-3307	162	4	.	.	PROPN
iajs-3307	162	5	,	,	PUNCT
iajs-3307	162	6	2022	2022	NUM
iajs-3307	162	7	;	;	PUNCT
iajs-3307	162	8	6	6	NUM
iajs-3307	162	9	,	,	PUNCT
iajs-3307	162	10	s2	s2	NOUN
iajs-3307	162	11	,	,	PUNCT
iajs-3307	162	12	10498–10504	10498–10504	NUM
iajs-3307	162	13	.	.	PUNCT
iajs-3307	163	1	9	9	NUM
iajs-3307	163	2	.	.	X
iajs-3307	163	3	buyuk	buyuk	PROPN
iajs-3307	163	4	,	,	PUNCT
iajs-3307	163	5	e.	e.	PROPN
iajs-3307	163	6	;	;	PUNCT
iajs-3307	163	7	asemota	asemota	PROPN
iajs-3307	163	8	,	,	PUNCT
iajs-3307	163	9	o.a	o.a	PROPN
iajs-3307	163	10	.	.	PROPN
iajs-3307	163	11	;	;	PUNCT
iajs-3307	163	12	merhi	merhi	PROPN
iajs-3307	163	13	,	,	PUNCT
iajs-3307	163	14	z.	z.	PROPN
iajs-3307	163	15	;	;	PUNCT
iajs-3307	163	16	charron	charron	PROPN
iajs-3307	163	17	,	,	PUNCT
iajs-3307	163	18	m.j	m.j	PROPN
iajs-3307	163	19	.	.	PROPN
iajs-3307	163	20	;	;	PUNCT
iajs-3307	163	21	berger	berger	PROPN
iajs-3307	163	22	,	,	PUNCT
iajs-3307	163	23	d.s	d.s	PROPN
iajs-3307	163	24	.	.	PROPN
iajs-3307	163	25	;	;	PUNCT
iajs-3307	163	26	zapantis	zapantis	X
iajs-3307	163	27	,	,	PUNCT
iajs-3307	163	28	a.	a.	NOUN
iajs-3307	163	29	;	;	PUNCT
iajs-3307	163	30	jindal	jindal	PROPN
iajs-3307	163	31	,	,	PUNCT
iajs-3307	163	32	s.k	s.k	PROPN
iajs-3307	163	33	.	.	PROPN
iajs-3307	163	34	serum	serum	PROPN
iajs-3307	163	35	and	and	CCONJ
iajs-3307	163	36	follicular	follicular	ADJ
iajs-3307	163	37	fluid	fluid	ADJ
iajs-3307	163	38	monocyte	monocyte	NOUN
iajs-3307	163	39	chemotactic	chemotactic	ADJ
iajs-3307	163	40	protein-1	protein-1	PROPN
iajs-3307	163	41	levels	level	NOUN
iajs-3307	163	42	are	be	AUX
iajs-3307	163	43	elevated	elevate	VERB
iajs-3307	163	44	in	in	ADP
iajs-3307	163	45	obese	obese	ADJ
iajs-3307	163	46	women	woman	NOUN
iajs-3307	163	47	ihjpas	ihjpa	VERB
iajs-3307	163	48	.	.	PUNCT
iajs-3307	164	1	37	37	NUM
iajs-3307	164	2	(	(	PUNCT
iajs-3307	164	3	1	1	NUM
iajs-3307	164	4	)	)	PUNCT
iajs-3307	164	5	2024	2024	NUM
iajs-3307	164	6	92	92	NUM
iajs-3307	165	1	and	and	CCONJ
iajs-3307	165	2	are	be	AUX
iajs-3307	165	3	associated	associate	VERB
iajs-3307	165	4	with	with	ADP
iajs-3307	165	5	poorer	poor	ADJ
iajs-3307	165	6	clinical	clinical	ADJ
iajs-3307	165	7	pregnancy	pregnancy	NOUN
iajs-3307	165	8	rate	rate	NOUN
iajs-3307	165	9	after	after	ADP
iajs-3307	165	10	in	in	ADP
iajs-3307	165	11	vitro	vitro	X
iajs-3307	165	12	fertilization	fertilization	NOUN
iajs-3307	165	13	:	:	PUNCT
iajs-3307	165	14	a	a	DET
iajs-3307	165	15	pilot	pilot	NOUN
iajs-3307	165	16	study	study	NOUN
iajs-3307	165	17	.	.	PUNCT
iajs-3307	166	1	fertil	fertil	PROPN
iajs-3307	166	2	.	.	PUNCT
iajs-3307	167	1	steril	steril	PROPN
iajs-3307	167	2	.	.	PROPN
iajs-3307	167	3	2017	2017	NUM
iajs-3307	167	4	;	;	PUNCT
iajs-3307	167	5	107	107	NUM
iajs-3307	167	6	,	,	PUNCT
iajs-3307	167	7	632	632	NUM
iajs-3307	167	8	-	-	SYM
iajs-3307	167	9	640	640	NUM
iajs-3307	167	10	.	.	PUNCT
iajs-3307	167	11	10	10	NUM
iajs-3307	167	12	.	.	PUNCT
iajs-3307	168	1	fakhrildin	fakhrildin	PROPN
iajs-3307	168	2	,	,	PUNCT
iajs-3307	168	3	m.-b.m	m.-b.m	PROPN
iajs-3307	168	4	.	.	PUNCT
iajs-3307	168	5	;	;	PUNCT
iajs-3307	169	1	al	al	PROPN
iajs-3307	169	2	-	-	PUNCT
iajs-3307	169	3	mafraji	mafraji	NOUN
iajs-3307	169	4	,	,	PUNCT
iajs-3307	169	5	h.m.j	h.m.j	ADV
iajs-3307	169	6	.	.	PUNCT
iajs-3307	169	7	impact	impact	NOUN
iajs-3307	169	8	of	of	ADP
iajs-3307	169	9	age	age	NOUN
iajs-3307	169	10	and	and	CCONJ
iajs-3307	169	11	weight	weight	NOUN
iajs-3307	169	12	on	on	ADP
iajs-3307	169	13	levels	level	NOUN
iajs-3307	169	14	of	of	ADP
iajs-3307	169	15	some	some	DET
iajs-3307	169	16	reproductive	reproductive	ADJ
iajs-3307	169	17	hormones	hormone	NOUN
iajs-3307	169	18	for	for	ADP
iajs-3307	169	19	iraqi	iraqi	ADJ
iajs-3307	169	20	infertile	infertile	ADJ
iajs-3307	169	21	women	woman	NOUN
iajs-3307	169	22	.	.	PUNCT
iajs-3307	170	1	world	world	PROPN
iajs-3307	170	2	j.	j.	PROPN
iajs-3307	170	3	pharmac	pharmac	PROPN
iajs-3307	170	4	.	.	PUNCT
iajs-3307	171	1	res	re	NOUN
iajs-3307	171	2	.	.	PROPN
iajs-3307	171	3	,	,	PUNCT
iajs-3307	171	4	2015	2015	NUM
iajs-3307	171	5	;	;	PUNCT
iajs-3307	171	6	5	5	NUM
iajs-3307	171	7	,	,	PUNCT
iajs-3307	171	8	1	1	NUM
iajs-3307	171	9	,	,	PUNCT
iajs-3307	171	10	517	517	NUM
iajs-3307	171	11	-	-	SYM
iajs-3307	171	12	522	522	NUM
iajs-3307	171	13	.	.	PUNCT
iajs-3307	171	14	11	11	NUM
iajs-3307	171	15	.	.	X
iajs-3307	172	1	davis	davis	PROPN
iajs-3307	172	2	,	,	PUNCT
iajs-3307	172	3	s.r	s.r	PROPN
iajs-3307	172	4	.	.	PROPN
iajs-3307	172	5	;	;	PUNCT
iajs-3307	172	6	wahlin	wahlin	PROPN
iajs-3307	172	7	-	-	PUNCT
iajs-3307	172	8	jacobsen	jacobsen	PROPN
iajs-3307	172	9	,	,	PUNCT
iajs-3307	172	10	s.	s.	PROPN
iajs-3307	172	11	testosterone	testosterone	PROPN
iajs-3307	172	12	in	in	ADP
iajs-3307	172	13	women	woman	NOUN
iajs-3307	172	14	—	—	PUNCT
iajs-3307	172	15	the	the	DET
iajs-3307	172	16	clinical	clinical	ADJ
iajs-3307	172	17	significance	significance	NOUN
iajs-3307	172	18	.	.	PUNCT
iajs-3307	173	1	lancet	lancet	PROPN
iajs-3307	173	2	diab	diab	PROPN
iajs-3307	173	3	.	.	PUNCT
iajs-3307	174	1	endocrinol	endocrinol	NOUN
iajs-3307	174	2	.	.	PUNCT
iajs-3307	175	1	2015	2015	NUM
iajs-3307	175	2	;	;	PUNCT
iajs-3307	175	3	3	3	NUM
iajs-3307	175	4	,	,	PUNCT
iajs-3307	175	5	980	980	NUM
iajs-3307	175	6	-	-	SYM
iajs-3307	175	7	992	992	NUM
iajs-3307	175	8	.	.	PUNCT
iajs-3307	176	1	12	12	NUM
iajs-3307	176	2	.	.	PUNCT
iajs-3307	177	1	randolph	randolph	PROPN
iajs-3307	177	2	jr	jr	PROPN
iajs-3307	177	3	,	,	PUNCT
iajs-3307	177	4	j.f	j.f	PROPN
iajs-3307	177	5	.	.	PROPN
iajs-3307	177	6	;	;	PUNCT
iajs-3307	177	7	zheng	zheng	PROPN
iajs-3307	177	8	,	,	PUNCT
iajs-3307	177	9	h.	h.	PROPN
iajs-3307	177	10	;	;	PUNCT
iajs-3307	177	11	avis	avis	PROPN
iajs-3307	177	12	,	,	PUNCT
iajs-3307	177	13	n.e	n.e	PROPN
iajs-3307	177	14	.	.	PROPN
iajs-3307	177	15	;	;	PUNCT
iajs-3307	177	16	greendale	greendale	PROPN
iajs-3307	177	17	,	,	PUNCT
iajs-3307	177	18	g.a	g.a	PROPN
iajs-3307	177	19	.	.	PROPN
iajs-3307	177	20	;	;	PUNCT
iajs-3307	177	21	harlow	harlow	PROPN
iajs-3307	177	22	,	,	PUNCT
iajs-3307	177	23	s.d	s.d	PROPN
iajs-3307	177	24	.	.	PROPN
iajs-3307	177	25	masturbation	masturbation	PROPN
iajs-3307	177	26	frequency	frequency	NOUN
iajs-3307	177	27	and	and	CCONJ
iajs-3307	177	28	sexual	sexual	ADJ
iajs-3307	177	29	function	function	NOUN
iajs-3307	177	30	domains	domain	NOUN
iajs-3307	177	31	are	be	AUX
iajs-3307	177	32	associated	associate	VERB
iajs-3307	177	33	with	with	ADP
iajs-3307	177	34	serum	serum	NOUN
iajs-3307	177	35	reproductive	reproductive	ADJ
iajs-3307	177	36	hormone	hormone	NOUN
iajs-3307	177	37	levels	level	NOUN
iajs-3307	177	38	across	across	ADP
iajs-3307	177	39	the	the	DET
iajs-3307	177	40	menopausal	menopausal	ADJ
iajs-3307	177	41	transition	transition	NOUN
iajs-3307	177	42	.	.	PUNCT
iajs-3307	178	1	j.	j.	PROPN
iajs-3307	178	2	clin	clin	PROPN
iajs-3307	178	3	.	.	PUNCT
iajs-3307	179	1	endocrinol	endocrinol	NOUN
iajs-3307	179	2	.	.	PUNCT
iajs-3307	180	1	metabol	metabol	PROPN
iajs-3307	180	2	.	.	PUNCT
iajs-3307	181	1	2015	2015	NUM
iajs-3307	181	2	;	;	PUNCT
iajs-3307	181	3	100	100	NUM
iajs-3307	181	4	,	,	PUNCT
iajs-3307	181	5	258	258	NUM
iajs-3307	181	6	-	-	SYM
iajs-3307	181	7	266	266	NUM
iajs-3307	181	8	.	.	PUNCT
iajs-3307	182	1	13	13	NUM
iajs-3307	182	2	.	.	X
iajs-3307	182	3	laven	laven	PROPN
iajs-3307	182	4	,	,	PUNCT
iajs-3307	182	5	j.s	j.s	PROPN
iajs-3307	182	6	.	.	PROPN
iajs-3307	182	7	follicle	follicle	PROPN
iajs-3307	182	8	stimulating	stimulate	VERB
iajs-3307	182	9	hormone	hormone	NOUN
iajs-3307	182	10	receptor	receptor	NOUN
iajs-3307	182	11	(	(	PUNCT
iajs-3307	182	12	fshr	fshr	ADJ
iajs-3307	182	13	)	)	PUNCT
iajs-3307	182	14	polymorphisms	polymorphism	NOUN
iajs-3307	182	15	and	and	CCONJ
iajs-3307	182	16	polycystic	polycystic	ADJ
iajs-3307	182	17	ovary	ovary	ADJ
iajs-3307	182	18	syndrome	syndrome	NOUN
iajs-3307	182	19	(	(	PUNCT
iajs-3307	182	20	pcos	pcos	PROPN
iajs-3307	182	21	)	)	PUNCT
iajs-3307	182	22	.	.	PUNCT
iajs-3307	183	1	front	front	ADJ
iajs-3307	183	2	.	.	PUNCT
iajs-3307	183	3	endocrinol	endocrinol	NOUN
iajs-3307	183	4	.	.	PROPN
iajs-3307	183	5	,	,	PUNCT
iajs-3307	183	6	2019	2019	NUM
iajs-3307	183	7	;	;	PUNCT
iajs-3307	183	8	10	10	NUM
iajs-3307	183	9	,	,	PUNCT
iajs-3307	183	10	23	23	NUM
iajs-3307	183	11	.	.	X
iajs-3307	184	1	14	14	NUM
iajs-3307	184	2	.	.	X
iajs-3307	185	1	le	le	PROPN
iajs-3307	185	2	,	,	PUNCT
iajs-3307	185	3	m.t	m.t	PROPN
iajs-3307	185	4	.	.	PROPN
iajs-3307	185	5	;	;	PUNCT
iajs-3307	185	6	le	le	X
iajs-3307	185	7	,	,	PUNCT
iajs-3307	185	8	v.n.s	v.n.s	PROPN
iajs-3307	185	9	.	.	PUNCT
iajs-3307	185	10	;	;	PUNCT
iajs-3307	185	11	le	le	X
iajs-3307	185	12	,	,	PUNCT
iajs-3307	185	13	d.d	d.d	PROPN
iajs-3307	185	14	.	.	PROPN
iajs-3307	185	15	;	;	PUNCT
iajs-3307	185	16	nguyen	nguyen	NOUN
iajs-3307	185	17	,	,	PUNCT
iajs-3307	185	18	v.q.h	v.q.h	NOUN
iajs-3307	185	19	.	.	PUNCT
iajs-3307	185	20	;	;	PUNCT
iajs-3307	185	21	chen	chen	PROPN
iajs-3307	185	22	,	,	PUNCT
iajs-3307	185	23	c.	c.	PROPN
iajs-3307	185	24	;	;	PUNCT
iajs-3307	185	25	cao	cao	PROPN
iajs-3307	185	26	,	,	PUNCT
iajs-3307	185	27	n.t	n.t	PROPN
iajs-3307	185	28	.	.	PROPN
iajs-3307	185	29	exploration	exploration	NOUN
iajs-3307	185	30	of	of	ADP
iajs-3307	185	31	the	the	DET
iajs-3307	185	32	role	role	NOUN
iajs-3307	185	33	of	of	ADP
iajs-3307	185	34	anti‐mullerian	anti‐mullerian	ADJ
iajs-3307	185	35	hormone	hormone	NOUN
iajs-3307	185	36	and	and	CCONJ
iajs-3307	185	37	lh	lh	PROPN
iajs-3307	185	38	/	/	PUNCT
iajs-3307	185	39	fsh	fsh	PROPN
iajs-3307	185	40	ratio	ratio	NOUN
iajs-3307	185	41	in	in	ADP
iajs-3307	185	42	diagnosis	diagnosis	NOUN
iajs-3307	185	43	of	of	ADP
iajs-3307	185	44	polycystic	polycystic	ADJ
iajs-3307	185	45	ovary	ovary	ADJ
iajs-3307	185	46	syndrome	syndrome	NOUN
iajs-3307	185	47	.	.	PUNCT
iajs-3307	186	1	clin	clin	PROPN
iajs-3307	186	2	.	.	PUNCT
iajs-3307	186	3	endocrinol	endocrinol	PROPN
iajs-3307	186	4	.	.	PROPN
iajs-3307	186	5	,	,	PUNCT
iajs-3307	186	6	2019	2019	NUM
iajs-3307	186	7	;	;	PUNCT
iajs-3307	186	8	90	90	NUM
iajs-3307	186	9	,	,	PUNCT
iajs-3307	186	10	579	579	NUM
iajs-3307	186	11	-	-	SYM
iajs-3307	186	12	585	585	NUM
iajs-3307	186	13	.	.	NOUN
iajs-3307	186	14	15	15	NUM
iajs-3307	186	15	.	.	PUNCT
iajs-3307	187	1	johansson	johansson	PROPN
iajs-3307	187	2	,	,	PUNCT
iajs-3307	187	3	j.	j.	PROPN
iajs-3307	187	4	;	;	PUNCT
iajs-3307	187	5	stener	stener	NOUN
iajs-3307	187	6	-	-	PUNCT
iajs-3307	187	7	victorin	victorin	NOUN
iajs-3307	187	8	,	,	PUNCT
iajs-3307	187	9	e.	e.	PROPN
iajs-3307	187	10	polycystic	polycystic	ADJ
iajs-3307	187	11	ovary	ovary	ADJ
iajs-3307	187	12	syndrome	syndrome	NOUN
iajs-3307	187	13	:	:	PUNCT
iajs-3307	187	14	effect	effect	NOUN
iajs-3307	187	15	and	and	CCONJ
iajs-3307	187	16	mechanisms	mechanism	NOUN
iajs-3307	187	17	of	of	ADP
iajs-3307	187	18	acupuncture	acupuncture	NOUN
iajs-3307	187	19	for	for	ADP
iajs-3307	187	20	ovulation	ovulation	NOUN
iajs-3307	187	21	induction	induction	NOUN
iajs-3307	187	22	.	.	PUNCT
iajs-3307	188	1	evid.-based	evid.-base	VERB
iajs-3307	188	2	complem	complem	NOUN
iajs-3307	188	3	.	.	PUNCT
iajs-3307	189	1	altern	altern	PROPN
iajs-3307	189	2	.	.	PUNCT
iajs-3307	190	1	med	med	PROPN
iajs-3307	190	2	.	.	PROPN
iajs-3307	190	3	,	,	PUNCT
iajs-3307	190	4	2013	2013	NUM
iajs-3307	190	5	;	;	PUNCT
iajs-3307	190	6	2013	2013	NUM
iajs-3307	190	7	.	.	PUNCT
iajs-3307	191	1	16	16	NUM
iajs-3307	191	2	.	.	PUNCT
iajs-3307	191	3	alsaadi	alsaadi	NOUN
iajs-3307	191	4	,	,	PUNCT
iajs-3307	191	5	y.l	y.l	PROPN
iajs-3307	191	6	.	.	PROPN
iajs-3307	191	7	;	;	PUNCT
iajs-3307	191	8	mohamad	mohamad	PROPN
iajs-3307	191	9	,	,	PUNCT
iajs-3307	191	10	b.j	b.j	PROPN
iajs-3307	191	11	.	.	PROPN
iajs-3307	191	12	prevalence	prevalence	NOUN
iajs-3307	191	13	of	of	ADP
iajs-3307	191	14	hyperandrogenism	hyperandrogenism	NOUN
iajs-3307	191	15	in	in	ADP
iajs-3307	191	16	iraqi	iraqi	ADJ
iajs-3307	191	17	women	woman	NOUN
iajs-3307	191	18	with	with	ADP
iajs-3307	191	19	polycystic	polycystic	ADJ
iajs-3307	191	20	ovary	ovary	ADJ
iajs-3307	191	21	syndrome	syndrome	NOUN
iajs-3307	191	22	.	.	PUNCT
iajs-3307	192	1	iraqi	iraqi	ADJ
iajs-3307	192	2	j.	j.	PROPN
iajs-3307	192	3	sci	sci	PROPN
iajs-3307	192	4	.	.	PROPN
iajs-3307	192	5	,	,	PUNCT
iajs-3307	192	6	2019	2019	NUM
iajs-3307	192	7	;	;	PUNCT
iajs-3307	192	8	2600	2600	NUM
iajs-3307	192	9	-	-	SYM
iajs-3307	192	10	2608	2608	NUM
iajs-3307	192	11	.	.	PUNCT
iajs-3307	193	1	17	17	NUM
iajs-3307	193	2	.	.	X
iajs-3307	193	3	bernard	bernard	PROPN
iajs-3307	193	4	,	,	PUNCT
iajs-3307	193	5	v.	v.	ADV
iajs-3307	193	6	;	;	PUNCT
iajs-3307	193	7	young	young	ADJ
iajs-3307	193	8	,	,	PUNCT
iajs-3307	193	9	j.	j.	PROPN
iajs-3307	193	10	;	;	PUNCT
iajs-3307	193	11	chanson	chanson	PROPN
iajs-3307	193	12	,	,	PUNCT
iajs-3307	193	13	p.	p.	NOUN
iajs-3307	193	14	;	;	PUNCT
iajs-3307	193	15	binart	binart	NOUN
iajs-3307	193	16	,	,	PUNCT
iajs-3307	193	17	n.	n.	ADJ
iajs-3307	193	18	new	new	ADJ
iajs-3307	193	19	insights	insight	NOUN
iajs-3307	193	20	in	in	ADP
iajs-3307	193	21	prolactin	prolactin	ADJ
iajs-3307	193	22	:	:	PUNCT
iajs-3307	193	23	pathological	pathological	ADJ
iajs-3307	193	24	implications	implication	NOUN
iajs-3307	193	25	.	.	PUNCT
iajs-3307	194	1	nat	nat	PROPN
iajs-3307	194	2	.	.	PUNCT
iajs-3307	195	1	rev	rev	PROPN
iajs-3307	195	2	.	.	PROPN
iajs-3307	195	3	endocrinol	endocrinol	PROPN
iajs-3307	195	4	.	.	PROPN
iajs-3307	195	5	,	,	PUNCT
iajs-3307	195	6	2015	2015	NUM
iajs-3307	195	7	;	;	PUNCT
iajs-3307	195	8	11	11	NUM
iajs-3307	195	9	,	,	PUNCT
iajs-3307	195	10	265	265	NUM
iajs-3307	195	11	-	-	SYM
iajs-3307	195	12	275	275	NUM
iajs-3307	195	13	.	.	PUNCT
iajs-3307	196	1	18	18	NUM
iajs-3307	196	2	.	.	PUNCT
iajs-3307	196	3	franik	franik	PROPN
iajs-3307	196	4	,	,	PUNCT
iajs-3307	196	5	g.	g.	PROPN
iajs-3307	196	6	;	;	PUNCT
iajs-3307	196	7	madej	madej	PROPN
iajs-3307	196	8	,	,	PUNCT
iajs-3307	196	9	p.	p.	PROPN
iajs-3307	196	10	;	;	PUNCT
iajs-3307	196	11	guz	guz	PROPN
iajs-3307	196	12	-	-	PUNCT
iajs-3307	196	13	lem	lem	PROPN
iajs-3307	196	14	,	,	PUNCT
iajs-3307	196	15	m.	m.	NOUN
iajs-3307	196	16	;	;	PUNCT
iajs-3307	196	17	owczarek	owczarek	PROPN
iajs-3307	196	18	,	,	PUNCT
iajs-3307	196	19	a.	a.	NOUN
iajs-3307	196	20	;	;	PUNCT
iajs-3307	196	21	chudek	chudek	PROPN
iajs-3307	196	22	,	,	PUNCT
iajs-3307	196	23	j.	j.	PROPN
iajs-3307	196	24	;	;	PUNCT
iajs-3307	196	25	olszanecka	olszanecka	NOUN
iajs-3307	196	26	-	-	PUNCT
iajs-3307	196	27	glinianowicz	glinianowicz	NOUN
iajs-3307	196	28	,	,	PUNCT
iajs-3307	196	29	m.	m.	NOUN
iajs-3307	196	30	daytime	daytime	NOUN
iajs-3307	196	31	decrease	decrease	NOUN
iajs-3307	196	32	of	of	ADP
iajs-3307	196	33	prolactin	prolactin	ADJ
iajs-3307	196	34	levels	level	NOUN
iajs-3307	196	35	is	be	AUX
iajs-3307	196	36	associated	associate	VERB
iajs-3307	196	37	with	with	ADP
iajs-3307	196	38	pcos	pcos	PROPN
iajs-3307	196	39	regardless	regardless	ADV
iajs-3307	196	40	to	to	ADP
iajs-3307	196	41	nutritional	nutritional	ADJ
iajs-3307	196	42	status	status	NOUN
iajs-3307	196	43	and	and	CCONJ
iajs-3307	196	44	other	other	ADJ
iajs-3307	196	45	hormones	hormone	NOUN
iajs-3307	196	46	levels	level	NOUN
iajs-3307	196	47	.	.	PUNCT
iajs-3307	197	1	gynecol	gynecol	PROPN
iajs-3307	197	2	.	.	PROPN
iajs-3307	197	3	endocrinol	endocrinol	NOUN
iajs-3307	197	4	.	.	PROPN
iajs-3307	197	5	,	,	PUNCT
iajs-3307	197	6	2017	2017	NUM
iajs-3307	197	7	;	;	PUNCT
iajs-3307	197	8	33	33	NUM
iajs-3307	197	9	,	,	PUNCT
iajs-3307	197	10	336	336	NUM
iajs-3307	197	11	-	-	SYM
iajs-3307	197	12	341	341	NUM
iajs-3307	197	13	.	.	NOUN
iajs-3307	197	14	19	19	NUM
iajs-3307	197	15	.	.	PUNCT
iajs-3307	198	1	paulson	paulson	PROPN
iajs-3307	198	2	,	,	PUNCT
iajs-3307	198	3	m.	m.	NOUN
iajs-3307	198	4	;	;	PUNCT
iajs-3307	198	5	norstedt	norstedt	PROPN
iajs-3307	198	6	,	,	PUNCT
iajs-3307	198	7	g.	g.	PROPN
iajs-3307	198	8	;	;	PUNCT
iajs-3307	198	9	sahlin	sahlin	PROPN
iajs-3307	198	10	,	,	PUNCT
iajs-3307	198	11	l.	l.	PROPN
iajs-3307	198	12	;	;	PUNCT
iajs-3307	198	13	hirschberg	hirschberg	PROPN
iajs-3307	198	14	,	,	PUNCT
iajs-3307	198	15	a.l	a.l	PROPN
iajs-3307	198	16	.	.	PROPN
iajs-3307	198	17	association	association	NOUN
iajs-3307	198	18	between	between	ADP
iajs-3307	198	19	prolactin	prolactin	ADJ
iajs-3307	198	20	receptor	receptor	NOUN
iajs-3307	198	21	expression	expression	NOUN
iajs-3307	198	22	and	and	CCONJ
iajs-3307	198	23	proliferation	proliferation	NOUN
iajs-3307	198	24	in	in	ADP
iajs-3307	198	25	the	the	DET
iajs-3307	198	26	endometrium	endometrium	NOUN
iajs-3307	198	27	of	of	ADP
iajs-3307	198	28	obese	obese	ADJ
iajs-3307	198	29	women	woman	NOUN
iajs-3307	198	30	with	with	ADP
iajs-3307	198	31	polycystic	polycystic	ADJ
iajs-3307	198	32	ovary	ovary	ADJ
iajs-3307	198	33	syndrome	syndrome	NOUN
iajs-3307	198	34	.	.	PUNCT
iajs-3307	199	1	gynecol	gynecol	PROPN
iajs-3307	199	2	.	.	PROPN
iajs-3307	199	3	endocrinol	endocrinol	NOUN
iajs-3307	199	4	.	.	PROPN
iajs-3307	199	5	,	,	PUNCT
iajs-3307	199	6	2020	2020	NUM
iajs-3307	199	7	;	;	PUNCT
iajs-3307	199	8	36	36	NUM
iajs-3307	199	9	,	,	PUNCT
iajs-3307	199	10	226	226	NUM
iajs-3307	199	11	-	-	SYM
iajs-3307	199	12	232	232	NUM
iajs-3307	199	13	.	.	NOUN
iajs-3307	199	14	20	20	NUM
iajs-3307	199	15	.	.	X
iajs-3307	200	1	szosland	szosland	PROPN
iajs-3307	200	2	,	,	PUNCT
iajs-3307	200	3	k.	k.	PROPN
iajs-3307	200	4	;	;	PUNCT
iajs-3307	200	5	pawłowicz	pawłowicz	NOUN
iajs-3307	200	6	,	,	PUNCT
iajs-3307	200	7	p.	p.	NOUN
iajs-3307	200	8	;	;	PUNCT
iajs-3307	200	9	lewiński	lewiński	NOUN
iajs-3307	200	10	,	,	PUNCT
iajs-3307	200	11	a.	a.	NOUN
iajs-3307	200	12	prolactin	prolactin	PROPN
iajs-3307	200	13	secretion	secretion	NOUN
iajs-3307	200	14	in	in	ADP
iajs-3307	200	15	polycystic	polycystic	ADJ
iajs-3307	200	16	ovary	ovary	ADJ
iajs-3307	200	17	syndrome	syndrome	NOUN
iajs-3307	200	18	(	(	PUNCT
iajs-3307	200	19	pcos	pcos	PROPN
iajs-3307	200	20	)	)	PUNCT
iajs-3307	200	21	.	.	PUNCT
iajs-3307	201	1	neuroendocrinol	neuroendocrinol	NOUN
iajs-3307	201	2	.	.	PUNCT
iajs-3307	202	1	lett	lett	PROPN
iajs-3307	202	2	.	.	PROPN
iajs-3307	202	3	,	,	PUNCT
iajs-3307	202	4	2015	2015	NUM
iajs-3307	202	5	;	;	PUNCT
iajs-3307	202	6	36	36	NUM
iajs-3307	202	7	,	,	PUNCT
iajs-3307	202	8	53	53	NUM
iajs-3307	202	9	-	-	SYM
iajs-3307	202	10	58	58	NUM
iajs-3307	202	11	.	.	PUNCT
iajs-3307	203	1	21	21	NUM
iajs-3307	203	2	.	.	PUNCT
iajs-3307	204	1	stamatiades	stamatiade	NOUN
iajs-3307	204	2	,	,	PUNCT
iajs-3307	204	3	g.a	g.a	PROPN
iajs-3307	204	4	.	.	PROPN
iajs-3307	204	5	;	;	PUNCT
iajs-3307	204	6	kaiser	kaiser	PROPN
iajs-3307	204	7	,	,	PUNCT
iajs-3307	204	8	u.b	u.b	PROPN
iajs-3307	204	9	.	.	PUNCT
iajs-3307	205	1	gonadotropin	gonadotropin	PROPN
iajs-3307	205	2	regulation	regulation	NOUN
iajs-3307	205	3	by	by	ADP
iajs-3307	205	4	pulsatile	pulsatile	NOUN
iajs-3307	205	5	gnrh	gnrh	NOUN
iajs-3307	205	6	:	:	PUNCT
iajs-3307	205	7	signaling	signal	VERB
iajs-3307	205	8	and	and	CCONJ
iajs-3307	205	9	gene	gene	NOUN
iajs-3307	205	10	expression	expression	NOUN
iajs-3307	205	11	.	.	PUNCT
iajs-3307	206	1	molec	molec	PROPN
iajs-3307	206	2	.	.	PUNCT
iajs-3307	207	1	cell	cell	NOUN
iajs-3307	207	2	.	.	PUNCT
iajs-3307	208	1	endocrinol	endocrinol	NOUN
iajs-3307	208	2	.	.	PROPN
iajs-3307	208	3	,	,	PUNCT
iajs-3307	208	4	2018	2018	NUM
iajs-3307	208	5	;	;	PUNCT
iajs-3307	208	6	463	463	NUM
iajs-3307	208	7	,	,	PUNCT
iajs-3307	208	8	131	131	NUM
iajs-3307	208	9	-	-	SYM
iajs-3307	208	10	141	141	NUM
iajs-3307	208	11	.	.	PUNCT
iajs-3307	209	1	22	22	NUM
iajs-3307	209	2	.	.	PUNCT
iajs-3307	210	1	orlowski	orlowski	PROPN
iajs-3307	210	2	,	,	PUNCT
iajs-3307	210	3	m.	m.	NOUN
iajs-3307	210	4	;	;	PUNCT
iajs-3307	210	5	sarao	sarao	PROPN
iajs-3307	210	6	,	,	PUNCT
iajs-3307	210	7	m.s	m.s	PROPN
iajs-3307	210	8	.	.	PROPN
iajs-3307	210	9	physiology	physiology	NOUN
iajs-3307	210	10	,	,	PUNCT
iajs-3307	210	11	follicle	follicle	AUX
iajs-3307	210	12	stimulating	stimulate	VERB
iajs-3307	210	13	hormone	hormone	NOUN
iajs-3307	210	14	.	.	PUNCT
iajs-3307	211	1	follicle	follicle	PROPN
iajs-3307	211	2	stimul	stimul	PROPN
iajs-3307	211	3	.	.	PUNCT
iajs-3307	212	1	horm	horm	PROPN
iajs-3307	212	2	.	.	PUNCT
iajs-3307	212	3	,	,	PUNCT
iajs-3307	212	4	2018	2018	NUM
iajs-3307	212	5	;	;	PUNCT
iajs-3307	212	6	6	6	NUM
iajs-3307	212	7	.	.	NOUN
iajs-3307	212	8	23	23	NUM
iajs-3307	212	9	.	.	PUNCT
iajs-3307	213	1	saadia	saadia	PROPN
iajs-3307	213	2	,	,	PUNCT
iajs-3307	213	3	z.	z.	PROPN
iajs-3307	213	4	follicle	follicle	VERB
iajs-3307	213	5	stimulating	stimulate	VERB
iajs-3307	213	6	hormone	hormone	NOUN
iajs-3307	213	7	(	(	PUNCT
iajs-3307	213	8	lh	lh	NOUN
iajs-3307	213	9	:	:	PUNCT
iajs-3307	213	10	fsh	fsh	ADJ
iajs-3307	213	11	)	)	PUNCT
iajs-3307	213	12	ratio	ratio	NOUN
iajs-3307	213	13	in	in	ADP
iajs-3307	213	14	polycystic	polycystic	ADJ
iajs-3307	213	15	ovary	ovary	ADJ
iajs-3307	213	16	syndrome	syndrome	NOUN
iajs-3307	213	17	(	(	PUNCT
iajs-3307	213	18	pcos)-obese	pcos)-obese	PROPN
iajs-3307	213	19	vs.	vs.	CCONJ
iajs-3307	213	20	non	non	ADJ
iajs-3307	213	21	-	-	ADJ
iajs-3307	213	22	obese	obese	ADJ
iajs-3307	213	23	women	woman	NOUN
iajs-3307	213	24	.	.	PUNCT
iajs-3307	214	1	med	med	PROPN
iajs-3307	214	2	.	.	PUNCT
iajs-3307	214	3	arch	arch	PROPN
iajs-3307	214	4	.	.	PUNCT
iajs-3307	214	5	,	,	PUNCT
iajs-3307	214	6	2020	2020	NUM
iajs-3307	214	7	;	;	PUNCT
iajs-3307	214	8	74	74	NUM
iajs-3307	214	9	,	,	PUNCT
iajs-3307	214	10	289	289	NUM
iajs-3307	214	11	.	.	PUNCT
iajs-3307	215	1	24	24	NUM
iajs-3307	215	2	.	.	PUNCT
iajs-3307	215	3	shaw	shaw	PROPN
iajs-3307	215	4	,	,	PUNCT
iajs-3307	215	5	n.	n.	PROPN
iajs-3307	215	6	;	;	PUNCT
iajs-3307	215	7	histed	histe	VERB
iajs-3307	215	8	,	,	PUNCT
iajs-3307	215	9	s.	s.	PROPN
iajs-3307	215	10	;	;	PUNCT
iajs-3307	215	11	srouji	srouji	PROPN
iajs-3307	215	12	,	,	PUNCT
iajs-3307	215	13	s.	s.	PROPN
iajs-3307	215	14	;	;	PUNCT
iajs-3307	215	15	yang	yang	PROPN
iajs-3307	215	16	,	,	PUNCT
iajs-3307	215	17	j.	j.	PROPN
iajs-3307	215	18	;	;	PUNCT
iajs-3307	215	19	lee	lee	PROPN
iajs-3307	215	20	,	,	PUNCT
iajs-3307	215	21	h.	h.	PROPN
iajs-3307	215	22	;	;	PUNCT
iajs-3307	215	23	hall	hall	PROPN
iajs-3307	215	24	,	,	PUNCT
iajs-3307	215	25	j.	j.	PROPN
iajs-3307	215	26	estrogen	estrogen	PROPN
iajs-3307	215	27	negative	negative	ADJ
iajs-3307	215	28	feedback	feedback	NOUN
iajs-3307	215	29	on	on	ADP
iajs-3307	215	30	gonadotropin	gonadotropin	NOUN
iajs-3307	215	31	secretion	secretion	NOUN
iajs-3307	215	32	:	:	PUNCT
iajs-3307	215	33	evidence	evidence	NOUN
iajs-3307	215	34	for	for	ADP
iajs-3307	215	35	a	a	DET
iajs-3307	215	36	direct	direct	ADJ
iajs-3307	215	37	pituitary	pituitary	ADJ
iajs-3307	215	38	effect	effect	NOUN
iajs-3307	215	39	in	in	ADP
iajs-3307	215	40	women	woman	NOUN
iajs-3307	215	41	.	.	PUNCT
iajs-3307	216	1	j.	j.	PROPN
iajs-3307	216	2	clin	clin	PROPN
iajs-3307	216	3	.	.	PUNCT
iajs-3307	217	1	endocrinol	endocrinol	NOUN
iajs-3307	217	2	.	.	PUNCT
iajs-3307	218	1	metabol	metabol	PROPN
iajs-3307	218	2	.	.	PUNCT
iajs-3307	218	3	,	,	PUNCT
iajs-3307	218	4	2010	2010	NUM
iajs-3307	218	5	;	;	PUNCT
iajs-3307	218	6	95	95	NUM
iajs-3307	218	7	,	,	PUNCT
iajs-3307	218	8	1955	1955	NUM
iajs-3307	218	9	-	-	SYM
iajs-3307	218	10	1961	1961	NUM
iajs-3307	218	11	.	.	PUNCT
iajs-3307	219	1	25	25	NUM
iajs-3307	219	2	.	.	PUNCT
iajs-3307	220	1	azziz	azziz	PROPN
iajs-3307	220	2	,	,	PUNCT
iajs-3307	220	3	r.	r.	PROPN
iajs-3307	220	4	polycystic	polycystic	ADJ
iajs-3307	220	5	ovary	ovary	ADJ
iajs-3307	220	6	syndrome	syndrome	NOUN
iajs-3307	220	7	.	.	PUNCT
iajs-3307	221	1	obstet	obstet	PROPN
iajs-3307	221	2	.	.	PUNCT
iajs-3307	222	1	gynecol	gynecol	PROPN
iajs-3307	222	2	.	.	PROPN
iajs-3307	222	3	2018	2018	NUM
iajs-3307	222	4	;	;	PUNCT
iajs-3307	222	5	132	132	NUM
iajs-3307	222	6	,	,	PUNCT
iajs-3307	222	7	321	321	NUM
iajs-3307	222	8	-	-	SYM
iajs-3307	222	9	336	336	NUM
iajs-3307	222	10	.	.	PUNCT
iajs-3307	223	1	26	26	NUM
iajs-3307	223	2	.	.	PUNCT
iajs-3307	224	1	li	li	PROPN
iajs-3307	224	2	,	,	PUNCT
iajs-3307	224	3	l.	l.	PROPN
iajs-3307	224	4	;	;	PUNCT
iajs-3307	224	5	ryoo	ryoo	NOUN
iajs-3307	224	6	,	,	PUNCT
iajs-3307	224	7	j.e	j.e	PROPN
iajs-3307	224	8	.	.	PROPN
iajs-3307	224	9	;	;	PUNCT
iajs-3307	224	10	lee	lee	PROPN
iajs-3307	224	11	,	,	PUNCT
iajs-3307	224	12	k.-j	k.-j	PROPN
iajs-3307	224	13	.	.	PUNCT
iajs-3307	224	14	;	;	PUNCT
iajs-3307	224	15	choi	choi	NOUN
iajs-3307	224	16	,	,	PUNCT
iajs-3307	224	17	b.-c	b.-c	NOUN
iajs-3307	224	18	.	.	PUNCT
iajs-3307	224	19	;	;	PUNCT
iajs-3307	224	20	baek	baek	NOUN
iajs-3307	224	21	,	,	PUNCT
iajs-3307	224	22	k.-h	k.-h	NOUN
iajs-3307	224	23	.	.	PUNCT
iajs-3307	225	1	genetic	genetic	ADJ
iajs-3307	225	2	variation	variation	NOUN
iajs-3307	225	3	in	in	ADP
iajs-3307	225	4	the	the	DET
iajs-3307	225	5	mcp-1	mcp-1	ADJ
iajs-3307	225	6	gene	gene	NOUN
iajs-3307	225	7	promoter	promoter	NOUN
iajs-3307	225	8	associated	associate	VERB
iajs-3307	225	9	with	with	ADP
iajs-3307	225	10	the	the	DET
iajs-3307	225	11	risk	risk	NOUN
iajs-3307	225	12	of	of	ADP
iajs-3307	225	13	polycystic	polycystic	ADJ
iajs-3307	225	14	ovary	ovary	ADJ
iajs-3307	225	15	syndrome	syndrome	NOUN
iajs-3307	225	16	.	.	PUNCT
iajs-3307	226	1	plos	plos	PROPN
iajs-3307	226	2	one	one	NUM
iajs-3307	226	3	,	,	PUNCT
iajs-3307	226	4	2015	2015	NUM
iajs-3307	226	5	;	;	PUNCT
iajs-3307	226	6	10	10	NUM
iajs-3307	226	7	,	,	PUNCT
iajs-3307	226	8	e0123045	e0123045	ADJ
iajs-3307	226	9	.	.	NOUN
iajs-3307	226	10	27	27	NUM
iajs-3307	226	11	.	.	PUNCT
iajs-3307	227	1	daan	daan	PROPN
iajs-3307	227	2	,	,	PUNCT
iajs-3307	227	3	n.m	n.m	PROPN
iajs-3307	227	4	.	.	PROPN
iajs-3307	227	5	;	;	PUNCT
iajs-3307	227	6	koster	koster	PROPN
iajs-3307	227	7	,	,	PUNCT
iajs-3307	227	8	m.p	m.p	PROPN
iajs-3307	227	9	.	.	PROPN
iajs-3307	227	10	;	;	PUNCT
iajs-3307	227	11	de	de	X
iajs-3307	227	12	wilde	wilde	PROPN
iajs-3307	227	13	,	,	PUNCT
iajs-3307	227	14	m.a	m.a	PROPN
iajs-3307	227	15	.	.	PROPN
iajs-3307	227	16	;	;	PUNCT
iajs-3307	227	17	dalmeijer	dalmeijer	NOUN
iajs-3307	227	18	,	,	PUNCT
iajs-3307	227	19	g.w	g.w	PROPN
iajs-3307	227	20	.	.	PROPN
iajs-3307	227	21	;	;	PUNCT
iajs-3307	227	22	evelein	evelein	VERB
iajs-3307	227	23	,	,	PUNCT
iajs-3307	227	24	a.m.	a.m.	ADV
iajs-3307	227	25	;	;	PUNCT
iajs-3307	227	26	fauser	fauser	PROPN
iajs-3307	227	27	,	,	PUNCT
iajs-3307	227	28	b.c	b.c	PROPN
iajs-3307	227	29	.	.	PROPN
iajs-3307	227	30	;	;	PUNCT
iajs-3307	227	31	de	de	X
iajs-3307	227	32	jager	jager	PROPN
iajs-3307	227	33	,	,	PUNCT
iajs-3307	227	34	w.	w.	PROPN
iajs-3307	227	35	biomarker	biomarker	PROPN
iajs-3307	227	36	profiles	profile	NOUN
iajs-3307	227	37	in	in	ADP
iajs-3307	227	38	women	woman	NOUN
iajs-3307	227	39	with	with	ADP
iajs-3307	227	40	pcos	pcos	PROPN
iajs-3307	227	41	and	and	CCONJ
iajs-3307	227	42	pcos	pcos	NOUN
iajs-3307	227	43	offspring	offspring	NOUN
iajs-3307	227	44	;	;	PUNCT
iajs-3307	227	45	a	a	DET
iajs-3307	227	46	pilot	pilot	NOUN
iajs-3307	227	47	study	study	NOUN
iajs-3307	227	48	.	.	PUNCT
iajs-3307	228	1	plos	plos	PROPN
iajs-3307	228	2	one	one	NUM
iajs-3307	228	3	2016	2016	NUM
iajs-3307	228	4	;	;	PUNCT
iajs-3307	228	5	11	11	NUM
iajs-3307	228	6	,	,	PUNCT
iajs-3307	228	7	e0165033	e0165033	PROPN
iajs-3307	228	8	.	.	NOUN
iajs-3307	228	9	28	28	NUM
iajs-3307	228	10	.	.	PUNCT
iajs-3307	229	1	wyskida	wyskida	PROPN
iajs-3307	229	2	,	,	PUNCT
iajs-3307	229	3	k.	k.	PROPN
iajs-3307	229	4	;	;	PUNCT
iajs-3307	229	5	franik	franik	PROPN
iajs-3307	229	6	,	,	PUNCT
iajs-3307	229	7	g.	g.	PROPN
iajs-3307	229	8	;	;	PUNCT
iajs-3307	229	9	choręza	choręza	NOUN
iajs-3307	229	10	,	,	PUNCT
iajs-3307	229	11	p.	p.	PROPN
iajs-3307	229	12	;	;	PUNCT
iajs-3307	229	13	pohl	pohl	PROPN
iajs-3307	229	14	,	,	PUNCT
iajs-3307	229	15	n.	n.	PROPN
iajs-3307	229	16	;	;	PUNCT
iajs-3307	229	17	markuszewski	markuszewski	PROPN
iajs-3307	229	18	,	,	PUNCT
iajs-3307	229	19	l.	l.	PROPN
iajs-3307	229	20	;	;	PUNCT
iajs-3307	229	21	owczarek	owczarek	PROPN
iajs-3307	229	22	,	,	PUNCT
iajs-3307	229	23	a.	a.	NOUN
iajs-3307	229	24	;	;	PUNCT
iajs-3307	229	25	madej	madej	VERB
iajs-3307	229	26	,	,	PUNCT
iajs-3307	229	27	p.	p.	PROPN
iajs-3307	229	28	;	;	PUNCT
iajs-3307	230	1	chudek	chudek	PROPN
iajs-3307	230	2	,	,	PUNCT
iajs-3307	230	3	j.	j.	PROPN
iajs-3307	230	4	;	;	PUNCT
iajs-3307	230	5	olszanecka	olszanecka	NOUN
iajs-3307	230	6	-	-	PUNCT
iajs-3307	230	7	glinianowicz	glinianowicz	NOUN
iajs-3307	230	8	,	,	PUNCT
iajs-3307	230	9	m.	m.	NOUN
iajs-3307	230	10	pentraxin	pentraxin	NOUN
iajs-3307	230	11	3	3	NUM
iajs-3307	230	12	levels	level	NOUN
iajs-3307	230	13	in	in	ADP
iajs-3307	230	14	young	young	ADJ
iajs-3307	230	15	women	woman	NOUN
iajs-3307	230	16	with	with	ADP
iajs-3307	230	17	and	and	CCONJ
iajs-3307	230	18	without	without	ADP
iajs-3307	230	19	ihjpas	ihjpa	NOUN
iajs-3307	230	20	.	.	PUNCT
iajs-3307	231	1	37	37	NUM
iajs-3307	231	2	(	(	PUNCT
iajs-3307	231	3	1	1	NUM
iajs-3307	231	4	)	)	PUNCT
iajs-3307	231	5	2024	2024	NUM
iajs-3307	231	6	93	93	NUM
iajs-3307	231	7	polycystic	polycystic	ADJ
iajs-3307	231	8	ovary	ovary	ADJ
iajs-3307	231	9	syndrome	syndrome	NOUN
iajs-3307	231	10	(	(	PUNCT
iajs-3307	231	11	pcos	pcos	PROPN
iajs-3307	231	12	)	)	PUNCT
iajs-3307	231	13	in	in	ADP
iajs-3307	231	14	relation	relation	NOUN
iajs-3307	231	15	to	to	ADP
iajs-3307	231	16	the	the	DET
iajs-3307	231	17	nutritional	nutritional	ADJ
iajs-3307	231	18	status	status	NOUN
iajs-3307	231	19	and	and	CCONJ
iajs-3307	231	20	systemic	systemic	ADJ
iajs-3307	231	21	inflammation	inflammation	NOUN
iajs-3307	231	22	.	.	PUNCT
iajs-3307	232	1	int	int	NOUN
iajs-3307	232	2	.	.	PUNCT
iajs-3307	233	1	j.	j.	PROPN
iajs-3307	233	2	endocrinol	endocrinol	PROPN
iajs-3307	233	3	.	.	PROPN
iajs-3307	233	4	,	,	PUNCT
iajs-3307	233	5	2020	2020	NUM
iajs-3307	233	6	;	;	PUNCT
iajs-3307	233	7	2020	2020	NUM
iajs-3307	233	8	.	.	X
iajs-3307	234	1	29	29	NUM
iajs-3307	234	2	.	.	PUNCT
iajs-3307	235	1	aksak	aksak	PROPN
iajs-3307	235	2	,	,	PUNCT
iajs-3307	235	3	t.	t.	PROPN
iajs-3307	235	4	;	;	PUNCT
iajs-3307	235	5	gümürdülü	gümürdülü	PROPN
iajs-3307	235	6	,	,	PUNCT
iajs-3307	235	7	d.	d.	PROPN
iajs-3307	235	8	;	;	PUNCT
iajs-3307	235	9	çetin	çetin	PROPN
iajs-3307	235	10	,	,	PUNCT
iajs-3307	235	11	m.t	m.t	PROPN
iajs-3307	235	12	.	.	PROPN
iajs-3307	235	13	;	;	PUNCT
iajs-3307	235	14	polat	polat	NOUN
iajs-3307	235	15	,	,	PUNCT
iajs-3307	235	16	s.	s.	PROPN
iajs-3307	235	17	expression	expression	NOUN
iajs-3307	235	18	of	of	ADP
iajs-3307	235	19	monocyte	monocyte	ADJ
iajs-3307	235	20	chemotactic	chemotactic	ADJ
iajs-3307	235	21	protein	protein	NOUN
iajs-3307	235	22	2	2	NUM
iajs-3307	235	23	and	and	CCONJ
iajs-3307	235	24	tumor	tumor	NOUN
iajs-3307	235	25	necrosis	necrosis	NOUN
iajs-3307	235	26	factor	factor	NOUN
iajs-3307	235	27	alpha	alpha	NOUN
iajs-3307	235	28	in	in	ADP
iajs-3307	235	29	human	human	ADJ
iajs-3307	235	30	normal	normal	ADJ
iajs-3307	235	31	endometrium	endometrium	NOUN
iajs-3307	235	32	and	and	CCONJ
iajs-3307	235	33	endometriotic	endometriotic	ADJ
iajs-3307	235	34	tissues	tissue	NOUN
iajs-3307	235	35	.	.	PUNCT
iajs-3307	236	1	j.	j.	PROPN
iajs-3307	236	2	gynecol	gynecol	PROPN
iajs-3307	236	3	.	.	PUNCT
iajs-3307	236	4	obstet	obstet	PROPN
iajs-3307	236	5	.	.	PUNCT
iajs-3307	237	1	human	human	ADJ
iajs-3307	237	2	reprod	reprod	PROPN
iajs-3307	237	3	.	.	PUNCT
iajs-3307	238	1	2021	2021	NUM
iajs-3307	238	2	;	;	PUNCT
iajs-3307	238	3	50	50	NUM
iajs-3307	238	4	,	,	PUNCT
iajs-3307	238	5	101971	101971	NUM
iajs-3307	238	6	.	.	PUNCT
iajs-3307	239	1	30	30	NUM
iajs-3307	239	2	.	.	X
iajs-3307	240	1	singh	singh	PROPN
iajs-3307	240	2	,	,	PUNCT
iajs-3307	240	3	s.	s.	PROPN
iajs-3307	240	4	;	;	PUNCT
iajs-3307	240	5	anshita	anshita	PROPN
iajs-3307	240	6	,	,	PUNCT
iajs-3307	240	7	d.	d.	PROPN
iajs-3307	240	8	;	;	PUNCT
iajs-3307	240	9	ravichandiran	ravichandiran	ADJ
iajs-3307	240	10	,	,	PUNCT
iajs-3307	240	11	v.	v.	ADP
iajs-3307	240	12	mcp-1	mcp-1	NOUN
iajs-3307	240	13	:	:	PUNCT
iajs-3307	240	14	function	function	NOUN
iajs-3307	240	15	,	,	PUNCT
iajs-3307	240	16	regulation	regulation	NOUN
iajs-3307	240	17	,	,	PUNCT
iajs-3307	240	18	and	and	CCONJ
iajs-3307	240	19	involvement	involvement	NOUN
iajs-3307	240	20	in	in	ADP
iajs-3307	240	21	disease	disease	NOUN
iajs-3307	240	22	.	.	PUNCT
iajs-3307	241	1	int	int	NOUN
iajs-3307	241	2	.	.	PUNCT
iajs-3307	242	1	immunopharmacol	immunopharmacol	PROPN
iajs-3307	242	2	.	.	PROPN
iajs-3307	242	3	,	,	PUNCT
iajs-3307	242	4	2021	2021	NUM
iajs-3307	242	5	;	;	PUNCT
iajs-3307	242	6	101	101	NUM
iajs-3307	242	7	,	,	PUNCT
iajs-3307	242	8	107598	107598	NUM
iajs-3307	242	9	.	.	PUNCT
iajs-3307	243	1	31	31	NUM
iajs-3307	243	2	.	.	PUNCT
iajs-3307	244	1	ambiger	ambiger	ADJ
iajs-3307	244	2	,	,	PUNCT
iajs-3307	244	3	s.	s.	PROPN
iajs-3307	244	4	;	;	PUNCT
iajs-3307	244	5	patil	patil	PROPN
iajs-3307	244	6	,	,	PUNCT
iajs-3307	244	7	s.b	s.b	PROPN
iajs-3307	244	8	.	.	PROPN
iajs-3307	244	9	;	;	PUNCT
iajs-3307	244	10	rekha	rekha	PROPN
iajs-3307	244	11	,	,	PUNCT
iajs-3307	244	12	m.	m.	NOUN
iajs-3307	244	13	;	;	PUNCT
iajs-3307	244	14	dhananjaya	dhananjaya	PROPN
iajs-3307	244	15	,	,	PUNCT
iajs-3307	244	16	s.	s.	PROPN
iajs-3307	244	17	role	role	NOUN
iajs-3307	244	18	of	of	ADP
iajs-3307	244	19	leutenising	leutenise	VERB
iajs-3307	244	20	hormone	hormone	NOUN
iajs-3307	244	21	lh	lh	NOUN
iajs-3307	244	22	and	and	CCONJ
iajs-3307	244	23	insulin	insulin	NOUN
iajs-3307	244	24	resistance	resistance	NOUN
iajs-3307	244	25	in	in	ADP
iajs-3307	244	26	polycystic	polycystic	ADJ
iajs-3307	244	27	ovarian	ovarian	ADJ
iajs-3307	244	28	syndrome	syndrome	NOUN
iajs-3307	244	29	.	.	PUNCT
iajs-3307	245	1	int	int	NOUN
iajs-3307	245	2	.	.	PUNCT
iajs-3307	246	1	j.	j.	PROPN
iajs-3307	246	2	reprod	reprod	PROPN
iajs-3307	246	3	.	.	PUNCT
iajs-3307	247	1	contracept	contracept	PROPN
iajs-3307	247	2	.	.	PROPN
iajs-3307	247	3	,	,	PUNCT
iajs-3307	248	1	obst	obst	PROPN
iajs-3307	248	2	.	.	PUNCT
iajs-3307	248	3	gynecol	gynecol	PROPN
iajs-3307	248	4	.	.	PROPN
iajs-3307	248	5	,	,	PUNCT
iajs-3307	248	6	2017	2017	NUM
iajs-3307	248	7	;	;	PUNCT
iajs-3307	248	8	6	6	NUM
iajs-3307	248	9	,	,	PUNCT
iajs-3307	248	10	3892	3892	NUM
iajs-3307	248	11	-	-	SYM
iajs-3307	248	12	3897	3897	NUM
iajs-3307	248	13	.	.	PUNCT
iajs-3307	249	1	32	32	NUM
iajs-3307	249	2	.	.	X
iajs-3307	249	3	yang	yang	PROPN
iajs-3307	249	4	,	,	PUNCT
iajs-3307	249	5	h.	h.	PROPN
iajs-3307	249	6	;	;	PUNCT
iajs-3307	249	7	di	di	PROPN
iajs-3307	249	8	,	,	PUNCT
iajs-3307	249	9	j.	j.	PROPN
iajs-3307	249	10	;	;	PUNCT
iajs-3307	249	11	pan	pan	PROPN
iajs-3307	249	12	,	,	PUNCT
iajs-3307	249	13	j.	j.	PROPN
iajs-3307	249	14	;	;	PUNCT
iajs-3307	249	15	yu	yu	PROPN
iajs-3307	249	16	,	,	PUNCT
iajs-3307	249	17	r.	r.	PROPN
iajs-3307	249	18	;	;	PUNCT
iajs-3307	249	19	teng	teng	PROPN
iajs-3307	249	20	,	,	PUNCT
iajs-3307	249	21	y.	y.	PROPN
iajs-3307	249	22	;	;	PUNCT
iajs-3307	249	23	cai	cai	PROPN
iajs-3307	249	24	,	,	PUNCT
iajs-3307	249	25	z.	z.	PROPN
iajs-3307	249	26	;	;	PUNCT
iajs-3307	249	27	deng	deng	PROPN
iajs-3307	249	28	,	,	PUNCT
iajs-3307	249	29	x.	x.	PROPN
iajs-3307	250	1	the	the	DET
iajs-3307	250	2	association	association	NOUN
iajs-3307	250	3	between	between	ADP
iajs-3307	250	4	prolactin	prolactin	NOUN
iajs-3307	250	5	and	and	CCONJ
iajs-3307	250	6	metabolic	metabolic	NOUN
iajs-3307	250	7	parameters	parameter	NOUN
iajs-3307	250	8	in	in	ADP
iajs-3307	250	9	pcos	pcos	PROPN
iajs-3307	250	10	women	woman	NOUN
iajs-3307	250	11	:	:	PUNCT
iajs-3307	250	12	a	a	DET
iajs-3307	250	13	retrospective	retrospective	ADJ
iajs-3307	250	14	analysis	analysis	NOUN
iajs-3307	250	15	.	.	PUNCT
iajs-3307	251	1	front	front	ADJ
iajs-3307	251	2	.	.	PUNCT
iajs-3307	251	3	endocrinol	endocrinol	NOUN
iajs-3307	251	4	.	.	PROPN
iajs-3307	251	5	,	,	PUNCT
iajs-3307	251	6	2020	2020	NUM
iajs-3307	251	7	;	;	PUNCT
iajs-3307	251	8	11	11	NUM
iajs-3307	251	9	,	,	PUNCT
iajs-3307	251	10	263	263	NUM
iajs-3307	251	11	.	.	PUNCT
iajs-3307	252	1	33	33	NUM
iajs-3307	252	2	.	.	PUNCT
iajs-3307	253	1	saei	saei	PROPN
iajs-3307	253	2	ghare	ghare	PROPN
iajs-3307	253	3	naz	naz	PROPN
iajs-3307	253	4	,	,	PUNCT
iajs-3307	253	5	m.	m.	NOUN
iajs-3307	253	6	;	;	PUNCT
iajs-3307	253	7	mousavi	mousavi	PROPN
iajs-3307	253	8	,	,	PUNCT
iajs-3307	253	9	m.	m.	NOUN
iajs-3307	253	10	;	;	PUNCT
iajs-3307	253	11	mahboobifard	mahboobifard	PROPN
iajs-3307	253	12	,	,	PUNCT
iajs-3307	253	13	f.	f.	PROPN
iajs-3307	253	14	;	;	PUNCT
iajs-3307	253	15	niknam	niknam	PROPN
iajs-3307	253	16	,	,	PUNCT
iajs-3307	253	17	a.	a.	NOUN
iajs-3307	253	18	;	;	PUNCT
iajs-3307	253	19	ramezani	ramezani	PROPN
iajs-3307	253	20	tehrani	tehrani	PROPN
iajs-3307	253	21	,	,	PUNCT
iajs-3307	253	22	f.	f.	PROPN
iajs-3307	254	1	a	a	DET
iajs-3307	254	2	meta	meta	ADJ
iajs-3307	254	3	-	-	PUNCT
iajs-3307	254	4	analysis	analysis	NOUN
iajs-3307	254	5	of	of	ADP
iajs-3307	254	6	observational	observational	ADJ
iajs-3307	254	7	studies	study	NOUN
iajs-3307	254	8	on	on	ADP
iajs-3307	254	9	prolactin	prolactin	ADJ
iajs-3307	254	10	levels	level	NOUN
iajs-3307	254	11	in	in	ADP
iajs-3307	254	12	women	woman	NOUN
iajs-3307	254	13	with	with	ADP
iajs-3307	254	14	polycystic	polycystic	ADJ
iajs-3307	254	15	ovary	ovary	ADJ
iajs-3307	254	16	syndrome	syndrome	NOUN
iajs-3307	254	17	.	.	PUNCT
iajs-3307	255	1	diagnostics	diagnostic	NOUN
iajs-3307	255	2	,	,	PUNCT
iajs-3307	255	3	2022	2022	NUM
iajs-3307	255	4	;	;	PUNCT
iajs-3307	255	5	12	12	NUM
iajs-3307	255	6	,	,	PUNCT
iajs-3307	255	7	2924	2924	NUM
iajs-3307	255	8	.	.	PUNCT
iajs-3307	256	1	34	34	NUM
iajs-3307	256	2	.	.	X
iajs-3307	256	3	underdal	underdal	NOUN
iajs-3307	256	4	,	,	PUNCT
iajs-3307	256	5	m.o	m.o	PROPN
iajs-3307	256	6	.	.	PROPN
iajs-3307	256	7	;	;	PUNCT
iajs-3307	256	8	salvesen	salvesen	PROPN
iajs-3307	256	9	,	,	PUNCT
iajs-3307	256	10	q.	q.	PROPN
iajs-3307	256	11	;	;	PUNCT
iajs-3307	256	12	schmedes	schmede	NOUN
iajs-3307	256	13	,	,	PUNCT
iajs-3307	256	14	a.	a.	NOUN
iajs-3307	256	15	;	;	PUNCT
iajs-3307	256	16	andersen	andersen	PROPN
iajs-3307	256	17	,	,	PUNCT
iajs-3307	256	18	m.s	m.s	PROPN
iajs-3307	256	19	.	.	PROPN
iajs-3307	256	20	;	;	PUNCT
iajs-3307	256	21	vanky	vanky	ADJ
iajs-3307	256	22	,	,	PUNCT
iajs-3307	256	23	e.	e.	PROPN
iajs-3307	256	24	prolactin	prolactin	PROPN
iajs-3307	256	25	and	and	CCONJ
iajs-3307	256	26	breast	breast	NOUN
iajs-3307	256	27	increase	increase	NOUN
iajs-3307	256	28	during	during	ADP
iajs-3307	256	29	pregnancy	pregnancy	NOUN
iajs-3307	256	30	in	in	ADP
iajs-3307	256	31	pcos	pcos	PROPN
iajs-3307	256	32	:	:	PUNCT
iajs-3307	256	33	linked	link	VERB
iajs-3307	256	34	to	to	ADP
iajs-3307	256	35	long	long	ADJ
iajs-3307	256	36	-	-	PUNCT
iajs-3307	256	37	term	term	NOUN
iajs-3307	256	38	metabolic	metabolic	NOUN
iajs-3307	256	39	health	health	NOUN
iajs-3307	256	40	?	?	PUNCT
iajs-3307	257	1	europ	europ	NOUN
iajs-3307	257	2	.	.	PUNCT
iajs-3307	258	1	j.	j.	PROPN
iajs-3307	258	2	endocrinol	endocrinol	PROPN
iajs-3307	258	3	.	.	PROPN
iajs-3307	258	4	,	,	PUNCT
iajs-3307	258	5	2019	2019	NUM
iajs-3307	258	6	;	;	PUNCT
iajs-3307	258	7	180	180	NUM
iajs-3307	258	8	,	,	PUNCT
iajs-3307	258	9	373	373	NUM
iajs-3307	258	10	-	-	SYM
iajs-3307	258	11	380	380	NUM
iajs-3307	258	12	.	.	PUNCT
iajs-3307	258	13	35	35	NUM
iajs-3307	258	14	.	.	PUNCT
iajs-3307	259	1	barartabar	barartabar	PROPN
iajs-3307	259	2	,	,	PUNCT
iajs-3307	259	3	z.	z.	PROPN
iajs-3307	259	4	;	;	PUNCT
iajs-3307	259	5	danesh	danesh	PROPN
iajs-3307	259	6	,	,	PUNCT
iajs-3307	259	7	h.	h.	PROPN
iajs-3307	259	8	;	;	PUNCT
iajs-3307	259	9	mazloomi	mazloomi	PROPN
iajs-3307	259	10	,	,	PUNCT
iajs-3307	259	11	s.	s.	PROPN
iajs-3307	259	12	;	;	PUNCT
iajs-3307	259	13	alizadeh	alizadeh	PROPN
iajs-3307	259	14	,	,	PUNCT
iajs-3307	259	15	n.	n.	NOUN
iajs-3307	259	16	;	;	PUNCT
iajs-3307	259	17	pilehvari	pilehvari	PROPN
iajs-3307	259	18	,	,	PUNCT
iajs-3307	259	19	s.	s.	PROPN
iajs-3307	259	20	association	association	PROPN
iajs-3307	259	21	of	of	ADP
iajs-3307	259	22	high	high	ADJ
iajs-3307	259	23	levels	level	NOUN
iajs-3307	259	24	of	of	ADP
iajs-3307	259	25	testosterone	testosterone	NOUN
iajs-3307	259	26	and	and	CCONJ
iajs-3307	259	27	ferritin	ferritin	VERB
iajs-3307	259	28	with	with	ADP
iajs-3307	259	29	overweight	overweight	NOUN
iajs-3307	259	30	in	in	ADP
iajs-3307	259	31	women	woman	NOUN
iajs-3307	259	32	with	with	ADP
iajs-3307	259	33	pcos	pcos	PROPN
iajs-3307	259	34	.	.	PUNCT
iajs-3307	260	1	j.	j.	PROPN
iajs-3307	260	2	adv	adv	PROPN
iajs-3307	260	3	.	.	PROPN
iajs-3307	260	4	biomed	biome	VERB
iajs-3307	260	5	.	.	PUNCT
iajs-3307	261	1	sci	sci	PROPN
iajs-3307	261	2	.	.	PROPN
iajs-3307	261	3	,	,	PUNCT
iajs-3307	261	4	2021	2021	NUM
iajs-3307	261	5	;	;	PUNCT
iajs-3307	261	6	11	11	NUM
iajs-3307	261	7	,	,	PUNCT
iajs-3307	261	8	3886	3886	NUM
iajs-3307	261	9	-	-	SYM
iajs-3307	261	10	3894	3894	NUM
iajs-3307	261	11	.	.	PUNCT
iajs-3307	262	1	36	36	NUM
iajs-3307	262	2	.	.	PUNCT
iajs-3307	263	1	rosenfield	rosenfield	VERB
iajs-3307	263	2	,	,	PUNCT
iajs-3307	263	3	r.l	r.l	PROPN
iajs-3307	263	4	.	.	PROPN
iajs-3307	263	5	;	;	PUNCT
iajs-3307	263	6	ehrmann	ehrmann	PROPN
iajs-3307	263	7	,	,	PUNCT
iajs-3307	263	8	d.a	d.a	PROPN
iajs-3307	263	9	.	.	PUNCT
iajs-3307	264	1	the	the	DET
iajs-3307	264	2	pathogenesis	pathogenesis	NOUN
iajs-3307	264	3	of	of	ADP
iajs-3307	264	4	polycystic	polycystic	ADJ
iajs-3307	264	5	ovary	ovary	ADJ
iajs-3307	264	6	syndrome	syndrome	NOUN
iajs-3307	264	7	(	(	PUNCT
iajs-3307	264	8	pcos	pcos	PROPN
iajs-3307	264	9	):	):	PUNCT
iajs-3307	264	10	the	the	DET
iajs-3307	264	11	hypothesis	hypothesis	NOUN
iajs-3307	264	12	of	of	ADP
iajs-3307	264	13	pcos	pcos	PROPN
iajs-3307	264	14	as	as	ADP
iajs-3307	264	15	functional	functional	ADJ
iajs-3307	264	16	ovarian	ovarian	ADJ
iajs-3307	264	17	hyperandrogenism	hyperandrogenism	NOUN
iajs-3307	264	18	revisited	revisit	VERB
iajs-3307	264	19	.	.	PUNCT
iajs-3307	265	1	endocr	endocr	PROPN
iajs-3307	265	2	.	.	PUNCT
iajs-3307	266	1	rev	rev	PROPN
iajs-3307	266	2	.	.	PROPN
iajs-3307	266	3	2016	2016	NUM
iajs-3307	266	4	;	;	PUNCT
iajs-3307	266	5	37	37	NUM
iajs-3307	266	6	,	,	PUNCT
iajs-3307	266	7	467	467	NUM
iajs-3307	266	8	-	-	SYM
iajs-3307	266	9	520	520	NUM
iajs-3307	266	10	.	.	PUNCT